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ABSTRACT
The role of cytochrome P-450 in me stimulation of lipid peroxidation induccd by thc
mycotoxin ochratoxin A (OTA) has been investigated. Purified cytochrome P-450 (liB I) could
effectively replace EDTA in stimulating lipid pefOxidation in a reconstituted system l'Onsisling of
phospholipid vesicles, NADPH-cYlochrome P-450rcduc!ase, FeJ+, EDTA and NADPll,
suggesting that it could mediate the transfer of electrons from NADPH to foc3,. Microsomcs
isolated from liven of cobalt protoporphyrin IX-treated rllts (in which cytochrome P-450 Wll"
depletedj underwent OTA-dependent lipid peroxidation much more slowly tlmn control
microsomes.
The role of cytochrome P-450 in OTA met.1bolism was also investigated. To dClermine
which cytochrome P·450 isoforms are involved in the metabolism ofOTA, we used different
cytochrome P-450 inducers to induce the major isofonns ofcytochrome 1'-450 in lhe rm liver.
Microsomes from these livers were used to investigate their effect on OTA metabolism.
Pretreatment ofmts with pregnenolone -16c(·carbonitrile (peN), phenobarbit.ll (PB), 3-ll1cthyl
cholanthrene (3MC), and isosafrole (ISF) greatly induced 4(R)-4-0H-OTA fonmllion; 4(5)-4-011-
OTA fonnation was also induced after pretreatment with PB, PCN, 3MC and ISr:. INII
pretreaunem primarily induced me 4(5) isomer formation, The fonnation of the 4(R) .md 4(5)
isomeri showed significant differences with respect to pH optima, effect of antioKidants ami iron
chelators, The 4(R) isomer fonnation showed a pH optimum of 6.0 using microsornes from rJIs
treated with 3MC and ISF, and 6.5 using mierosomes from rats treated with PI] :tnd peN and Wi!S
not inhibited by antioxidants or iron chelators. In contmst, both the 4(5) isomer fonmllion and
lipid pcroxidation showed a pH optimum of 7.0 - 7,5 and both activities were highly sensitive to
inhibition by antioxidants and iron ehelators. Lipid peroxides were no: involved in the 4(5) isomer
fonnation since addition of linoleic acid hydroperoxidc to microsomcs did not give rise 10 the 4(5)
isomer, Cytochrome P-450 appeared to be essenlial since other hemoprolcins such as horseradish
peroxidase and hemoglobin were ineffective in metabolizing OTA. Microsomes from rats
pretreated with Co-protoporphyrin IX resulted in no metabolil,rn of ochratoxin A. 7-Ethoxy- and
7-pentoxyresorufin assays showed specificity towards cytochromes P-450 induced by 3MC
(fA I/lA2) and PB (IIBI) respectively. Also, metyrapone (inhibitor of cytochrome P·450 IIBt)
preferentially inhibited OTA mel1bolism by microsomes from rats treated with PB, and
I(-naphthoflavone (inhibitor of cytochrome P-450 IAI/lA2) preferentially inhibited OTA
metabolism by microwmes from 3MC and ISF treated rats_ Monoclonal antibodies (MAbs) 1-7-1
(against P-450 lA 1/lA2) and 2-66-3 (against P-450 liB I) showed preferential inhibition ofOTA
metabolism by microsomes from 3MC and PB treated rats respectively.
Excretion of renal enzymes in urine is a sensitive non-invasive index of renal dam:lge.
Therefore. we examined the effect of cytochrome P-450 induction on the excretion of alkaline
phosphatase alld l$-glutamyl trallsfernse (t -aT) in a PB-treated tal group and a control rat group
(both groups received OrA). Atthe fourth day ofOTA treatmt:rl.t higher enzyme levels were found
in the control group compared to the PB group. The results pmvide evidence for the stimulatory
role or cytochrome P-450 in OTA-induced lipid peroxidation. Also, our data suggest th1ll4(R)-4-
OH-OTA is formed by nonml mixed function oxidation bUlthat 4(S)-4..QH·OTA formation may
involve free iroll. Also, our results show that the major cylClchrome P-450 isofonns catalyzing
OTA hydroxylation ure IA l/IA 2 (3MC and rSF). IID I (PB) ami lIlA l/lllA2 (PeN). The results
from ill vivo experiments suggest a protective effect of PB a,gainst OTA toxicity (through inducing
cytochrome P-450, thus metabolizing more otA and excreting it faster from the body compared to
controls). This was also evident from in vivo experiments of PHIOTA distribution. Therefore,
OTA hydroxylation is more likely to be n detoxification pathway.
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CHAPTER 1
INTRODUCTION
J,I OCIIRATOXIN A
I,Ll Natural Occurrence and human exposure
Ochratoxin A (OTA) is a mycotoxin produced by some species of the fungal genera
~and~. It was first reported in 1965 by De Scott (1965) as the toxic
metabolite in a culture medium of~~wilh. OTA was chemically
characterized by Va!" der Merwe et al. (l965a,b) and Steyn and Holzapfel (1967). It
consists of a 5'·chloro-8-hydrolty-3,4-dihydro-3-methyl isocoumarin moiety linked by an
amide bond to L-B-phenylalanine (Figure I). The toltigenic molds known to produce the
toxin are the following species:
Aspergillusspecit':s
8..~
A.ll>liJInll>
A._
A.1l<IIilkii
A._
A. ilIIohlIrw
Penicillium species
f.>CililIi<nlwn
f.~
f.<llJIllIlllllJO
f.1lJlliIan>
f. Illlll!llI=W
f._
The occurrence of OTA in food and feed is widespread (Krogh and Nesheim,
1982). II is present as a contaminant in plant products, especially, cereals, beans and
peanuts (Kurala, 1978). OTA is also found in meat, dried fish (Ueno, 1985a) as well as in
the kidneys, liver and blood of slaughtered pigs (Huh et aI., 1980). Scott el at. (1972)
detected OTA in concentrations of up to 27 ~glgm in 18 out of 29 samples of heated grain
from Saskatchewan fanns in Canada. In a recent analysis of 1200 blood samples obtained
from pigs slaughtered in Western Canada, Marquardt et al. (1988) found Ihat76% of the
samples hnddelcctable levels ofOTA and 11.3% had OTA levels of> 10 nglrnL with the
highest being 229 ng/mL. The World Health Organization (WHO) recently reviewed OTA.
and in theirrcpon they summarized the: occwrc:nce ofOTA in food and anim.,t feed ofplnm
origin around the world (WHO, 1990). Among the highestle:vels ofOTA were those
samples listed in Table 1.
Residues ofOTA are not generally found in ruminants, because OTA is c1e:llved in
their forestomachs by protozoan and bacterial enzymes (Galtier and Alvinerie, 1976; Hult et
aI., 1976); the non·toxic hydrolytic cleavage product is ochrmoxin n(ochmloxin A without
the phenylalanine moiety). When two milking cows were fed a ration conmining 317-1125
~gOTA/kgbody weight for II weeks, a residue of 511S0TAlkg was found in the kidneys
of one of the animals but not in any other tissue or the milk. Qchrnloxin II wa.~ nol found in
any tissue (Shreeve et aI., 1979). Residues ofOTA have been detected in a number of
tissues in single-stomached animals such as pigs (Huh et al., (980). OTA is also present
in the blood because it binds \0 serum albumin (Chu, 1971; Gallier, 1974). The incidence
ofOTA in meat and meat prodUCIS has been reviewed by Marquanltet at (1990) (ruble 2).
Human exposure occurs through the direct consumption of contamimucd food
(mainly cereals) aneVor meal from anim,lls Ihat reL.'lin orA in their tissues after being red
contaminated feed (see diagtam, Figure 2). OTA levels in humans were reported in a
review by Kuiper-Goodman and Scott (1989) (fable 3).
1.1.2 Stability of OTA and dfccts of food processing
UfA is moderately stable, even on healing, in such food as wheat, pork und beans.
However, levels of OTA added to ground green coffee beans were reduced 87% on
roasting for 20 min at 2000c (Levi et aI., 1974). Tsubouchi et al. (1987) found thut after
Inoculation withA.~, roasting green coffee beans for 20 min at 2lXJOC reduced the
concentration ofOTA by a maximum of only 12% in whole beans and 18·22% in ground
beans. They concluded that the mode of OTA contamination wa.~ the reason for Ihis greater
heat resistance. Cleaning and milling of wheat and barley did not remove aTA in naturally
contaminated samples, and levels in flour Bnd bran were the same (Chelkowski et aI.,
1981). There was. however, a marked reduction of orA levels in pearlcd barley compared
to those in bran (Chelkowski et al., 1981). Cooking of polished wheat by an Egyptian
method destroyed only 6% of added OTA, and during cooking of faba beans by two
methods the average destruction was 16% and 20% (EI-Banna and SCOll, 1984).
1.1.3 Toxicity
OTA is known to be highly toxic to animals (Van der Merwe et al.. 1965 8;
Purchase and Theron, 1968; Peckham et aI., 1971 and Szczech et al., 1973). The main
pathological changes associated with aTA toxicity arc primarily damage 10 the kidney and
to a lesser extent damage to the liver (Harwig, 1974 and Krogh. 1978). Alterations in a
variety of biochemical and immunological paramelers have also been observed following
OTA adminiSlrlltion (Berndt et aI., 1980; Meisner and Meisner, 1981; Haubeck et at.,
1981; and Kane et aI., 1986). The changes in renal function in OTA~cxposed rats and pigs
are characterized by polyuria, glucosuria, proteinuria and an increase in blood urea
nitrogen, and a decrease in urine osmolarity and glomerular filtration rate (Berndl et aI.,
1980). Kane et al. (1986) observed a good correlation betwc<:n the increase in urinary
excretion o~glutamyl transferase, alkaline phosphatase and leucine aminopeptidase and a
decrease in renaillctivities of these same enzymes within a week of the oral administration
of 145 JlgOTMg body weight for 12 weeks.
An inhibition oftenal gluconcogenesis was also observed in kidney-conex slices
from rats which had been fed with 2 mg OTAlkg body weight for 2 days (Meisner and
Selanik, 1979) moSt probably because renal phosphoenolpyruvate carboxykinase was
inhibited (Meisner and Meisner. 1981). After the daily administmtion of OTA (5 mg/kg)
for 3 days to rats, Suzuki ela!. (1975) observed a 60% decrease in hepatic glycogen levels
and a concomilant increase in serum glucose, and blood and liver lactate Icvels. Latcr,
Subrnmanian et al. (1989) showed Ihat OTA drastically depleled liver glycogcn. increascd
blood glucose level and lowered serum insulin level ill rats. The/ concluded that OTA is
diabetogenic in nature, and exens its effect by reducing the level of insulin. thereby
suppressing glycogenesis and enhancing glycogenolysis. Administl1uion ofOTA to mice
inhibited protein synthesis, the degree of inhibition 5 hr after administration of I Illg
OTA/kg body weight being 26% in liver, 68% in kidney and 75% in spleen (Crcppy cIIII..
1984). Phenylalanine (100 mg/kg body wcight) injccted together with OTA (10 lI1g/kg
body weight) prevented the inhibition of protein syathesis in ull of thcse organs (Crcp!'y Cl
aI., 1984). OTA is thought to inhibit protein synthesis through its cornlletition Wilh
phenylalanine in the reacdon catalyzed by phenylalanyl t-RNA synthetase (Creppy Cllll..
1984). Interestingly, babies born with phenylketonuria are less susceptible teOTA toxicity
because of theirelev3ted level of phenylalanine (Woolf, 1986). OrA was shown 10 inhibit
Tat liver mitochondrial respiration by acting as a competitive inhibitor of carrier proteins
located in the inner mitochondrial membrane (Meisner and Chan, 1974; Wei ct aI., 1985).
TheLD50valuesofOTA in various speeiesare listed in Table 4 (WHO, 1990).
1.1.4 Teratogenicity
OTA is a potent teratogen in mice, rats and hamslers. OTA injected
intraperitoneally in pregnant mice at 5 mglkg body weight on onc of gestation days 7·12
resulted in increased prenatal monality, decreased fetal weight, and various malfonn:llions,
including exencephalyand anomalies of the eyes, face, digits and lail (Hayes et aI., 1974).
When lats were treated orally with OTA at 0.25.0.50,0.75, 1,2,4 or 8 rng/kg body
weight on gestation days 6·15, matemal toxicity was not observed below 4 mg/kg body
weight, but an increased incidence of felal resorptions wus observed above O.5() mgtkg
body weight (Brown et aI., 1976). Subcutaneous administration of OTA (1.75 mglkg
body weight) on gestation days 5-7 resulted in the highest number of malfonnations,
including hydrocephaly, omphalcx:eJe and anophthalmia, as well as a shift in position of the
oesophagus (Mayuro et al., 1982). Increased prenatal monality and malfonnations,
including hydrocephaly, micrognathia, and heart defects were observed in hamsters
injected intraperitoneally with OTA at doses of 5-20 mg/lcg body weight on one of gestation
days 7-9 (Hood ct a!', 1976).
1.1.5 Immunoloxlclty
In chickens fed 2-4 ppm OTA in the diet for 20 days thcre was a depression of IgO,
IgA lind IgM in lymphoid tissues and serum (Dwivedi and Bums, 1984). OTA in the
concentration mnge studied (20·1667 ~moVL) caused a 47-50% inhibition of macrophage
migration (Klinken et al.. 1981): this effect could be prevented by the simultaneous
addition of phenylalanine to the medium. In Balb/e mice, a dose of OTA as low as 0.005
I1g/1cg was able to suppress the immune response to sheep red blood cells (Haubeek et at.,
1981). In the standard plaque counting assay for the estimation of antibody-producing
spleen lymphocytes OTA (I Ilg/kg body weight) given once intraperitoneally to Balb/e
mice, R-12 weeks of age, had an immunosuppressive effect on both IgM and IgO
rcsponses to a single injection of sheep red blood cells (Creppy et aI., 1982). The
immunosuppressive effects of OTA could be prevented by the intraperitoneal administration
of phenylalanine at 10 Ilg/kg body weight (Haubeck et aI., 1981 and Creppy et ai., 1982).
11IOS, the immunosuppressive action of OTA could be due to its action on protein
synthesis. When female 86C3FI mice were administered ochratoxin A 6 times during 12
days in amounts of 0.34, 6.7, or 13.4 mg/lcg body weight (total dosage), the natural killer
CCllllctivity was inhibited at all dose levels, and the growth of tt'ansplantable tumour cells
was increased without affecting T-cell or macrophage-mediated antimmour activity.
Ochratox.in B did not innuencc immune function at 13.4 mw'kg body weight administered 6
times during 6 days (Luster I:t aI., 1987). The inhibition by OTA of natuml killer cell
activity appeared to be caused by reduced production of basal interfcron. Bec:lUSC natuml
killer cells are involved in the destruction of tumour cells, the ability ofOTA 10 modul:ue
the activity of these cells might contribute to its capacity to induce renal lind hcpmic
carcinomas. Lea et al. (1989) reponef!thal OTA has a potent inhibitory effcct both at the
level of Band T lymphocytes.
1.1.6 Carcinogenicity and mutagenicity
Kanisawa and Suzuki (1978) reponed renal and hepatic tumors in male ddY mice "fter
they were fed a diet containing 40 mg OTAlkg for 45 weeks. Dietary fceding ofOTA (40
mg/kg diet for 20 months) has also been shown to induce ren,,1 ndenomas :llld
hepatocellular carcinomas in mice (Bendele et aI., 1985). It WllS quoted thai ochnlloxin A
is one of the most potent toxic carcinogens ever tested by the National Toxicology I'rob'Tllm
(Dietrich and Swenberg, 1993). In that extensive carcinogenicity study by the Naliomtl
Toxicology Program, orA administered by gastric intubation in com oil:lt levels of70 and
210 ~g/kg body weight/day for 24 months induced high incidences of renal cell curcinoma
of a clearly malignant nature in rotS (Doonnan, 1988). OTA has also becn associated wilh
Balkan endemic nephropathy (BEN), a disease that affects residents of l,:crtain regions of
Bulgaria, Romania and Yugoslavia where OTA contaminates their crops (Krogh, 1974).
In these infected areas, OTA was isolated from the sera of residents and those who hlld
high OTA levels also (often) had urinary tract tumors and BEN (Hult et al., 19112a,b and
Pctkova-Bocharova el aI., 1(88). Creppy et al.(l985) showed that OTA administration
induced single strand breaks in DNA in liver, kidney and spleen, and they suggestcd that
OTA is weakly genotoxic to mammalian cells. OTA has been tested for mutagenicity in a
variety of Salnwnella typllimuriW1l strains, with and without metabolic activation, and
results were negative (Wehner et aI., 1978; Bansch el aI., 1980). Recently, ilfter
incubation with cultured hepatocytes for 24 hours, orA was shown to be mutagenic to
Salmnnella ryphimurium in a cell·free cultW'C medium (Henniget at, 1991).
l.l.? Absorption, distribution and metabolism
Small intestine is thought to be the primary site of ochratoxin A absorption. When
OTA was injected into the lumen of the stomach, the small intestine, cecum or colon of
male Wistar rats, the highest absorption was in the proximal jejunum (Kumagai and Aibara,
1982). When OTA was given orally to mice. the site of highest absorption was the
duodenum (lee et at. 1984). In the latter study. immunohistochemical staining revealed
that the highest concentration of OTA was in the intestine with decreasing levels in the
kidney and liver (Lee et aI., 1984).
Gahler et at (1979) studied the phannacokinetic profile of ochratoxin A using
114CJOTA injected intravenously to mts. Six hours after injection, 24% of the administered
dose was in the plasma, 12% in muscle, 11.1% in skin, 2.63% in the liver and 0.64% in
the kidneys. Per gram of tissue, the concentration of OTA was higher in the kidneys than
in the liver. The stomach, small intestine, cecum and large intestine contained 0.34%,
2.14%,0.66% and 0.57% of the administered dose, respectively. The contents of the
stom3ch, small intestine, r:ecum and large intestine contained 0.33%, 4.02%, 4.02% and
1.87% of the administered dose respectively.
A number of studies have shown that, in the presence of NADPH, OTA is
metabolized by liver microsomes from several species (rat. pig and hum3n) primarily to
4(R)-4.QH·OTA, and to a small:r extent to the epimeric 4(S)·4·0H-OTA (Stonneret aI.,
1981,1983; Veno. 1985; Osteret aI., 1991; Hietanen et al., 1986). OTA metabolism has
also been shown to be induced by PB and/or 3MC in Wistarrats (Stonner and Pedersen,
1980), DA and Lewis rats (Hietanen et aI., 1986) and in rats of unidentified strain (IJeno,
1985).
1.1.8 Mechanisms of ochratoxin A toxicity
The mechanism by which ochratoxin A exerts its toxic effects is not known yet. In
a recent review by Marquardt and Frohlich (1992), thrce potcntial mechanisms of
ochratoxicosis were recogniz-~ which involved effects of OTA on the enl,Ymcs involved in
phenylalanine metabolim, effects on lipid peroxidation, and effects on mitochondrial
function.
Ochratoxin A affects DNA, RNA, and protein synthesis in nlilny different
organisms (Meisner and Meisner, 1981; Creppy et aI., 1983a.b, 1986; Meisner et ill ..
1983; Roschenthaler et al.. 1984; Meisner and Krogh. 1986: Meisner and Polsinclli,
1986), presumably due to an effect by the phenylalMine moiety ofOTA. Administr.ttion of
OTA to mice inhibited protein synthesis: the degree of inhibition 5 hr after administration of
1 rog OTNkg body weight was 26% in liver, 68% in kidney and 75% in spleen (Crcppy ct
aI., 1984). Phenylalanine (100 mg/kg body weight) injected together with ochratoxin A
(to mglkg body weight) prevented the inhibilion of protein synthesis in all ofthcsc organs
(Creppy et at, 1984). OTA is thought to inhibit protein synthesis through competition
with phenylalanine in the reaction catalyzed by phenylalanylt-RNA synthetase. OTA also
inhibited phenylalanine hydroxylase (Creppy et aI., 1990). Ochratoxin a (OTA without the
phenylalanine moiety), in contrast, was not effective. which indicates the imporlance of
phenylalanine for the inhibition. The blockage of phenylalanine hydroxylase activity could
produce phenylketonuria-like effects, including an enhanced production ofphenylpyruv'lIc
and phenylaeetate (Creppy et aI., 1990)
Rahimtula et at. (1988) have demonstrated Ih:1I when adminislered to rats in villo or
when added 10 liver or kidney microsomes in vitro, OTA greatly enhanced lipid
peroxidation (Rahimtula et aI., 1988). In a subsequent study (Omar et aI., 1990) using a
reconstituted microsomal lipid peroxidation system consisling of microsomal phospholipid.
the flavoprotein NADPH cytochrome P-450 reductase (Fp) and iron ions. we demonstr.ttcd
that UTA induced lipid pcroltidation bychclating Felt, that the resulting OTA-feli' chelate
was readily reducible by Ihe flavoprotein NADPH cytochrome P-450 reductase to the
OTA-Fe2+ complex. The laller in the presence of oltygen provided the active species that
initiated lipid peroxidation. Using electron spin resonance, the production of the extremely
toxic hydroxyl radicals by the Fe'+ complex of OTA in the presence of the NADPH-
cytochrome P-450 reductase system was also demonstrated (Hasinoff et aI., 1990). Khan
et al. (1989) have shown that OTA-stimulated lipid pcroltidalion is also accompanied by Ihe
leakage of calcium from calcium-loaded microsomes. Lipid peroxidation may be an
important process in heplliotoxicity, which results in Slructural changc.s in the cell
membrane sufficient to allow an influx of extracellular calcium to cause changes in
metabolic I\clivity within the cell (Orrenius and Bellomo, 1986). Aleoet al. (1991) have
reponed thoU OTA stimulated lipid peroxidation in isolated nil renal proximal tubules.
Because mitochondrial toxicity was not changed by the iron chelatOl" desferal, they
suggested that OTA toxicity in the proximal tubules (indic;ued by increased lactate
dehydrogenase release and decreased ATP production) was prinurily related to inhibition
of mitoehondri:a.1 function 31id not 10 iron-mediated lipid peroxidation. OTA toxicity to the
mitochondria is discussed funher below. The laller study, however, did not conclusively
rule out the imponance of lipid peroxidation, and the role of lipid peroxidation in the
toxicity ofOTA remains to be detennined.
Ochratoxin A has been shown to inhibit the respiration of whole mitochondria by
llcting liS a competitive inhibitor of carrier proteins located in Ihe inner mitochondrial
membrane (Meisner and Chan, 1974; Wei et aI., 1985). Meisner (l976) has shown that
the uptake of OTA by mitochondria resulted in intramilochondrial ATP depletion. He also
showed that OTA inhibited intramitochondri:a.1 phosph:a.te transport, resulting in
dcteriOTalion of the mitochondria. The f:a.ilure of OTA 10 deplete ATP in Tat hepatocyles
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observed by Creppy et al. (1990), and the ability of 011(, which is non-loxic. 10 inhibit
mitochondrial respiration more effectively than OTA (Moore and Truelove, 1970) would
suggest that mitochondrial effects probably did not contribute to the toxic effects of OTA.
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1.2 LIPID PEROXIDATION
1.2.1 Definition
In clikaryotcs, membrane fluidity is maintained by the incorporation of
polyunsaturated fatty acid (PUFA) chains into membrane lipids. Most of th~ PUPA
chains oa:ur on the 2·C position of the glycerol moiety of phospholipids. paHicularly
phosphatidylcholine :md phosphalidylethanolamine. although some also occur in neutral
lipids. In Ihe membmncs oCral liver microsomes, the most abundant PUFAs (expressed as
percentage of total fatly llcids) are: arachidonic acid (17%), linoleic acid (10%),
docosahexanoic acid (5%) and linolenic acid (5%) (Honon and Fairhurst. 1987). In these
acids lhe presence of an lldjacent double bond weakens the carbon-hydrogen bonds. These
allylic hydrogens can be abstracted by reactive species containing one or more unpaired
electrons (free radicals). The lipid radical thus fonned will then react with molecular
ollygen, and the ensuing chain reaction results in the breakdown of the PUFA. This
reaction sequence is known as lipid perollidalion. Lipid peroxidation propagates by
reaction between a radical molecule and a non-radical molecule and terminates when two
radicals react with each (Miler. The reactions of lipid peroxldation may be categorized into
three main steps: I) initiation, 2) propagation and 3) tennination (Figure 3).
1.2.2 Measuremenl
The products of lipid peroxidation include lipid epoxides, hydroperoxides, epoxy
alcohols, and the short·ch3in compounds such as malondialdehyde (MDA), ethane.
pentane, and 4-h}'droxy alkenals (Dahle et aI., 1962; Dillard et al.. 1977; Hafeman and
Hoekstra. 1977; Benedetti et aI., 1980). Lipid peroxidation has been measured by the
detection of conjugated dicnes fonned during the early phase of the peroxidation reaction
sequence (Corongiu and Mili:t. 1983; Recknagel:md Glende, 1984), aod less commonly
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by measurement of lipid hydroperoxides (Calheart et al., 1983; Pryor and Castle. 1984),
The most common procedures are based on the measurement of Ihe pnxlUCIS of lipid
hydroperoxide breakdown such as malondialdehyde (MDA). 1l1is is the most widely usro
method because of its simplicity and sensitivity, lU'Id MDA h:ls been commonly detCCted by
the thiobarbiluric acid (TBA) reaction (Niehaus and Samuelsson. 1968; May and McCay,
1968; Frankel and Neff, 1983; Csallany et at. 1984). In addition. lipid pcroxid:l1ion has
been assayed recently by the evolution ofshort-chllin 1Ilknnes (ethane and pent:lIIe) both in
vivo nnd in vitro (Lnwrcnce and Cohen, 1982; Kappus lind Muliawan, 1982; Kunel1 lind
Tappet, 1983; MullcTllnd Sics, 1984).
1.1.3 Enzymatic lipid pcroxldation systems
Enzymatically induced microsomal lipid peroxidalion was first described by
Hochstein and Ernster in 1963. who demonstrated Ihe requirement for rc:duced
nicotinamide adenine dinucleotide phosphate (NADPH) and adcnosine S'-diphosphate
(ADP) and the enzymatic nalUn: of the process (Hochstein and crnstcr, 1963). In a
subsequent study, they showed the neeessity for iron (Hochslein et aI., 1964) which had
been a contaminant of their original ADP solulions. utcr, Pedcrson and Aust (1912)
characlerized the enzymatic nature of lipid peroxidation funher by demonstrating that
NADPH-cylochrome P-4S0 reductase (Fp) was the enz.yme linking NADPH oxidation 10
the ADP-Fe3+-dependenl peroxidation of microsomal membranes (Pederson nnd AUM,
1972). They also developed a reconstituted lipid peroxidalion syslcm con~isting of
phospholipid vesicles (Iiposomes), purified Fp, ferric chelalCS and NADPH. In lhelr
reconstituted system, a second ferric chelate, EDTA-Fel+ (in addition 10 ADP-Fel+) wal;
also required (Pederson and Aust, 1972). Therefore, they suggested thatlhere may be a
microsomal component(s) that directly reduces ADP-Fel + (for which EDTA-Fel+ can
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substitute) in the reconstituted lipid peroxid31ion system. Later, Morehouse and Ausl
(1988) demonstrated that when cytochrome P·450 was incorporated into phospholipid
vesicles, EDTA· Fe3.. was not required suggesting Ihal cytochrome P·450 may be the
endogenous component replacing EDTA-Fe3+.
1.2.4 Initiation
Lipid peroxidntion is sometimes a major cause of cellular injury in organisms
subjected 10 oxidative stress (reviewed Comporti. 1985; Sics, 1985; Poli et al.. 1987).
Surprisingly little is knOWll about the chemistry of initiation of peroxidation in membmne
systems such as liposomes or microsomes. and the nature of the free radical species
responsible for the initiation ofimn-der:ndent lipid peroxidation has been the subject of
consid~rabledebale, The principal candidates suggested for Ihis role are the hydroxyl
radical (·OH) and Ihe ferrous dioxygen complex (FeZ+·-Oz, perferryl ion). The hydroxyl
radical is an extremely reactive species. reacting very rapidly with most organic molecules,
Hydroxyl radicals can be fanned via the Fenton reaction as follows:
Fe2+ + H202 ••....> Fe3+ + OH' + .QH
The superoxide radical (02") is produced at a number of intracellular sites (Fridovich,
1974; Mishin et al.. 1976; Chance et aI., 1979) and H202 can then be fanned readily from
the nonenzymic or superoxide dismutase·caUllyzed dismutation of Oz·, (Chance et aI.,
1979). Subsequently, chelated iron can yield .QH in the Femon reaction as above. An
alternative hypothesis is that ferrous ion. in undergoing autoxidation to ferric ion, passes
through Fe2+··02 and Fe3+··02·· as intermediates. Upon the discovery of ADP·FeJ+-
initiated microsomal lipid peroKidation, Hochstein and Ernster (1964) postulated the
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involvement of an ADP-Fc2t----02 complex. Aust's group ha!\ also pursued the idea thm llll
ADP-ferrous dioxygen complex initiates lipid peroxid3tion (Svingen et aI., 1978; Ails! lind
Svingen. 1982). The involvement of a ferrous dioxygen complex has been criticized ollihe
grounds that the complex is insufficiently reactive townrds PUFA (Halliwell and
Guueridge. 1985). The highly reactive hydroxyl radical can often be detected in
microsomal or Iiposomallipid peroxidalion systems (Guttcridgc. 1982; Morehollse CI aI.,
1983; GUlIcridge, 1984; Beloqui and Cederbaum, 1986). The hydroxyl radical is known
10 be capable of initiating lipid perollid:uion by abstnlcting a hydrogen atom fmm fUlly ncids
(Barber and Thomas, 1978; O'Connell and Gamer, 1983). 1-I20rdcgrndingcnz)'mcs or
scavengers of .QH. however. rarely inhibit iron-dependent pcroxidmion in microsomal or
liposomnl systems (Gutteridge. 1982; Morehouse et al.. 1983; Gllttcridgc. 1984; Bdoqui
and Cederbaum. 1986). It has been proposed that the fcrryl ion (see below) is the true
Fenton reagent, rather than .QH, and this would not be scavenged by conventional ·01-1
scavengers (Fee. 1981; Koppenol, 1981).
Fe'2.+ + H'2.0'2. --\> Fe3+-0H --\"> [Fe3+-0' <_••_> Fe'2.+-01 i;> Fe2+ + Oil
OH· H+ ferry1 ion H+
Superoxide rddieals may playa minor role in initiating lipid pcroxidation under conditions
in which they act to reduce Fe)+ to Fe2+ (Gutteridge 1977; Tien et al .• 19KI). Recently.
Minotti and Aust (Minotti and Aust, 19870. and b) have proposed that a specific Fe2t-02-
Fe3+ complex. or at least a 1:1 ratio of Fe2+ to Fe3.... acts as an initiator of peroxidation in
Iiposomal and microsomal systems, but some doubts have been raised about this complex
as a specific initiator of peroxidation. Attempts to isolate such a complex have failed
(Minotti and Aust. 19870.; Aust, 1988). The Fe2+/Fe3+ ratios required for maximal
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Slimulalion of peroxidalion have been reponed 10 vary from 1:1 10 1;7 in different
experiments (Braughler cl ai., 1986), perhaps suggesting that a specific sioichiomc:uic
complclt is not required. It must be cooc1uded that the identity of the initialing species of
lipid peroxidation produced by ferrous iron is still an open question.
1.2.5 Cellular toxicity
Membrane lipid pero)l;idation is an important pan ofoxidative tissue injury and can
be an effect as well as a cause of reactions culminating in cylOloxicity (Halllwcll and
Guueridgc, 1986). The peroxidalive breakdown of PUFA has been implicated in the
pathogenesis of many types of injury and especially in the hepatic damage induced by
several toxic substances. Among these toxic substances are the haloalkanes. carbon
Ictrnchloride (Componi. 1965; Slater, 1972), trichlorobromomclhane (Slater, 1972; Sillter,
1982), chlorofonn (Ekstrom and Hogberg, 1980), 1,2·dibromomethane (Albano et aI.,
1984) and halothane (Tomasi et OIl., 1983). In addition, paracetamol (Wendel and
Feuerstein, 1981), bromobenzene (Casini et 'tl., 1985), iron (Halliwell, 1981), bipyridyl
compounds (Sandy et aI., 1986), allyl alcohol (Jaesc:hke er ai., 1987) and in some
inst:mees, ethanol (Dianzani and Torrielli, 1981; Sics, 1985; Dianzani, 1985) have been
shown to stimulatc lipid peroxidalion. Thc peroxidation of PUFA within biological
membranes results in a complex series of biochcmical and biophysical events which lead to
inactivation of enzymatic funclions in several subcellular organelles (Componi, 1965;
Sinter, 1972; Dianlllni and Ugazio, 1978; Vladimirov et al., 1980; Recknage1 el al., 1982).
These alterations include changes in the physical properties of the lipid bilayer, reactions
bctween acylperoxyl radicals and membrane proteins, and the formation of reactive
prodUCIS originating from the degradation of peroxidized fatl)' acids (Dianzani and Ugazio,
1978; Vhtdimirov et aI., 1980: Recknage1 et al., 1982).
The stimulation of lipid peroxidarion in either artificial membranes of liposomes or
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in subcellular organelles has been shown to increase membrane rigidit), (Cunis ct al.. )9R4;
Bruch and Thayer, 1983). Such a loss of fluidity docs nOI seem to be dependent upon nn
increase in the ratio between cholesterol ,md phospholipids (Curtis c! aI., 19R4), hut is
ralher an effect of the formation of cross-linking between acyl chains (Eichenberg ct :11.,
1982) and of the depiction of long chain PUFA (Curtis et at, 19R4). In addition to Ihe
changes in fluidity, lipid peroxidation causes an increase in the ionic penllcability. and
affects the surface potentials of the membranes (Vladimirov el aI., IlJRO). In the liver, the
membranes of the mitochondria and endoplasmic reticulum contain ullsaturated fally llcids
in high proportion, lind therefore arc vulnerable to peroxid:ltive Httack. At the samc timc
they contain enzymcs of the electron transport systems which make them cllpable of
producing free radical species (Componi, 1965; Slater, 1972; Vladimirov Cl HI., 19MU;
Recknagel et aI., 1982). The consequences for the cell of lipid pcroxidation reactions and
products are many. Microsomal membranes undergoing pero:'tid:uion ill vitro show
fragmentation and turbidity changes, destruclion of cytochrome P·450 (Hogberg et aI.,
1973), and 1055 of latency and activity of glucose·6·phosphatc and UDP-glucuronyl
transferase (Hogberg et aI., 1973; Ferrali et aI., 1980; de Groot ct aI., 1985). The plasma
membrane Ca2+-ATPase is inactivated becnuse of the oxidation of essential suln'ydryl
groups in the enzyme (Jones el aI., 1983), resulting in defectivc control of cytosolic
calcium. Ribosomes become detached from the endoplasmic reticulum during lipid
peroxidation (Palmer el aI., 1978). In mitochondria, peroxidtuion causes membrane
swelling, deterioration of electron transport, and organelle lysis (Hunter Cl al., 1903;
Narabayashi et at, 1982). Lipid peroxidation of Iysosomes causcs lysis and cn7.yme
release (Wills and Wilkinson, 1966; Fong ct al., 1973), and the erythrocyte plasmH
membrane responds in a similar manner (Brownlee et at, 1971).
Like OTA, cephaloridine, a beta-Iactam antibiotic of the cephalosporin type, causes
renal injury in man and in animals. affecting the ptoximallUbules {i\tkinwn el "I., 19C16;
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Silverblatt et al., 1970). Of the several biochemical mechanisms proposed to explain the
nephrotoxic effects of cephaloridine (rune and Fravert, 1980; Kuo et aI., 1983; Goldstein
et ai" 1986), the most recent hypothesis suggests an involvement of lipid peroxidation
(Kuo et al., 1983; Cojocel et aI.• 1985a). Furthennore, recent studies showed that the
(annalian of cephaloridine-induced reactive oxygen species and peroxidation of renal
conical membrane lipids was inhibited by radical scavengen and Rnlioxidants (Cojocel,
1985h: Goldstein et aI.• 1986).
18
1.3 Cylochrome P-4S0
1.3.1 Background and role in xcnobiotic metabolism
The carbon monoxide-binding pigments of liver microsomes nrc hemoprolcins Iltut
have a characteristic absorption maximum ncar 450 nm, Rod hence are called cylochromcs
P-4S0. The cytochromes P-450 enzymes comprise a family of hcmoprolcins with lIll
identical prosthetic group (a thiolatc-bound heme), but widely different apoprotein
structures which are responsible for the different substrate specificities of reactions in
which they are involved. Many families of cytochrome P-450 have been described
including l.t:~ in mammals, two in insects, one in SOlli!, one in plun!s ilf'.lI six in bacteria
(Gonzalez. 1992). The ten mammalian cytochrome P·4S0 families can be fUllctionlllly sub-
divided into two major classes; those involved in synthesis of steroids nnd bile acids
(families 7, 11, 17, 19,21 and 27) and those thai primarily metnbolize xenobiotics
(families 1, 2, 3 and 4) (Gonzalez, 1992), Xenobiotie-mclabolizing cytochroll1cS 1~-450
probably evolved from the cytochromes P-450 involved in steroid synthesis. lmd then
began to oxidatively degrade dietary chemicals which were easily eliminated from animals
only after they were convened to more hydrophilic derivatives, The cytochromcs P·450
are tenninal oxidoreductases of the microsomal, nuclear membrane, mitochondriul and
soluble monooxygenases, Microsomal cytochromes P·450 catalyze the mctilbolisrn of a
wide variety of endogenous tlnd exogenous compounds including drugs. steroids,
prostaglandins, chemical carcinogens and other xenobiotics (Guengerich, 1!1){); Wislocki ct
aI., 1980). They catalyze the incorporation of one atom of molecular oxygen into the
substratc to give a product, while the other oxygen atom is rcduced by two electrons to give
water. Although these enzymes play an imponanl role in the dctoxiflcation of many drugs.
chemical carcinogens, and other toxic agents, they are also responsible for clllalyzing the
metabolic activation of some compounds to highly reactivc intenncdiatcs which then rcact
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wilhcritical ccllularmacromolecules and initiate toxic and carcinogenic events (Gucngerich,
1991). The critical role these enzymes play, in the metabolic activation and detoxification
of 11 wide variety of carcinogens and other toxic agents, makes them of particular
imponnnce in light of human exposure to these compounds in the environment. The
microsomal cytochrome P-450·dependcnI mixed function oxidase enzyme system is
composed of NADPH-cytochrome P·450 reductase, phospholipids. and cylochromes p.
450, and for catalytic activity it exhibits an absolute requirement for NADPH and 02
(Gucngcrich, 1990 and 1991; Wislocki et aI., 1980).
cytochrome P-450
RH + 02 + NADPH + H+ .--.----•••-••--••--.--.--.> R-OH + H20 + NADP"
reductase
The ctuulytic cycle for cytochrome P-450-catalyzed reactions is thought to consist of
at least six discrete renctions (Hollenberg, 1992) (see Figure 4). The first step involves
binding of the substrate to the ferric form of the enzyme. The second step involves the
transfer of one electron from the NADPH-cytcr.hrome P-450 reductase to the iron of the
ferric cytochrome P·450 enzyme!O give a ferrous enzyme-substrate complex. The reduced
cytochrome P-450-substrate complex then binds 02 to form a ferrous enzyme-02-substfate
ternary complex with the 02 bound 10 the iron. The addition of a second electron tl') this
ternary complex by the reductase results in the formation of an iron peroxo species, best
represented tiS FeJ~02'2·. The next step involves cleavage of the oxygen-oxygen bond.
One of the oxygens is released with the uptake of two protons, resulting in the formation of
w:llcr. The rel:lincd oxygen remains nssociated with the heme iron as nn activated oxygen.
The :lctiv:llcd oxygen atom associated with the iron is then inserted into the substrate,
resulting in a two·electron oxidation of the substrate to the alcohol (ie. hydroxylated
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substrate),
1.3.2 Induction
Some cytochrome P-450 isozymes are expressed constitutively, while olhers nrc
expressed only in response [0 specific chemical stimuli (see Table 5). Exmnplcs of such
chemical stimuli (inducers) arc polycyclic aromatic compounds (e,.g, 3-
methylcholanthrene), b3rbiturates (e.g. phenobarbital), :and steroids (e.g. pregnenolone
16«:-carbonitrile) (more inducers and references to them nre given in the Methods section
2.5.1). After induction, the activity of panicular isofonns increases and the conccnlr.lIiol1
of total cytochrome P·450 may increase. Elevated levels of cytochrome 1'-450 lIre the
result of multiple mechanisms (Monastory et aI., 1992). The major mechanism is
increased transcription of cytochrome P·450 genes (higher levels of specific mRNAs <Ire
detectable soon after treatment with some inducers of cytochrome P-450). A second
mechanism is message stabilization and enhancerltrnnsport ofmRNA from the nucleus to
the cytoplasm so thm mRNA levels at the site of protein synthesis arc increased. A thin!
mechanism is stabilization of cytochrome P·450 protein and/or mRNA (Monostory ct "I.,
1992). The fact that induction is prCKluced by a large variety of xcnobiotics and is mcdiated
by multiple mechanisms suggests tllallhe cylOchromc P·450 systcm can provide im.:rca.'iCd
protection for organisms in potentially hostile chemical cllvironments. Since cytochrome
P·450 induction is a charactcristic response to chemicals of various living organisms
ronging from microorganisms to man, it seems to be an adaptive mechanism for ors:mi.~ms
to increase the ehnnce for survival.
1.3.3 Inhibition
The catalytic cycle of cytochrome P·450 (see Figure 4) traverses three main slcps
that are particularly vulnerable to inhibition: I) the binding of substrates. 2) the binding of
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molecu[aroxygen ~ub5equent to the ftrSt electron transfer, and 3) the catalytic step in which
the substrate is actually oxidized (Ortiz de Montellano and Reich, 1986). Cytochrome p.
450 inhibitors can be divided into three mechanistically differentiable categories: 1) agents
that bind reversibly, 2) agents that (onn quasi-irreversible complexes with the heme iron
atom, and 3) agents that bind irreversibly to the protein or the prosthetic heme group (Ortiz.
de Montellano and Reich. 1986). On the whole. inhibitors that interfere in the catalytic
cycle prior to the actual oxidative event are reversible inhibitors, whereas agents that act
during or subsequent to the oxygen transfer step are generally irreversible.
1.3.30. Reversible Inhibitors:
Inhibitors that compete reversibly with substrates for occupancy of the active site
include substances that bind to its hydrophobic domain, that coordinate to the prosthetic
heme iron mom, or that panicipate in specific hydrogen bonding or ionic interactions with
specific active-site residues (Testa and Jenner, 1981) include the following:
Coordinators to ferric heme· e.g. cyanide (Kitada et aI., 1977).
ii. Coordinators to ferrous heme· e.g. carbon monoxide (Hanson et ai.,
1976).
iii. Heme coordinators and lipophilic binders· e.g. metyrapone (Dominguez
and Samuels, 1963).
1.3.3b Catalysis·dependent inhibition:
Several c1a£Ses of inhibitors are known to be catalytically activated by the enzyme to
transient species that irreversibly or quasi-irreversibly inhibit the enzyme. These
mechanism-based (catalysis-dependent) inhibitors are potentially more enzyme-specific
than reversible inhibitors beCause: I) the inhibitor must first bind to the ferric enzyme, 2)
the inhibitor must then be catalytically activated and therefore must be acceptable as a
substrate, and finally, 3) the reactive species produced irreversibly alters the enzyme and
renders it inactive (Oniz de Momellano and Reich, 1986). Examples include compounds
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which undergo or cause:
Covalent binding 1,0 Ihe protein· e.g. carbon disulfide (Bond lind Dc
Malleis, 1969).
ii. Quasi.irreversible coordin:uion 10 the prosthetic heme - e.g. alkyl and
aromatic amincs (fCSla and Jenner, 1981; Franklin, 1977).
iii. Cuvalent binding 10 the prosthetic heme· e.g. dihydropyridincs and
dihydroquinolines (heme alkylation) (Ortiz de Montcllano and Correia,
1983; Gayarthri and PadmaMbnn, 1974).
iv. Heme degradation· e.g. carbon tetrachloride (Guzdinn Mid Swisher.
1979).
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Objectives of this work
Recently, using a reconstituted microsomal lipid peroxidation system, we
demonstrated that OTA induced lipid peroxidalion by chc:lating Fe3t ions, and that the
resulting complex was more readily reducible by the navoprotein NADPH cytochrome: p.
450 reductase to the OTA-Felt complex which, in the presence or oKygen. provided the
active: species that initiated lipid peroxidalion (OmllT et a!., 1990). Cytochrome P-450 has
been shown to play an important role in stimulating lipid peroxidation in ADP·Fe3+ system
(Morehousc:and AUSI, 1988).
A number of slUdies have shown Ihat OTA is metabolized by liver microsomes
from several species (rJI, pig and human) primarily to 4(R)·4-0H-OTA and to a smaller
C'.xlcnl to the epimeric 4(S)-4-0H·OTA in the presence of NADPH (Stonner et aI., 1981,
1983; Veno, 1985; Crcppy ct al., 1991; Hietancnetal .• 1986). OTA metabolism has also
been shown to be induced by PB and/or 3MC in rots (Stonner and Pedersen. 1980; Deno,
1985; Hietanen et aI., 1986). In most of these studies. the effects of these cytochrome P-
450 indocers were not examined under the same experimental conditions. In addition, the
effects of other imponant cytochrome P-450 inducers were never investigated.
The objectives of my study were:
i) To investigate the possible role of cytochrome P-4~1J in OTA-induced lipid
peroxidation.
ii) To characterize which cytochrome P-450 isofonns are capable of metabolizing orA
through the use of a variety of inducers, specific inhibitors and monoclonal
antibodies.
iii) To exmnine tlte effect of cytochrome P~450 induction on OTA-induced tox.icity in
24
iv) To examine the drcci of CYloch.-on'IC P-450 induction on OTA 3bsorplion lind
diwibution in raiS.
Figure 1
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Structures or ochratoxin A llnd its metabolites.
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Ochratoxin A (OTAl
4 (RI-4-0H-OTA
4 (5J -4 -OH-OTA
OH
R1 " R2 I11 H
R1 "'OH. RZ"'H
Rl -H, R2 :oOH
Table l. Occurrence orOTA in food and animal feed or plant origin (adapted from WHO, 1990).
Commodity Country Samples %ConL OTA range Reference
analyzed (ug/kg)
Wheat, hay Canada 95 7.4 30-6.000 Prior. 1976
Wheat, oats, Canada 32 56.3 30-27,000 Scott el al., 1972
barley. rye
Mix. feed Canada 51 7.8 48-5,900 Abramsonetal .. 1983
Maize Yugoslavia 191 25.7 45-5.125 Balzer et al.. 1977
Mix. feed Australia 25 4 70.000 Connole er aL. 1981
Flour UK 7 28.5 490-2.900 Osborne. 1980
!'; Maize UK 29 37.9 50-500 Ministry of
Agriculture. 1980
Cornflour UK l3 30.8 50-500
Soya bean UK 25 36 50-500
Cocoa beans U.K. 56 17.9 100-500
(raw)
Barley Czechoslovakia 48 2.1 3.800 Veselaelal.• 1978
Coffee beans US.A 267 7.1 20-360 Levi et aI.. 1974
wheat U.S.A. 577 3.8 5-115 Shollwenelal .• 1976
Beans Sweden 71 8.5 10-442 Akustrand and
Josefsson.1979
Maize France 924 3.9 15-200 Galtierelal.. 1977b
Table 2. The incidence or OTA in meat and meat products (adapted from Marquardt et al.. 1990).
Product Country Samples %C;onL OTA range Rercrcncc
analyzed (ug/kg)
Kidney
Swine Hungary 122 39 2-100 Jelinek et aI.• 1989
Meats
Ham Yugoslavia 206 29 40·70
Bacon 19 37-200
13 Kulen 13 10-460
Sausage 12 10-920
Blood
Swine Canada 1200 0.5 100-229 Marquardt et aI.. 1988
4.1 20-229
72 5-20
Figure Z
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Factors Innuendng the occurrence or mycotoxJns In human
rood and animal reed (redrawn from Smith and Moss. 1985).
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Insect, bird &
rodent damage
Fungal infection
Microbial
Infection
Environmental
Interactions:
drought & temp.
Fungal growth &
toxin production
Mold growth
during storage
Microbial
degradation
Physicochemical
breakdown
Foods for human Feeds for animals
consumption ~I ,----, Absorption .
~intissues
Metabolism
'-----I Milk & secretion
MYCOTOXICOSES
IN MAN
MYCOTOXICOSES
IN ANIMALS
Table 3. OTA levels in humans (adapted from Kuiper-Goodman and Scotl. 1989).
Sample Country Incidence OTA levels
(uglkg or IL)
Reference
Blood serum (from patients with urinary tract tumor#BEN)
Bulgaria 26% Up 1035
(mean 20)
Pelkova·Boeharova et al., 1988
Blood serum (from non-endemic areas)
Bulgaria 7.7 mean 10
;;; Blood serum Gennany 1731306 0.1·14.4
Kidneys Gennany 3/46 0.1-0.3
Milk Germany 4/36 0.02-0.03
Blood serum Poland 91216 1.3-4.8
Bauer and Gareis, 1987
Golinski and Grabarkiewicz-Szczesna.
1985
Blood serum (from village with endemic nephropathy)
Yugoslavia 25/420
Blood serum (from non-endemic village)
Yugoslavia 171219
1-40
1-10
Hultelal.,1982a,b
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Table 4. LDso or OTA in different species.
Species Route of LDso (mg/kG)*
administration
Rat (male) oral 28.0
Rat (female) oral 21.4
Rat (male) Lp. 12.6
Rat (female) Lp. 14.3
Rat Lv. 12.7
Mouse oral 46.0
Mouse Lp. 22.0
Mouse Lv. 25.7
Dog oral 0.2
Guinea Pig (m) oral 9.1
Guinea Pig (f) oral 8.1
Chicken oral 3.3
Turkey oral 5.9
RainbowTrout Lp. 4.7
• Adapted from WHO. 1990 and MSDS, Sigma Chemical Co., 1989.
Figure 3
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Simplified reactions of the process of lipid peroxldation
(Gutteridge, 1988).
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Lipid peroxidotion
(1) LH+R' ------7 L'+RH
(2) L' + 02~ LOO'
LH + LOO'~ LOOH + L'
(3) L + L' ~ LL
LOO' + LOO'----7 LOOL + 02
LOO' + L'~ LOOL
ao a free radical
LH lipid undergoing lipid peroxidation
L' • lipid radical
Loo' • lipid pet'oxy radical
Initiotion
Propagatiol
Terminatior
Figure 4
3'
The catalytic cycle or cytochrome P.450.calalyzed reactions
and OTA hydroxylation.
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Table 5. Regulation of P·450 gene expression (Adapted from Soucek and
Gut.. 1992),
CYP Regulation of gene expression
IAI Inducible (all tissues) ~ 3MC. 15Ft BNF: transcriptional activation + mRNA
stabilization.
1A2 Constitutive (liver): transcriptional activation +mRNA stabilization.
Inducible (all tissues) - 3MC. ISF, BNF: transcriptional activation + mRNA
stabilization.
llB 1 Constitutive (lung, testis) - age, strain, colony, growth hormone:
transcriptional activation.
Inducible (all tissues) - PS. starVation: transcriptional activation + mRNA
stabilization.
DEI Constitutive (liver, kidney) - age. growth hormone: transcriptional
activation; diabetes. starvation: transcriptional activation + mRNA
stabilization.
Inducible (liver. lung) - INH. EtOH: protein stabilization.
mAl Inducible - peN, DEX, hypertension: transcriptional activation + mRNA
stabilization.
mA2 Constitutive (liver, intestine) • age, sex (m), growth hormone, diabetes,
starvation: transcriptional activation.
Inducible· PB: activation.
IVAI Constitutive (liver. kidney): transcriptional activation.
Inducible· Clofibrale, starvation. transcriptional activation.
CHAPTER 2
MATERIALS AND METIIOI '8
2.1 Chemicals· Ascorbate, balhophenanthroline disulfonic acid, bUl)'loled
hydroxyanisole. catalase. clofibrate, FeCIJ. FeS04. H202, isocitric acid, isocitric
dehydrogenase. isoniazid, isosafrole. Iipoxygenase, mannitol, 3-methylcolanlhrcnc.
metyrapone, NADPH, «-naphlhonavone. ochratoxin A, phenobarbital, pregnenolone-I 6«-
carbonitrile, superoxide dismutnsc and 2-thiobarbiluric acid were purchased from Sigmll
Chemical Co. (SI. Louis. MO). pHICkhrntoxin A was obtained from Amcrshllnl, U.K.
lind funherpurified by thin layerchromatogrnphy (TLC). 7-Ethoxyrcsorufin,7-
penloxyresorufin and resorufin were purchllsed from Pierce (Rockford, IL).
Co-protoporphyrin IX was obtained from Porphyrin Products (Logan, UT, USA).
Sephadex G-5O was obtained from Pharm3cia (Toronto, Canada). All other chemicals
were of the nighest grade commercially available.
2.2 TLC purificalion of PH)OTA • Two mL of PHIOchratoxin A was lIsed, the
solvent was evaporated under a stream of nitrogen and the residue was redissolved in
methanol. The whole sample was applied as a streak along the lower pari (Ihe origin) of:l
Ihin layerchromalography (1l.C) plate (K5F silica gel, layer Ih"ickness 250 1-1, Wh:uman).
Standard OTA was applied as 1I spot. The chromalogmm was developed with ben7.cm::
acetic acid (4: I. v/v), and aflcrevaporalion ofsolventcxamincd under V.V.light. 1111:
silica gel wilh the band corresponding to OTA WllS scraped off (removed), and OTA elulcd
with methanol. The solution contained 83% of Ihe IOlal radioactivity. The laller OTA from
the first chromatography was fUMher purified on a second 1l.C plote following the So1nlC
steps described above and the rcsulting OTA solulion from the second chrom:llogr.lphy
contained 92% of the tOlal r.ldioactivilY.
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2.3 Preparation of ochratoxin A ·OTA was purchased from Sigma chemical Co.,
but was also produced in the lab according to the procedul'Csdescribcd in my Master's
thesis (Omar. 1990). The UV and fluorescence spectra orDTA are given in Figures 5 and
6. The purity of the prepared IOltio was checked by TLC [fable 6) and HPLC (Figure 7).
The identity of the toxin was checked by NMR (Figure 8). OTA concentration was
calculated using the absorption coefficient at 332 om of 6330 em'! M-I (pohland et aI.,
1982).
2.4 Anim:lIs· Male Sprague-Dawley rats (200-250 g), obtained from Canadian
Breeding Fanns, Halifax, Nova Scotia, were used in all experiments. Animals were
maintained on a 12 hr light and dark cyde and had free access to standard lJbonltorychow
and water.
2.5 Treatments of rnts for in vitro experiments
2.5.1 Treatments with cytochrome P-4S0 inducers - The various treatments (n
= 4/treaunent) are listed in Table 7. Isoniazid was given as a 0.1 % solution in drinking
wlller for 10 days and rtlts were sacrificed on day 11 (Ryan et ai., 1985). PeN (IOOmglkg
body weight in I mL of 1% Tween 80) was administered by gastric intubation once daily
for 4 days and rats were sacrificed 24 hr after the lasl dose (Graves et aI., 1987). PB was
given as a 0.1 % solution in drinking water for 5 days and rats were sacrificed at the end of
Ihat time period (Graves et aI., 1987). 3MC (20 mg/kg body weight in com oil) was
administered intrnperiloneally once each day for 3 successive days, and rats were sacrificed
24 hr after the lasl dose (Guengerich et al., 1982a). Clofibrate was administered by g.astric
intubation (200 mglkg in I mL sucrose syrup containing I% gum ambic) once each day for
5 consecutive days, and rats were sacrificed 24 hr after the last dose (Fournel el al., 1987).
lsosafrole (120 mg/kg body weighl in com oil) was given intrnperitoneally once each day
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for 3 successive days, and Tats were sacrificed 24 hI' after the last do~e (Fisher elll\..
1981),
2.5,2 Treatments with Cobalt protoporphyrin IX for microsomal
preparations. Rals received 2 doses each of 50 Jlmo!/kg body weight of CObllil
protoporphyrin IX (Co-heme) 9 days and 2 days prior to killing, while control rals rccdvcd
the vehicle saline at the same time as Ihe treated ralS (Dmmmond and Kllppas, 19H2). Co-
heme (24.8 mg) was dissolved in 0.4 ml of 0.1 M NaOH.the pH was adjusted 107.4
with Hel and the solution was made up to 4 ml with nonnal saline (final conccnlrllliorl of
Co-heme, 10 mM). The freshly prepared Co-heme was administered sulx:ln:lncolls]y to
rats al a dose orO.5 ml)IOO gm body weight. After sacrifice. liver microsolllcs showed
20% of cytochrome P-450 content of controls.
2.6 Treatments of rals for In vivo studies·
2.6.1 Inducing cytochrome P·4S0 • Four rats were used per treatment group.
Control rats had free access 10 drinking water and standard lab chow for 5 days, whereas
PB treated rats were given 0.1 % PB in drinking water for live days (as the control mIs, PB
treated rats also had free acce$S to the drinking water with PO :lnd standard lab chow)
(Graveset aI., 1987). Animals were maintained ona 12 hrlight and dark cycle. On the
fifth day, all animals (8 rats) were placed individually in mctabolic cages and 24 hr urincs
were collccted (fora base line). On the sixth day, nIl rats received OTA by gastric
intubation (0.5 mglkg booy weight in 50 mM sodium bicarbonatc, about 0.5 mL); this
treatment of OTA was given for live successive days. Twenty four hour mincs wen.:
collected every day until one day after the last OTA treatment. After sacrifice, livcr
microsomes from PB treated rats showed a 2.5 fold increase in cytochrome P-451J contcnl~
as compared 10 c(!lltrol microsomes.
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2.6.2 PHIOTA experiments. Rats were divided into twO groups (n = 4/treatment),
one group received drinking water whereas the other received water containing 0.1 % PO
for five days before OTA treatment. All animals had free access to food (standard lab
chow). After the five days, both groups were treated with [3H]OTA (288 Jlg/kg booy
weight in 50 roM NaHCOJ once by gastric intubation). Rats were kept in metabolic cages
for6hrtocollecturine.
2.7 Preparntion of liver microsomes - Liver microsomes were isolated by
differential centrifugation of liver homogenates as described earlier (Rahimtula et at,
1979). Liver from c3ch rat was excised and placed in icc-cold 0.1 M potassium phosphate
buffer, pH 7.4. The liver was chopped into pieces, homogenized in 3 parts (by volume) of
the above buffer 10 one pan liver (wet weight) using a polytron homogenizer (Brinkman
Instruments), and the homogenate was centrifuged at to,OOO x g for 10 min. Following
filtration of the resulting supernatant through cheesecloth, microsomes were isolated from
the 10,000 x g supernatant by ultrncentrifugation at 110,000 x g for 60 min. The
microsomal pellet was suspended in 0.1 M potassium phosphate buffer, pH 7.4 and again
centrifuged at 1to,OOO x g for 60 min. The final microsomal pellet was suspended in 0.1
M potnssium phosphate buffer, pH 7.4 and stored at-700C until used. Protein was
measured by the Lowry method (Lowry et al., 1951). Cytochrome P-450 levels were
measured as described by Omura and Sato (1964) (see below, section 2.9). NADPH-
cytochrome P-450 reductase (Fp) was assayed as described by Lake (1987) using
cytochrome cas the electron acceptor (explained below, section 2.11).
2.8 Cylochrome P·450 purification - Cytochrome P-450 was purified (rom liver
microsomes isolated from PB-pretreated rats as described by Guengerich (1982), All steps
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were carried QUI at 4OC, Microsomes were suspended (02 mg prolcin/mL in 0.1 M
potassium phosphtltc buffer (pH 7.25) containing 20% glycerol. I mM EDTA, and 20 J.lM
BHT. Sodium chelate (recrystallized from 50% aqueous eth:lnol) was added dropwi~c
(from a separatol)' funnel) 10 the stirring suspension over 20 min to give 0. final
concentration of 0.6% (weight/volume. w/v). After stirring for an additional 30 min, the
clarified solution was centrifuged at 100,000 x g for I hr. An amount of the supemat3nt
equivalent 10 2,000 nmoles of cytochrome p·450 was applied at a now nile of I mLJmin 10
an w-amino-octyl agarose column (2.5 x 50 em) previously equilibrnlcd wilh 3()() mL of
0.1 M potassium phosphate buffer (pH 7.25) containing 1 mM EDTA, 20% glycerol. lind
0.6% (w/v) sodium cholate. The cytochrome P·450, a reddish brown protein, was bound
to the top one-third of the column, The column was washed with 800 mL of 0.1 M
potassium phosphate buffer (pH 7.25) containing 1 mM EDTA, 20% glycerol
(volume/volume, v!v) and 0.42% (w/v) sodium cholate. Cytochrome P-450 was e1utcd
using about 1.500 mL of 0.1 M potassium phosphate buffer containing I mM EDTA, 20%
glycerol, 0.33% (w!v) sodium cholate and 0.06% (w/v) Renex 69() (lei Americas Inc..
WA, U.S.A.). The eluted fractions were monitored for cytochrome PASO by measuring
the absorption at 417 nm (A411), The A.!11 peak fractions were pooled and concentrated to
about 50 mL using an Amicon ultrafiltration apparatus and a PM·3D membrane. loe
concentrated solution was dialyzed against I L of a 20% glycerol-D. I mM EDTA solution
(about 3 hr) and then versus I L of to mM potassium phosphate buffer (pH 7,7)
containing 0.1 mM EDTA, 20% glycerol, 0,1% (w/v) Lubrol PX and 0,2% (w/v) sodium
cholate (not recrystallized) (about 3 hr),
The cytochrome P-45D was further purified by DEAE cellulose chromatogmphy at
room temperature (about 22OC). The dialyzed cytochrome P·450 solution was applied to a
2,5 x 50 em column of Phannacia DEAE-Sephacel previously equilibrated with I L of I()
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mM potassium phosphate buffer (pH 7.7) containing 0.1 mM EDTA, 20% glycerol. 0.1 %
(w/v) Lubrol PX and 0.2% (wlv) sodium cholate (not recrystallized). The column was
washed with 700 mL of the same buffer in which the concentration of NaCl was increased
linearly to 0.25 M. The lasl major ~11 peak contains the bulk of the cytochrome P-450.
The peak (ractions were pooled and concentrated to about 20 mL with an Amicon
ultrafiltration apparatus using a PM·30membrane. The concentrated solution was stirred
with Dio-Beads SM·2 (Bio-Rad Labs; 0.2 gm/mg protein) for 3 itT to remove excess
detergent and then filtered through glass wool. Finally, the enzyme preparation
(cytochrome P-450 lIB1) was dialyzed overnight against 50 volumes of 10 mM Tris-
acetale buffer (pH 7.4) containing 0.1 mM EDTA and 20% glycerol. The dialyzed enzyme
was stored in aliquols (0.25 mL each) at - 800c. 50S-polyacrylamide gel electrophoresis
revealed the presence of a single major protein band with a very minor band underneath.
2.9 Cylochrome P-450 assay - Cytochrome P-450 concentration was measured
spcctrophotometricnlly as described by Omura and Sato (1964) using an extinction
coefficient of 91 cm-] mM-I. Briefly, 6 mg microsomal protein or 0.6 mg protein of the
cytochrome P-45O prepar3lion was suspended in 6 mL of 0.1 M potassium phosphate
buffer (pH 7.4) and a few small crystals of sodium dithionite were added 10 it. After
mixing, the contents were divided between 2 matched cuvettes (3 mL in each) and scanned
between 500-400 nm (scan speed 120 nm/min, chart speed 30 mm/min) to obt.o.in a
baseline. The sample cuvette was bubbled for about 40 sec to 1 min with CO gas and then
re-scanned to obtain the characteristic peak for the cytochrome P-450 at 450 nm.
My cytochrome P-450 preparation contained 8.25 nmol/mg protein which was
lower than expecled, bUI it showed a I;omplete absence of NADPH cytochrome P-450
rcduct.o.se activity (Fp). Morehouse and Aust, 1988 satisfactorily used a cytochrome P·450
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preparation which contained 10 nmoVrng protein. Also, Laclhem ct ;11. (1992) purified
cytochrome P·450 with specific activity of 8.4 nmoVmg protein. Usually, some of the
enzyme activity is losl during the purification and also some heme-degr.ldation occurs wilh
the use of detergents. Atlcmpts to restore cytochrome P·450 by llddition of heme liM not
mel wilh success so far.
2.10 NADPH-cytochromc P-4S0 reduclasc purification. The n:lyoprotcin
NADPH-cytochrome P·450 reductase (Fp) was purified from liver microsome!: isolated
from PB-pretreated rats essentially as described by Ardies et al. (1987). 'nIc following
procedures were all performed a14OC. Mil:rosomcs (SO mg prolcin/mL) were diluted to ]{J
mg proteinlmL with ]00 mM Tris·HCI buffer (pH 7.7) containing I.n 111M EDTA, UI mM
dithiothreilol (Om, 20 j.LM BHT, 5IJ.M flavin mononuclcotidc (FMN), and 30% glycerol
(buffer A). CHAPS (3-[(cholamidopropyl)·dimcthylammoniol-l-prop:mc3ulforHne) was
prepared as a 20% (will) solution in water, and neutrnlized to pH 7.4 with dilute KOB.
Immediately prior to use, CHAPS was diluted 1:1 (vlv) with buffer A. The latter solution
of 10% CHAPS (in buffer A) was added to the microsomes slowly dropwise with slirring
to a final concentration of 1% and the mixlure was stirred for 30 min. TIlcn, II 1.5%
solution of protamine sulfate was 3dded dropwise to 3 fin31 concentration of 0.07% (w/v).
After stirring for 3n additional 20 min, the mixture W3S centrifuged at IIO,O<X> x g ror 60
min. The liupc:matanl was removed. and the resulting gray-colored, tightly packed pellct
was resuspended with the aid of a Teflon/glass homogenizer ut a protein concentration of
50 mg/mL in buffcr A; protein was measured by the Lowry method (Lowry ct aI., 1951).
A 10% (w/v) solution of sodiumcholate in water was then added dropwise with stirring to
a final detergenl : protein ratio of 3 mg/mg. Ten minutes later, a 20% (v/v) solution of
Lubrol PX (Sigma Chemical Co., MO, USA) in water was added dropwisc to a final
concentration of 0.5% (w!v) and the mixture was stirred for an additional 3n min. The
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detergent-treated fraction was centrifuged at 110,000 x g for 60 min, and the resulting
supernatant was applied directly to a 2',S'·ADP agarose column (2.5 x 4.0 em) at a now
rale of I mllmin. The affinity column had been equilibrated previously with lQOmM
phosphate buffer (pH 7.7) containing 0.4% chelate, 0.1 mM EDTA, 0.1 mM OTI,20 11M
BHT, 5 11M FMN, and 20% glycerol. Once loaded. the column was washed with 15
column volumes of equilibration buffer, 12 column volumes of 100 mM phosphate buffer
(pH 7.7) containing 1.0% ('11'1) CHAPS, 0.5% ('11'1) Lubrol PX, 0.1 mM EDTA, 0.1 roM
OlT, 20 I-LM BHT, 5 11M FMN, and 20% ('11'1) glycerol, and again with 15 column
volumes of equilibration buffer. All washes were perfonned at a flow ratc of a I mLlmin.
Fp was then eluted from the affinity resin wilh a small volume (about 25 roL) of
equilibration buffer 10 which 10 mM NADP+ had been added (flow rate = 0.5 mUmin).
The peak Fp-containing fractions (detected by measuring Fp in fractions as described
below, section 2.11) were pooled and dialyzed twice against 2 Lof 50 mM phosphate
buffer (pH 7.4) containing 0.1 mM OIT and 20% (v/v) glycerol for a total of 28 hr. The
purified Pp was then stored in small aliquolS (0.5 mL each) at -BOOC. The purified Fp
showed a single band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
2.11 NADPH-cy(oehrome P-4S0 reductase Dssay- The enzyme was assayed as
described by Lake (1987) using cytochrome c as the electron acceptor. Briefly, 1mL of
0.125 mM cytochrome c solution in 0.1 M phosphate buffer, pH 7.0, and 0.2 mLof 15
mM KeN in water were pipetted into each of two matched 3 mL spectrophotometer
cuvettes. Ten microliters of Pp was pipetted into each cuvelle and phosphate buffer was
added to the test and reference cuvette contents to bring the volumes up to 2.4 and 2.5 mL.
respectively_ After mixing, the cuvettes were placed in the spectrophotometer
(thennoslntted to 22OC), and 3 min later the reaction was initiated by adding 0.1 mLof 10
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mM NADPH to the test cuvelle only. Thecomcms were again mixed and the increase in
absorbance with lime was recorded at SSO nm. Using an cJuinction coefficient for the
reduced cytochrome c at 550 nm of 0.021 cm"IlM-I, the specific activity orlhe
flavoprotein was calculated to be 18,lXXl units (Of' nmolYminJmg prolein (1..:Ike, 19K1).
One unit of enzyme activity is defined as that amount which catalyzes lhe ~duetion of I
nrool cytochrome c/min.
2.12 Fortincnlion of microsomes from Co-heme trclllcd rats wilh Fil • Co-
heme drastically depicted cytochrome P-450 (> 80% depletion of cytochrome P-4S0
content compared to conlTOls). NADPH.cylochrome P·450 reductase (Fp) wa~ also
depicted (abouI75% depiction). To avoid me possible effect of reduced Fp, Co-herne
microsomes were fortified by incubating them with purified Fp. Microsomes (2 mg
protein) were incub:ued with Fp (640 nmol) in a lillie microfugc lube (;about 15()~L
capacity) for I hr al22O<: and then cenlrifuged 01.1110.000 x g fot 5 min to collect
microsomes.. The microsomes were fCSuspended in buffer and assayed for Fp conlent ;LS
described above. Fortified microsomes were found to have a Fp eontenl of70 nmoVlIlg
protein as compared to 20 nmoVmg protein in non-fonified microsomes.
2.13 Prepnrntion of phospholipid vesicles· Total lipid was extracled from
untreated rat liver microsomcs by the method of Folch et 01.1. (1956) wilh care being taken 10
flush all solvents with nitrogen and to perfonn all operations under nitrogen m() - 41'C to
minimize auto-oxidation of polyunsatumted lipids. TIle eXlracted lipid in chlorofonn :
methanol (2; I) was SIOred in aliquots underniltogen at -8OCC. Total lipid phosphorus
was determined as described by Bartlett (1959). Phospholipid vesicles were prepared fresh
daily by sonication of the extr.lcted lipid under anaerobic conditions as described hy
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pcdct-Jon et Oil. (1973). Brieny, an aliquot of the phospholipid solution was evaporated to
dryness in a plastic lube under nilJOgen. and nitrogen.saNrated Tris·HCl buffer (0.25 M,
pH 6.8) was added to give a final lipid phosphorus concemration of10~. The
lube was flushed with nitrogen,capped, and placed in a glass beaker filled with a mixture
of ice and water. Phospholipid vesicles were obtained by placing the probe of a Branson
ronifier(model WI8S) in the beaker and applying a power of SO W for 5 min.
2.14 lipid pcroxidation IlSS3yS (incubation conditions) •
2.14.1 Reconstituted system incubntlons • Unless otherwise specified.
incubations were carried out in duplicate al370C in 0.25 M Tris·Hel bufferlO,25 M Nnel
(pH 6.8) and contained per mL: phospholipid vesicles (I J.Lntol P), 3.2 U Fp, 110 nmol
Fe3' ,500 nmol OTA, and 200 nmol NADPH. Cytochrome P·450 IIBt or EDTA, when
included. were added allhe indiCOlted concentr.llions (see Table 8).
2.14.2 Microsomal incubations· Incubations were carried out at 370C in 0.1 M
potassium phosphate buffer (pH 7.4 or different pHs as indicated in the figure legends) and
cOfllained per mL: 2 mg microsomal protein (from eilher control animals, those induced,
those treated wilh Co-heme. Ol" those trealed with Co-heme and microsornes fortified with
Fp). 125 nnlOl OTA:lJld 1 mM NADPH.
Lipid peroxid:uion WolS estimated by measuring MDA levels (Rahimlula el aI.,
198ft). For Ihis purpose. 0.5 mL of 30% TCA and 50 ~L of BHT (2% in ethanol) were
added to 0.5 mL of each incubation. Finally. 0.5 mL of 50 mM TBA was added and the
mixtures were placed in II boiling water b:nh for 15 min. After centrifugation for 5 min at
2000rprn (bench top centrifuge), the absorbance orthe MDA·TDA complex in lhe
supernatant was read nt 535 nm (ESJ5 =: 156 roM·lcm· l) (Jordan and Schenkman, 1982).
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2.15 Metabolic studies
2.15.1 Metabolism of OTA In "itro - Unless otherwi~ indicated, incubations
were carried OUI in dupHcate at370C for 30 min in 0.1 M potassium phosph:\Ie burrer (pH
7.4) and contained in a IOlal volume of I mL: 2 mg microsom•.,1 protein. 125 mnol OTA and
a NADPH-rcgenerating system (consisting ofO.41UT1OI NAOP". 511mo1 MgCh.5l1mol
Dvisocitratc and 0.65 units of isocitric dchydrogcn::lsc). C'1t:l.lasc (800 unil~). SOD (~S
units), mannitol (11 mM), DHA (IO~M). DPPD (JOI1M), Dcsfcr:ll (50 11M) Ol'" Ill'S (IIXI
11M), when included, were added prior to initiating the renction with NADNI. Allhc end
of 30 min, a0.5 mL aliquot from each incubation was withdr;Jwn for l1\CnSUrClUClll ofQTA
melabolites and the remaining 0.5 mL was used 10 measure lipid pcroxidmion.
Time-course studies were carried OUI in an identical m;uIDer exccpt that the incubation
volume was 10 mL
Incubations with hemoproteins and hydroperoxides were c:trricd out in duplic:nc in
0.5 niL of 0.1 M potassium phosphate buffer (pH 7A) and contained (i) OTA (625 nmoll.
(ii) hemoprotein - microsomes from PeN ucated rats (I mg protein; 1.2 nmol cytochrome
P4SO) orHb (640 Ilg; IO nmol) or hematin (2.5 nmol) or I-IRP (400 Ilg; 10 nmol) and (iii)
hydroperoxide - CHP (0.5 mM) or H2Ch (5 mM) orLAHP (6511M). Incubations were
terminated after 30 min and analyzed forOTA meUlbolites as de.u:ribcd below. Ll\IIP wao;
prepaml from linoleic acid and lipoxygenase as described earlier (O'Brien, 1969).
2.15.2 Effect of monoclonal antibodies on OTA mclobulism ill vitro-
Monoclonal antibodies (MAlls) were obtained from Dr. H. Gelboin, U.S. National Cancer
Institute, Lab of Molecular Carcinogenesis, Bethesda, MD. Clones 1-7-1 (agaiml
cytochrome P-4SO IA t/lA2) and 2-66-3 (against cytochrome P-4SO IIU 1/l11l2) were u!iCd
in my studies. R:abbit IgG W3.S used to dClennine :any non-specific re<lclion. Microsome.~
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wue p~incub:l.ledwilh MAbs in buffeT al room temperature 30 min (Nalcajima ICC at, 1991)
prior to initiating the OTA mel.3.bolism assay a1370C by addition of a NADPH·regenerating
system and substrate (OTA).
2.15.3 An:alysis of OTA metabolites formed in In pilro studies· Aliquois (0.5
mL) were removed (rom incu~tions. and the reaction was termin:ued by the addition of I
M HO (0.1 mL) and saturated NaO (0.5 mL). The mixtures were extracted with
chloroform (2,1t 2 mt), and the two chloroform extr:l.CIS from each incubation were
combined and dried under nitrogen. The residues were dissolved in 500 ~L of methanol
Qnd.'iO ilL or each sample was analyzed by HPLC (Perkin Elmer, Series 4) on a Partisil 10
005·2 column (0.45 em,lt 2S em) using a solvent system consisting of (i) a mixlure of
acetonitrile: methanol (1 : I, v/v) 60% and (ii) 5 mM sodium acetate: acetic acid (500: 14,
v!v) 40%. The now r:lle was 1.5 m1.Jmin. Ochratoxin A and its metabolites were detected
fluorimetriClllly using light at 340 nm for excitation and measuring the emission at 465 nm.
4(S)4-0H.()TA, 4(R)-40H-OTA and OTA eluted at 4.2, 5.1 and 10.1 min respectively.
Metabolites were identified and quantitated using standards generously provided by Dr. M.
C:astegnaro, IARC. Lyon, France.
2.16 Elhoxy- and pcntoxyrcsoTufin Q.dealkylotion assays - EROD/PROD
assays were carried out as described by Burke et ai., 1985. Incubations were carried oul at
370C for 10 min in 0.1 M polassium phosphate bufrer (pH 7.8) and comained per mL 50
J,tg microsomal protein, I.G mg BSA, 5 IlM substrltte (ethoxy- or pentoxyresorufin) and n
NADPH-regenemting system (consisting ofO.4llmol NADP+, 5 J.lmol MgCI2. 5 J.lmol
DL-isocitrate and 0.65 units of isocitric dehydrogenase). The incubation volume was 1.25
mL. The reaction was SlOPped by the addition of2.5 mL methanol (total volume 3.75). the
mixture w:l.scenuifugcd for 3 min (bench lopcemrifuge, '112,000 rpm), and the
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flourcscence due 10 the fonnation of resorufin in the clear supernatant was measured at
excitation wavelength of 350 nm and emission wavelength of 585 nm, clIcit:uioniclIlission
slits 5/3 nm respectively (Instrument: Perkin-Elmer LS-5 spectronuorimetcr). Standard
curve of resorufin was used for calculations.
2.17 p-Amino hippurate (PAH) (ransporl - Three animal groups were used for
this experiment: control rats, ralS treated with OTA, and PB-pretreated mts treated with
OTA. The latlertwo groups-wcrcrats used losiudy urinaryenzymcs (n =4). PAil
transport was measured in vitro as described by Berndt and Hayes (1979). Briefly, :lflcr
animal sacrifice by cervical dislocation, kidneys weTC removed rapidly am.I plllcctl in cold
Krebs-Ringer phosphate buffer pH 7.4. The renal slices (0.25 - 0.40 mm) were prepared
freehand and stored in the same Krebs-Ringer phosphate buffer until used. All ineub;lIions
were performed in a shaking wa'.er bath at 250C in an atmosphere of 95% oxygcn/5% COl
and were initiated within 30 min of the preparntion of the slices. 100 - ISO mg of tissucs
from all groups were incubated for 10 and 30 min in 2 mL C'f Krebs-Ringer phoSllh;IlC
buffer after the addition of fl4C]PAH (2 )lCi, 50 IlM; leN, Canada). At the end of the
incubation. tissues were removed from the buffer, blotted. and homogenized in 1m!.. of
distilled waler. 0.5 mL of the homogenate was solubilized in 4.5 mL NCS-tissue
solubilizer (Amersham), and I mL of the solution was counted for mdioactivity after thc
addition of scintillation liquid (Scimiverse). Also, I mL of the bathing solution was IIscd
to count its radioactivity. The uptake (tmnsport) of PAH is presentcd as slice/medium
(SIM) ratio, i.e., the radioactivity/gm of lissue divided by the mdioactivity/mL or bathing
solution.
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2.18 III vivo studies -
2.18.1 Urinary enzyme experiments.
2.18.1a Preparation of urine samples· Samples (whole 24 hr mines) were
centrifuged for 5 min 314,000 rpm. The c1earsupematants were removed carefully and
used for analysis.
2.18.lb Gel filtration of urine samples- This was done :Iccording to the method
described by Werner el a1. (1969). Eight glass columns with small dead space (inner
diameter 1 em, height 30 em) were each filled to a height of about 18 em with hydrated
Sephndcx G-50, giving II gel bed ofaboul 14 em3 in each column. Separation was
pcrfonned at room temper:llure, and physiological saline (0.154 M NaCI) was used as
cluan!. Each urine sample (3 mL) was washed intothecolurnn with I mLsaline followed
by another I mL of saline. The liquid emerging from the column up to that time (5 mL)
was discarded. Silline was placed on each column, and 6 mLof eluates was collected for
enzyme analysis. The columns were finally Iilled and rinsed with saline to prepare them
for reuse.
2.18.le MC:lsuremcnl of urinary enzymes - Alkaline phosphatase and ~-glutamyl
transfera.~ activities were measured using kits (kits numbers 104-LL and 545-A
respectively) from Sigma Chemical Co. (SI. Louis. MO). To avoid experimental variations
due to different urine volumes, the enzyme activities were expressed as units/mg creatinine
(creatinine kit number 55S-A, Sigma Chemical Co.).
2.18.2 PH IOTA experiments· Rats were anaesthetized with diethyl ether (6 hr after
QTA treatment), and blood was withdrawn from the abdominal aorta. After sacrifice,
kidneys, liver, stomach, small intestine and caecum were excised, and the small intestine
(Int.) was divided into four equal partS by length (Int. I tolnt.4). GUI segments [stomach,
small intestine (Inl.l. 101.2, Im.3 and ImA), and cecum} were rinsed twice with I mL
portions of 0.5% sodillill t:lllrochol:lle in nonnal saline and then twice with 1 mL portions
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of 50 mM sodium bicarbonate to ensure complete removal of all contents which was kepI
for extraction. Tissues were homogenized in water using a polytroll. Tissue homogenutes
and conlenlS were acidified lopH 2 and cltlractcd three tim~s wilh chlorofonll (5 mL lOiS).
After drying the combined CKtnlcts under nitrogen, samples were redissolved in 400 IJL
methanol. and 200J,lL samples were counled forrndioaclivity. Blood samples were
allowed to stand at room temperature for alleast I hr and tncn centrifuged looh\ain scnllll.
Calculation or total serum volume was done assuming the blood volume (mL) is given hy
the numerical valueof7% ofa rJI'S mass (in gm) and thcscnnl1 volume to he 55% uf
blood volume. Samples of urine and serum (SO· IOD ilL) were "Iso counled for
radioactivity.
2.19 Speclropholomctric/spct:lronuorometric measurcmcnts-
Spectrophotometric measurements were conducted on a Ptlrkin-Elmer L'lnlbda 3n (Inuhle
beam spectrophOlo-meter in cells with a I cm light path. Fluorescence measuremen1s were
I1UIde in a Perkin·E,lmer LS-5 ~pectrotlllOrirnclerjn cells with a S(!lIare em scelioll, I em in
each dimension.
2.20 Statistical amllysis •
The non-parametric Mann-Whitney test was used for thc .malysis of results from in ~ivlJ
experiments (N = 4 or 8) and results from in vitro experiments where N '" 4. A difference
at P < 0.05 was considered to be statistically significant. For the rcst uf ill vilm
experiments, the number of animals from which samples were used was \(Ml small to Ix.:
analysed. When an experiment was done on samples from (WO different animals from cadi
treatment group. the results from each animal were given scpardtcly. When ,In experiment
wasdonc on more than two animal (three or four) per treatment group, the results were
given as the mean±S.D. from all animals.
Figure 5
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The UV spectrum or orA.
The continuous line represents standard OTA from Sigma Chemical Co.
(ST•....,. while the broken line represents my OTA preparation (OT••_).
Both samples were at a concentratiOll of 25 ~OTA in melhanol. The
~~~I~;h~~~~~oo~~~::s~~~~r:2tS:~:s;~:60
nm/min.
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WAVELENGTH(nm)
Figure 6
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The nuorescence spectrum or OTA.
The continuous line represents standard OTA from Sigma Chemical Co.
(ST,-), while the broken line represcnts my OTA preparation (OT, ••).
Both samples were at a concentnltion of SO JiM OTA in methanol. The
}~i:::w~~tx~~~~ ~=I~~':'~~~~l~~~~;:e~cd
between 300 and 5llO nm. The excitation/emission slits were set at 513
nm, chart speed 60 nun/min and scan speed 120 nm/min.
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Table 6. The Rr values or ochraloxin A.
Solvent syslem Sigma OTA* Prepared OTA*
Benzene: acetic acid 0.68 0.68
(4: I. v/v)
Benzene: acetic acid 0.41 0.41
(8: I. v/v)
Benzene: acelic acid: Methanol 0.45 0.45
(95: 5 : 5. v/v/v)
* 3 ~ of 25 mM were spotted on TLC plates with fluorescent indicator.
Figure 7
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The HPLC profile of our OTA preparation.
Sample (20~ of 251JM solution in meth:mol) was injecl.ed into a Perkin
Elmer-Series 4 liquid chrom:uogr.:aph. The column used was Partisil to
005-2. The solvent system consisted of a mixture of a)
acetonitrile:methanol (500:500, vlv) 65%:md b) 5 mM sodium
acctalC:acctic acid (SOO: 14. v/v) 35%. The flow rate was 1.5 mUmin and
the fluorimctrie detection was performed at excitation wavc!cnn1.1 of34O
nm, emission wavelengl.h of 465 om and excitation/emission slits of 5/10
nm.
J
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Dcteccor Response (lllVolts)
l
Figure 8
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Proton NMR sptdrum of my OTA prcpllration.
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Table 7. List of various treatments and cytochromes P450 induced.
Treatment Major P-450 Route of Administration, Dose
Enz.lnduced and Vehicle
Control No treaunent.
PO UBI' 0.1 % in drinking water for 5 days.
3-MC IAI 20 mgIKg in com oil i.p. once each day
for 3 successive days.
Clofibrate IVAI 200 mglKg in 1 mL sucrose syrup containing
1% arabic gum given by gastric intubation
:<l once each day foe 5 days.
lsosafrole IAIIIA2 120 mgIKg in com oil i.p. once each day
for 3 successive days.
PCN WAII1lIA2 l00mgIKg in I mL 1% Tween 80 given by
gasbic intubation once each day for 4 days.
Isoniazid UEI 0.1% in drinking water for 10 days (pH 7.4).
N"" 4/treatment group.
Reference
Graves. 1987
Guengerich.1982
Fournel. 1987
Fischer. 1981
Graves. 1987
Ryan. 1985
CHAPTER 3
RESULTS
3.1 Role 'Jf EDTA and cytochrome P·4S0 in the stimulation of OTA·
induced lipid peroxidnlion in reconstituted systems.
In a reconstituted microsomal lipid peroxidation system consisting of microsomal
phospholipid, Fp, Fe)+,OTA and NADPH (see Methods section 2.14.1), the
concentrations of MDA obtained were 1.65/2.20 and 2.46/4.60 nmoVmL 1\1 the end of
20 and 40 min respectively (values from two different experiments). In this experiment,
purified cytochrome P-450 and Fp (from 6-8 rats each) not microsomes from in<lividual
rats were used. Hence, experiments I and 2 were pcrfonned on two different days (each in
duplicate) but using the same purified enzymes (as these were isolated only once).
Addition of EDTA (25 nmoVmL) 10 the reconstituted system led to a three- to four-fold
increase in the concentration of MDA formed yielding 6.62/7.45 and 10.24/13.60 mnol
MDA/mL at 20 and 40 min respectively (fable 8). Replacement of EDTA by purified
cytochrome P-450 liB I also led to a stimulation of lipid peroxidation. Figure 9 shows the
extent of this stimulation in the presence of increasing conc:ntrations of cytochrome P-450
1181. Concentrations up to 0.3 nmol cytochrome P-4501mL had a stimulatory effect on
MDA production. which amounted to 6.5/8.5 and 10/13 nmol MDA at the end of 20 and
40 nlin respectively. Intact cytochrome P-450 seems to be essential since the heat-
denatured enzyme, hematin. or a variety of hemoproteins were all ineffective in stimuillting
lipid Ilcroxidation (Table 9), but carbon monoxide (CO) did not inhibit the stimulatory
effect of cytochrome P-450. It is clear that the addition of only cytochrome P-450, but not
other heme or hemoproteins stimulated lipid peroxidation (in this experiment. purified
cytochrome P-450 from 6·8 mts not microsomes from individual rats wa:. used).
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3.2 Erred of microsomes from Co-heme pretrealed rats on OTA-slinmlatcd
lipid peroxidation.
This was studied as described in Methods sections 2.5.2, 2.12 nnd 2.14.2. The
dala in Figure to suggeslrnat cytochrome P·450 may also be involved in OTA·depcndent
microsomal lipid peroxidation. The ratc of MDA fannation was highest in microsomes
isolated from untreated rats. Thus, at the end of a ID-min incubation period. micmsomcs
from untreated flUS produced 7.6/9.4 nmol of MDA (values from two differenl
experiments). In contrast, microsomes isolated from Co-herne-pretreated mts showed u
much lower rate of lipid peroxidalion which, at 10 min, amounted to only 2.2/2.5 nmol of
MDA. Treatment ofmls with Co-heme has been shown \0 lower hepatic cytochrome P-
450 levels (Drummond and Kappas, 1982; Spaethe and lo11ow, 1989), and also to reduce
Fp activity (Spaethe and Jollow. 1989). Miaosomes from Co·hcrne-pretreated rats
contained 0.6 nmol of cytochrome P-450 and 22 units of Fp per mg protein. These valucs
are 20% and 25% of the respective values in control microsomcs (Table 10). To establish
that the greatly reduced rate of MDA fonn:l.lion by microsomes from Co-heme-prctre:lleJ
rats was not due primarily to lower Fp levels. microy.mcs from Co-herne-pretreated rats
fortified by Fp were examined for their ability to carry out OTA-dcpcndent lipid
peroxidation. Fp fonified microsomes contained 78% of Fp of control microsomes. The
results show that Fp-fonificarion of microsomes from Co-heme-prctreateJ rats only
marginally increased MDA formation to 3.4/4.1 nmol at 10 min.
3.3 Effect of various cytochrome P-450 inducers on OTA metabolism by
liver microsomes.
The structures orOTA and its metabolites 4(R)- and 4(S)-4-0H-OTA are shown in
Figure I. Figure 11 shows the HPLC profile ofOTA and it'i metabolites. Table 7 lists the
various methods of inducing cytochrome P-450 (Methods section 2.5.1).logether with thc
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major isoforms of cytochrome P-450 induced (the unified nomenclature by Neben et aI.,
1987 is used). The effect of these inducers on the hepatic cytochrome P·450 concentration
in liver microsomes is shown in Table II, Some of the cytochrome P-450 inducers
increased lIle tOlal cytochrome P-450 concentration (e.g. PB, 2.5 fold increase over
control; 3MC. 2 fold; CLF and peN. about 1.7 fold and ISF, about 1.2 fold) while other
only induced specific cytochrome P-450 isozymes without increasing the total content (e.g.
INH). The extent orOTA metabolism by microsomes from rats treated with the
cytochrome P·450 inducers is shown in Figure 12. Arter the induction of cytochrome P-
450 in liver with 3MC, ISF, PB and PeN, the microsomal metabolism orQTA in vitro
(Methods section 2,15.1) gave 4(R)-4·0H·OTA as the major metabolite. After induction
with eLF both 4(R) lind 4(5) isomers were produced in increased but equal amounts, and
after induction with INH the 4(8) isomer predominated. Results from a completely
different balch (Batch II) are shown in Figure 13. Figure 14 shows the effect of vehicle
controls of the different inducers of cytochrome PASO on the metabolism of OTA.
3.4 Substrate specificity of cytochromes P-4.;O JIBI and IAI/IAZ.
The substrntes 7-penroxyresorufin (specific for PB inducible cytochrome P·450
lIB I, Lube! et aI., 1985) and 7-ethox.yresorofin (specific for 3MC·inducible cytochrome P-
450 IA 1/IA2, Burke and Mayer, 1983) showed selective or preferential reactions with the
appropriate cytochrome P·450 isoforms. Thus, liver microsomes from PB-treated nilS
dealkylated 7'pentoxyresorufin about 30 times more rapidly than those from control rats,
anrlliver microso.nes from 3MC-tre:lled rats dealkylated it at a rate of only about 4.5 times
that of microsomes from control animals. In contrast, microsomes from 3MC treated rats
dcalkylated 7·ethoxyresorufin about 82 188 times as rapidly as those from controls, and
microsomes from PB treated nits increased its rate of metabolism only about 10.5120 fold
over controls (Table 12).
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3.5 Effect of speciric inhibitors of cytochromes P·4S0 IAIIIA2 and lInl
on the metabolism of OTA in vitro.
Figure IS shows Ihe effect ofcE-na~thon3vone(a known inhibitor of cytochrome
P-4SO IA 1/2. Wiebel et 31., 1971) and metyrapone (a known inhibitor of cytochrome P·4SO
IlBI,Jonencllll.• 1974)00 the mtt:lbolismof OTA lo4(R)4·0H-OTA by microsomes
from PO, 3MC. and ISF ucatments. (-Naphthonavone selectively inhibited the fOml:llion
of 4(R) isomer by microsomes from rats pretreated with 3MC and ISF (- 89/95%
inhibition in both cases: results from two diffcrem experiments). The inhibition was - IRI
41 % using microsomes from rats treated with PD. On the other hand, metyrapone
inhibited the (annation of 4(R) isomer by microsomes from rillS trented with PO (- 94/
96% inhibition), and also inhibited (to a lesser extent) its (ormation (-40/11% and - 40/
16% inhibition) by microsomes from 3MC and ISF trealed I1llS rc...peclively (Figure 15).
The effect of the two inhibitors on 4(S) isomer fOltnlllion WllS Jess sclcctive (Figure 16).
3.6 Effed of monoclonal antibodies (MAbs) against cytochromcs P-4S0 011
the metabolism of OTA by liver microsomn in. ,Urn.
Two main monoclonal anlibodies were used: clone 1-7-1 against cytochrome P..:lSO
1A 1/lA2 and clone 2-66-3 against cytochrome P-4SO 1[81/1182. The pn:ineubation of liver
microsomes from rats pretreated with 3MC, with monoclonal antibody 1-7-1 reduced the
subsequent formation of 4(R)-4-0H-OTA from orA in vitro (Figure 17:1). AI a MAb to
microsomal protein ratio of 5, the fonnation of the 4(S)-isomer was also partially inhibited
(Figure 178). Rabbit 19O was used to detennine the non specific inhibition ofOTA
metabolism in vitro. The preincubation of liver microsomes from row; pretreated with
3MC, with rabbit IgO slighlly inhibited the fonnalion oflhe 4(R)-isomcronly at IgG to
microsomal protein ratio of 5 (Figure 17b). Preincubating liver micro.o;omes from rnl..
treated with P8, with MAb 2-66-3 reduced the subsequenl forrtUtion of 4(R)-4-0H-OrA
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fromOTA in vitro (Figure 18a). At MAb to microsomal protein ratiosof2, 3 and 5, the
Connalion of the 4(S)- isomer was also reduced (Figure 18a). The non specific inhibition
of OTA metabolism resulting from preincubating rabbillgG with liver microsomes from
PB treated rats is shown in Figure 1Sb. Table 13 shows the cross reactivity creach aCthe
two monoclonal antibodies with microsomes from rats treated with PB and 3MC. With
re:;;pect 10 inhibition of the 4(R)-isomer (onnation, MAb 2-66-3 showed greater specificity
towards microsomes from PB-treated rats whereas MAb 1-7-1 showed greater
specificity towards microsomes from 3MC treated rats (Table 13). However, both
antibodies especially 2·66-3 showed substantial cross-reactivity. MAhs against
cytochrome P-450 enzymes are very expensive; if they were to be purchased, the cost
would hllve been several thousand dollars. the fact that we obtained them as a gift and in
small quantity, we were not able to repeat these experiments again.
3.7 Time course of OTA metabolism by liver microsomcs from rats treated
with INH and peN.
OTA metabolism by liver microsomes from untreated (control) rats was very poor
giving rise t04(R)-4-0H·OTA and 4(S)-4-0H-OTA levels that averaged O.oJ5 and 0.014
nmoVmg prolein re.<;pectively over a 30 min incubation period (Table 14). Microsomes
from INH-treat«! rilts were chosen to funher study the 4(S)-isomer fonnation since this
pretreatment induces 4(SHsomer {onnalion (about 7 fold) without concomitantly
increasing 4(R)-isomer fonnation. Microsomes from PCN-trated rats were selected to
study 4(R)-isomcr formation since this pretreatment increased 4(R)-4-0H-OTA formation
55-fold over control microsomes. PCN pretreatment also increased 4(SHsomer formation
by IO-fold overcontrol microsomes (Table 14).
Figure 19 shows the time course of OTA metabolism and lipid peroxidation using
microsomes from INH-prelre3led mts. There was very little 4(R)-4-0H-OTA fonnation
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which reached a maximun 0£0.017 nmoUrng prOiein al40 min. In COOlmst.
4(S)-4-0H-OTA fonnation continued to increase steadily reaching a maximulIl of D.ORO
nmoUrng prOlcin at 40 min, the final time point tested (Figure 19a). In parallel
measurements, MDA fOrmlluon also increased steadily reaching 16 nmoVmg protein by 40
min (Figure 19b). The time course of OTA metabolism and lipid pcroxidation by
microsomes from PeN-pretreated mts is shown in Figure 20. In camms! to microsomcs
from INH-treated mts, microsomes from PeN·treated rats efficiently c3lnlyzcd the
formation of 4(R)-4-0H-OTA which steadily increased 10 about 1 nmoVmg protein at 40
min,lhe final time point tested. 4(S)-4-0H-OTA fomlalion also increased stc3dily with
time to reach 0.17 nmoUrng protein by 40 min (Figure 20a). As in the case of microsorncs
from INH·rreated rots, MDA formation also increased with time reaching 20.5 nmol/mg
protein at 40 min (Figore 20b).
3.8 Effect of pH on OTA metabolism and !.pid peroxidatiun.
The pH optima for the fonnation of 4(S)4-0H·OTA (Figure 21a) and lipid
pcroxidation (Figure 21b) by microsomes from INH·treated rats were 7.0 and 6.5 - 7.5
respectively. 4(R) did nOI show a very distinct pH optimum, possibly because of the very
low levels produced. The pH optima for the fonnation of 4(R)-4·0H-OTA (Figure 22u)
and lipid peroxidation (Figure 22b) by microsomes from peN-treated rUl~ were 6.S and
7.0·7.5 respectively. 4(S) did not show a distinct pH optimum, possibly because of low
levels of production.
3.9 Effect of active oxygen SCQYangers, antioxidants and iron chclalllrs 011
OTA metabolism and lipid peroxidalion.
Tables 15 and 16 shows the effect of superoxide dismutase (SOD), catalase,
mannitol, butylatcd hydroxyanisole (BHA), N,N·diphenyJ-I,4-phcnylcncJiaminc (DI'PD),
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bathophcnanthrolinedisulfonic acid (BPS) and Desferal addition on QTA metabolism and
lipid pcroxidation by microsomes from INH- and PeN-pretreated rots. With microsomes
from INH.pretremed ....lIS, 4(S)·4-DH-0TA fannadan was inhibited 100% by BHA, over
90% by DPPD. Desferal and BPS, aboul30% by mannitol and about 15% by SOD and
catalase. In contrast, none of these agents inhibited 4(R)·4-0H..QTA fonnalion with the
exception of DPPD which exened about 40% inhibilory effect In fact. both Desfeml and
DPS increased the yield of 4(R)-4-0H-OTA by 60-170% with microsomes from both
sources (Table 16). Parallel delcnninations of lipid peroxidation indicated that BHA,
OPPO, Desferal and BPS all inhibited MDA fonnation by >90%, mannitol was slightly
inhibitory (15%) while catalase and SOD had no effeci.
When microsomes from PeN treated rats were used, both antioxidants (BHA and
OPPD) inhibited 4(S)-4-0H-OTA fonnation by - 50% while BPS exened a 35% inhibitory
effect, but SOD, catalase and Oesferal increased 4(S)-4-0H.OTA levels by 35%, 50% and
30% respectively: mannitol was withoul effect. 4(R).4-0H.OTA fonnation was not
affected except by catalase, Desferal and BPS which increased it by about 30%, 100% and
170% respectively. As expected, MDA formation was strongly inhibited by BHA, DPPD,
Desferal and BPS (>90%) while both catalase and mannitol were mildly inhibilory (15-
20%). Figure 23 shows that varying concentrations of BHA inhibited to roughly the same
elttenl both 4(S)·4-0H·OTA formation and lipid peroxidation by liver microsomes from
INH treated roiS. Thus, 2.5 IJ.M and 5 IlM BHA were required 10 completely inhibit
4(S)-4·0H·OTA fonnalion at 10 min and 30 min respectively (Figure 23a), and 5IJ.M
BHA WQS required to inhibit MDA fonnation (Figure 23b) at 10 min and 30min. Lower
concentrations of 8HA were correspondingly less inhibitory. In contrast, 4(R)-4-0H-OTA
fom13tion was not inhibited (data not shown; sec also Tables 16 and 17).
Incubation of liver microsomes from INH- or PCN-treatedl1l.ts with NADPH and
OTA for 30 min resulted in the destruction of cytochrome P-450 by 40% and 75%
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respectively. Inclusion of Desfera1 provided complete protection against cytochrouw: p·450
loss in the case of mlcrosomes from INH·uuted animals. and redlK:cd the cytochrome P-
450 loss from 15% to 37% in the ease ofmicrosomes From PCN-tre:ued animals (Table
16).
Replacement ofNADPH by ascOOxue/Fe2... almost vir1ually c1imin:lled
4(R)-4-0H·OTA fonnation by microsomes from PCN·tre:lled rnts, but did not aITect
4(S)-4-0H-OTA formation by microsomes from either PeN- or INH-tre;llcd rats (ruble
17). As expected, the inclusion of BHA strongly inhibited 4(S)·4.QH·OTA {onnation as
well as MDA (annatia" (-90%) by microsomcs from both sources. Addition of mannitol
did not appreciably change the formation of 4(S)-4-0H-OTA, 4(R)-4-0H-OTA or MDA.
3.10 Effecl of v3rious hemoproteins and hydropcroxides on OTA
metabolism.
Cumene hydroperoxide (CHP, 0.5 mM) could effectively repl:lce NADPl1 in
calalyring lhe formation or 4(R)-4-0H-QTA and 4(S}-4·0H.QTA by liver microsomes
from PCN-treated rats (2 mg microsomal protein/ml) giving 0.53 nnd 0.03 nmol
melabolil~nmol heme respectively (Table 18). By oomparison. HA (5 mM) w:lS much
less effective giving onlyO.Ol5 and 0.013 nmol of the 4(R)· and 4(S)-isomer.;
respectively, while linoleic acid hydroperoxide (LAHP, 65 ~M) was locally ineffective.
When microsomes wert replaced with other hemoprotcins e.g. hcmoglobin or I-IRP (20
mmVrnL), or by hematin (5 nmoVmL) no OTA metabolism was observed in the presencc
ofa variety of hydroperoxides (CUP, 0.5 mM; H202, 5 mM or LAHP, 65 ~M) (fahle
18).
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3.11 Erred of pH on OTA metabolism and lipid peroxidation by liver
microsomes, and on cytochrome P-4S0 content of Chese microsomes.
The pH optima for the formation of 4(R)-4.QH.QTA and 4(S}-4-0H.()TA, and for
lipM:l peroxidation in liver microsomes from rats given different treatments are given in
Figures 22, 24 and 25. The pH optimum for the fonnation of 4(R)·isomer was 6.0 using
microsomes from nilS treated with 3MC (Figure 25) and ISF (data nOI shown), and 6.5
using microsomes form rats treated with PB (Figure 24a) and PeN (Figure 22). The pH
optimum for the form:llion of 4(S)·isomer was 7.0 (Figures 21 a. 2'1a and 25), which
coincided with that for lipid perox.idation (Figures 2Ib, 22b and 24b). Table 19 shows a
comparison between the eFfect of pH 6.0 and 7.4 on OTA metaboUsin using microsomes
from nus treated with 3MC. (SF and PB. The (annadan of 4(R)-isomer increased at pH
6.0 (compared to pH 7.4) by 7.7- and 5,().fold using liver microsomes from 3MC and ISF
treated rats respeclively. AI pH 7.4 (compared to pH 6.0), the formation of 4(S).isomer
increased 3.4- llnd 2.7·fold using liver microsomes from ISF and pa treated rats. Table 20
shows the MDA formed and cytochrome P-450conlenl$ at the end of3O min incubation
using liver microsomes from I'11IS treated with 3MC. ISF and PB al pHs 6.0 and 7.4. More
MDA and lower cytochrome P·450 callenlS were observed al pH 7.4 as compared to pH
6.0. Thus. MDA formed al pH 7.4 was 26.8. 17.1 and 20.2 nmoVmg protein using liver
microsomes (onn rats treated with 3MC.ISF and PO as compared to 18.9.8.0 and I!,S
nmoVmg prol:ein respectively at pH 6.0 (or microsornes from the same sources. At pH
7.4.1hc percentage loss of cytochrome P4S0 contents was 57. 43 and 59 using liver
microsomes (onn rals treated with 3MC, ISF and PB as compued 1032,15 and 51
respectively al pH 6.0 for microsomes from the same sources (fable 20). It seems that the
loss in cytochrome P·450 at pH 6.0 for microsomes from 3MC and ISF trealed rats is nOI
as much as thaI for microsomes from PB treated mlS. This may, partly. explain the 5.Q..
and 7.7·fold increase in the 4(R) isomer formation (al pH 6.0) using microsomes from ISF
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and 3MC treated rats, and fhe 1.8-fold increase using microsomcs from PB trented nils
(Table 19). It aJso seems !hat the loss in cytochrome P-450 is gremcr when Ihere is more
lipid peroxidation (i.e. at pH 7.4 compared to pH 6.0. Table 20).
3.12 Effecl of pH on Ihe Km and Vmax of OTA hydroxylase in liver
mlcrosomcs from rats treated with 3MC and 'SF.
The Km forOTA hydroxylation (measured at pH 7.4) was calculated to be 74 ~M
for microsomes from rats treated with 3MC (Figure 26a), whereas lhe Vmax wns 38
pmoVminfmgprotein. AlpH 6.0, Kmdropped 1031 11M and Vmax increllsed to 195
pmoVmin/mg protein (Figure 26b). The Km and Vmalt for OTA hydroxylation (mc:lsurcd
at pH 7.4) by mh:rosomes from rats treated with ISF were 92 11M and 13 pmoVmin/mg
protein (Figure 27a). The corresponding values at pH 6.0 were 150 JIM and 27!J
pmoVmin/mg protein (Figure 27b).
3.13 III .,;110 experiments.
3.13.1 Effect of PO treatment on OTA-induced release of enzymes ill IIle
urine.
Figure 28 shows urine alkaline phosphatase levels both in PB-treated and control
ral groups on day 0 (before OTA treatment) and days )-5 of OTA treatment. Enzyme level
was elevated significantly (compared to base !inc, day 0) on the founh day ofOTA
treatment in the control group (four fold increase), whereas there was no increase in
enzyme level for the PB-treated group. In case of ¥ -glutamyl i,'ansferase, enzyme levels in
the urine increased on days 1, 2. 3 and 4 afOTA treatment in the control group by 2.5-,
2.0-, 1.7- and 3.5-fold (compared to base line. day 0). For the PB group. cnzyme levels
increased al days 2 and 3 by 2.7- and 2.6-fold (Figure 29).
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Transpon of the anion p·amino hippurate (PAH) in kidney conex slices obtained
from PB'pretreated rats lfCaled with OTA (PB +OTA) and rats treated with OTA (OTA)
was significantly inhibited to the same extent (55% - 60%) as compared to control animals
(C) (Figure 30). However, there was no significant difference between the two groups
(OTA and PO + OTA) in terms of their inhibition orPAH transpon (Figure 30).
3.13.1 Effect of PD freatmcnl on (he distribution of OTA.
Figure 31 shows the percentage of adminISlered [3H10TA found in serum and urine
efP8-treated and control rats 6 hr afterOTA administrntion. Even though it was not
significantly different, there was a tendency of increased OTA concentration in the serum of
control (12.4% of administered dose) as compared to PB-treated rats (8,4%), whereas
there was an increase in OTA concentration in the urine ofPB treated rats (5.2%) as
compared 10 control rats (2.0%). OTA levels in the liver (1.5% for control group and
1.24% for the PB·treated group) and the kidney (0.15% for control group and 0.13% for
PB group) did not show a significant difference between the two groups (Figure 32). The
percentage of the toxin accumulated in the whole organ is more in the liver (1.2% - 1.5%)
as compared to the kidney (0.13% -0.15%), buton a per gram basis, more toxin
accumulated in the kidney than in the liver. This is in agreement with the finding ofGaitier
el al. (1979). The pc:reenlage of administered [JHjOTA in the gut tissues (stomach, the
four ponions of smail intestine :lnd cecum) are shown in Figure 33. The levels of OTA in
the gut contents are shown in Figure 34. HigherOTA levels were found in the small
intestinal tbsuc (2 - 6 fold increase) and gut contents (4 - 8 fold increase) of control rats
thanofPB rots.
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Table 8. Involvement or EDTA or cytochrome P·450 in the
stimulation or lipid peroxidation by OTA in a reconstituted
system.
Addition to system MDA rormcd
(nmol/mL)
20 min 40 min
Exp.1 Exp.2 Exp.1 E ....).2
None 1.65 2.20 2.46 4.60
EDTA (25 nmol/mL) 6.62 7.45 10.24 13.6
EDTA (50
nmol/roL) 5.14 6.30 7.96 11.20
Cyt. P-450 (0.3 nmol/mL) 4.30 6.20 7.11 10.03
Cyt. P~450 (0.5 nmol/mL) 5.35 4.40 8.45 9.78
Incubations were carried out as described in the Methods section 2.14.1. Each of
the two experiments were carried out in duplicate. MDA values arc mcans of the
two separate incubations.
Figure 9
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Eff«t of <:ytoc:hromc P-4S0 <:on<:cnlrQtion 011 OTA slimulDlcd
lipid pcroxidalion.
Incubations were carried out in doplicatc :1.I37OC for 20 and 40 min in
0.25 M Tris·HCl buffer, pH 6.W.25 M NaCI and conlaincd per lilt.:
phospholipid vesicles (1 pmol Pl, In ng Fp (3.2 units), 500 nmol OTA,
varying amounts of cytochrome P-4SO (o· 0.3 nmol), liD nmol Fel' :ll\d
200 nmol NADPH. The reaction volume W3S I mL Results of hvo
separnte experiments {A and B);m shown.
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Table 9. Requirement for cytochrome P·450 in NADPH·dcpcndcnl
lipid pcroxidation.
HemoprotcinlTrcatmcnt
None
Cyt. P~450
C)'t. P·450 (heat denatured) I
Cyl. P·450 +carbon monoxide 2
Hematin
Hemoglobin
Cyt.c
Horseradish peroxidase
MDA formed
(nmol/mL)
1.98
7.56
2.02
7.33
2.12
2.67
2.43
2.38
Incubations were carried oul for 40 min as described in the Methods section
2.14.1. Hematin and all hemoproteins were added in an amount corresponding to
0.3 nmol heme/mL. MDA values are means from quadruplicate incubations Ihal
did not vary from eaeh other by more than 10%.
ll000Cfor2min.
ZCarbon monoxide was bubbled through the incubalion mixture for 30 scc prior
to addition of OTA.
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Figure 10 Effect of depleting cytochrome P.4S0 on OTA stimulated lipid
pcroxidation.
Incubations were carried oul in duplicate at37CiC for 0, 5, 20 and 40 min
in 0.1 M phosphate buffer, pH 7.4 and containcd permL: 2 rng
microsomal protein (from control or Co-heme treated rats). and 125 nmol
OTA. The reaction was initiated with 1 roM NADPH (final
concentration). "fhe reaction volume was I mL, Microsomes from rats
treated with Co-hemc (before use in lipid permddation) were first fonified
for Fp by incubating them with the purified enzyme preparation (as
described is the Methods section 2.12. Results of two separate
experiments (A and B) from two different animals are shown.
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Table 10. Errecl of Co·heme pretreatment on Iivf!.r microsomal
NADPH.cytochrome P.450 reductase (Fp) and cytochrome
P·4S0 levels.
Treatment
None
Co-heme
Co-heme + Fp
P-450 Reductase I
88.2 ± 7.3
22.3 ± 2.7'"
70.1 ± 6.8'"
Cytochrome P-450 1
2.92±0.31
0.60 ± 0,05*
0.57 ± 0.05*
Animals received either Co-heme (50 ~niolJkg body weighl; sub-cutaneously)
or saline 9 days nnd 2 days prior to being sacrificed. NADPH-cytochrome P450
reductase and cytochrome P·4S0 levels were detennined as described in the
Methods seclions 2.11 :lI'Id 2.9. Results are~ns ± S.D of values from four
individual raLs/treatmenl group. "', means significantly different from no
rreatment (p < 0.05. Mann Whitney tcst).
) nmol cytochrome c reduced/min/mg protein
2 "mol/mg protein
Figure 11
"I
HPLC profile of OTA and its metabolites <I(R). lind 4(8)·4-
OH-OTA.
Typical HPLC profile of OTA metabolitcs fonm:d during incubation of
OTA wilh liver microsomes from peN treated flitS. OTA metabolites wcm
analysed as described in the Methods section 2.15.3. Extracted sample:
(50~ of 0.5 roL) was injected into a Perkin Elmer-St·rics 4 liquid
chromalograph. The column used was Partisil 10 OD8-2. TIlc solvclll
system consisted of a mixture of a) acctonitrile: meth,mol (500:50:), v/v)
65% and b) 5 mM sodium acetate;acetic acid (500:14, v/v) 35%. 111C flow
F.lte was 1.5 mLlmin and the fluorometric detection was performed at
excitation wavelength of 340 nm, emission wavelenglh of 465 11111 and
excitation/emission slits of5/10 nm.
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Table 11. Total cyrochromes P-4S0 content of liver microsomes
isolated from rats followlng various treatments.
Treatment-
Control
PO
3·MC
Clofibrate
Isosafrole
PCN
Isoniazid
Cyt. P·450 contcnl
(nmol/mg protein)
0.85 ±0.07
2.15 ±O.14*
1.70 ± 0.18·
lAO ± 0.20·
1.00 ±O.02'"
1.45 ±O.I7*
0.80 ± 0.03
... The various treatments are given in Table 7. Values shown are
means ± S.D. of duplicate detenninations from four individual "liS
per treatment group.•, means significantly different from conlrol
(p < 0.05, Mann Whitney lest).
Figure J2
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The form:alion of 4(R). and 4{S)·4·0H·OTA in vitro using
liver microsomes from rals Ireal<!d wilh dirf<!rent induc<!rs of
cytochrome P·450.
Incuh:ations were camed out in triplicate at 370C for 30 min in 0.1 M
potassium phosphate buffer (pH 7.4) and contained per mL: 2 mg
microsomal protein, 125 nmol OTA and a NADPH-regenernting system
(consisting of 0.4 IlfllOl NADP~. 5 JlmoJ MgCh. 5 Jlmol DL-isociuate and
0.65 units of isocitric dehydrogenase). Details are described in the
Methods section 2.15.3 for analysis of metabolites. Results are means ±
S.D. of four individual rats per treaunent group. These results are from
Balch III. Results from Batch II (a completely different batch orall
treatments) mshown in figure 13. Balch I (nOI shown) was a trial run to
detennine lite optimum dt;)ses of the various cytochrome P-450 inducers
and lheir effects on OTA metabolism. *, means significantly different from
control (p < 0.05, Mann-Whitney test).
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The formallon of 4{R). and 4(S).4.01l.0TA in vitro using
liver mk..-osomes from rats trealed with different inducers or
cytochrome P·450 (Batch 11).
Incubations were carried out in lriplicate at 370<: for 30 min in 0.1 M
potassium phosphate buffer (pH 7.4) and contained per mL; 2 mg
mk:rosomal protein, 125 nmol OTA and a NADPH-regenerating system
(consisting of0.4 pmol NADP+• .5 J.1rnOI Mg02• .5~I DLrisocitrate and
0.6.5 units o( isocitric dehydrogenase). Details L-e described in the
Methods section 2.1.5.3 (or analysis of metabolites. Results are means ±
S.D. of lhree individual rats per U'eatment group.
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Figure 14 The formation of 4{R). and 4(S)·4.0U.OTA in ~itro using
liver microsomcs from control rals treated with the vchides
of (he dirrcrcnt inducers of cylochrome P-4S0.
Incubations were carried out in triplicate at 370C tor 30 min in 0.1 M
potassium phosphate buffer (pH 7.4) and contained per mL: 2 mg
microsomal protein, 125 nmol OTA and a NADPH-regenerating system
(consisting orO.4 jlmol NADP+, 5 pOlOI MgCI2. 5 jlmol DL-isocittate and
0.65 units of isociuic dehydrogenase). Details are described in the
Methods section 2.15.3 for analysis of metabolites. Results are means ±
S.D. of three individual rats per treatment group. Results are plolted 10 lIle
same scale as the figure afme actual treatments (Figure 12 in the Results
Section) for comparison.
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Table 12. Ethoxy. and pcnfoxyrcsorufin O·dcalkylation by liver
microsomcs from control. 3MC and PO treated rats.
Sample PROD EROD
(pmollesorufin released/min/mg protein)
Exp.l Exp.2 Exp,) Exp.2
Control 17.8 19.4 22.4 19.0
3MC 82.2 83.3 1840.0 1678.2
PO 543.6 594.7 234.1 379.7
Details arc described in the Methods section 2.16. Results are means of triplicate
incubations from two separate experiments.
Figure 15
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Erred of the cytochrome P·450 inhibitors l(-nnphlhon:lVone
(SO j.lM) and metyrapone (100 j.lM) on (he mdDbolism of OTA
to 4(R).4·OH·OTA by liver microsomts from PO, 3MC nnd
ISF trealed rats.
Incubations were carried out in duplicate::at 370C for 20 min in O. t M
potaSSium phosphate buffer (pH 7.4) and contained per mL: 2 mg
microsomal protein. 125 nmol OTA and a NADPH·~gener.tting system
(consisting of 0.4~I NADP+. 51!mol MgOz. 5 J,lmol DL-isocilr:lIe and
0.65 units of isocitric dehydrogenase). Det3.ils~ described in lhc
Methods section 215.3 for ::analysis of metabolites. Results arc means of
two sepanue experiments (A and B) from [wo differenlllnimals. The
uninhibited activity was normalized to 100%. The uninhibiled values were
0.58/0.53 for PB, O.38,u.87 for 3MC and 0.51/1.19 for ISF omol 4(R)·
4·0H·OTNmg protein.
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Erred of Ihe cylochrome P-450 inhibitors .·naphlhonavonc
(50 IlM) and metyrapone (100 J.1M) on (he metabolism of OTA
10 4(S).4·0H.OTA by liver microsomcs from PD, 3MC and
ISF (realed rats.
Incubations were carried out in duplic:l\e at 370C for 20 min in O. I M
potassium phosphatc buffer (pH 7.4) and contained per mL: 2 mg
microsomal protein. 125 nmol OTA and a NADPH-regenerJting system
(consisting of0.4 lJ.mol NADJ4. 5 J.1.mol MgCh. 51-10101 DL-isocitratc nnd
0.65 units of isocitric dehydrogenase). Details arc: described in the
Methods section 2.15.3 for analysis of mctabolitcs. Results are mcalls of
two separnte experiments (A and B) from two diffcrcnl anim.,ls. 111C
uninhibited activity was normalized to 100%. Thc uninhibitcd values were
0.18/0.20 for PB. 0.13/0.14 for 3MC and 0.0910.13 for ISF nmol 4(R)-
4-0H·OTNmg protein.
94
C
0 100
'C A
'"§
<E
~ 75
0
:i: 50i
~
'<T 25
tf
PB 3MC ISF
• ·lnh
I"'l .NF
IIIl • Met
".~ 100
E
<E 75~
~ 50
0
i
~ 25
....
tf
PB 3MC ISF
95
Figure 17a Effect or monoclonol antibody (MAb) 1-'-1 on the
metabolism or OTA by microsomes from fnls trcured with
3MC.
MAb WllS preincubated with microsomes in 0.1 M potassium phosphate
buffer (pH 7.4) for 30 min at room temperature. Microsomal protein
concentration was 2 rnglmL and the lotal incub:uion volume was 100 pL
Reaction was started by adding substrate (OTA. 125 11M) and NADPH·
regenerating system and was carried out in duplic;llC al 37OCfor 30 min.
Figure 17b Effect or rabbit IgG on the metabolism of ()TA by
microsomes trom rals treated with JMC.
IgG was preincubated with microsome... in 0.1 M potassium phosphate
buffer (pH 7.4) for 30 min at room temperature. Microsomal protein
concentration was 2 mg/rnL and the tOlal incubation volume was 100 ilL
Reaction wasslnrted by adding substrate (OTA, 1251lM) and NADPH·
regenerating system and was carried out in duplicate III 37OCfor 30 min.
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97
Effect of monoclonal antibody (MAb) 2·66-3 on the
metabolism of OTA by microsomes from rats treated wilh PD.
MAb was preincubated with microsomes in 0.\ M potassium phosplullc
buffer (pH 7.4) for 30 min at room tcmperalUre, Microsomal protein
concentration was 2 mg/rnL and the total incubation volume was 100 ilL.
Reaction was started by adding substrate (OTA, 1251lM) and NADPH-
regenerating system and was carried out in duplicate at 370C for 30 min,
Efff'-:1 of rabbit IgG un Ihe metabulism of OTA by
microsomes from PO treated rats.
IgO was preincubated with microsomes in 0,1 M potllSsium phosphate
buffer (pH 7.4) for 30 min at room temperature. Microsomal protein
concentration was 2 mg/mL and the total incubalion volume WBS 100 IJ.L.
Reaction was started by adding substrate (OTA, 1251lM) and NADPH-
regenerating syslem and was carried OUI at 370C for 30 min.
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Table 13. Cross reactivity of MAb 1·7·1 and 2·66·3 with
cytochromes P·450 in liver microsomes isolated frollt
rats treated with PB or 3MC.
Treatment
4(R)-4·0H·OTA InhlMUon (%)
MAb
1·'·)·
PB
3MC
23.2
63.8
58.3
39.0
Treatment
4(S)-4·0H·OTA Inhibition (%)
MAb
2-66-3·
PB
3MC
19.2
0.0
38.0
15.0
Conditions are as described in the legend of Figure 17a.
.. MAb protein/microsomal protein 2 : I.
100
Table 14. Effeel of INH- and peN-pretreatments on hepatic
cytochrome P·4S0 levels and OTA metabolism.
Pretreatment Cyt. P·4S0 4(R).4-0H.OTA 4(S).4·0H-OTA
-----------nmolimgprowin-------------
None
!NH
peN
0.85 ± 0.07
0.80 ± 0.03
1.45 ± 0,17'"
0.0l5± 0.004 0.014± 0.006
0.032 ± 0.030 (2) 0.093±Q.031 (1)'
0.816 ± 0.150 (55)' 0.194±O.040 (14)'
Pretreatment of rats and measurement of cytochrome P·4S0 levels and OTA
metabolites was carried out as described in the Methods (sections 2.5.1, 2.9 and
2.15.3). Values shown are means ± S.D. from four individu:l1 rats. The
numbers in parenthesis arc fold increase in OTA metabolites compared to no
treatment.
*'. means significantly different from no treatment (p < 0.05, Mann Whitney
lest).
Figure 19
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A. Timc course of OTA metabolism by Iivcr mlcrosolllcs
from INH·trealcd rals.
B. Time course of lipid peroxidation in liver microsomes
from INH·(rcated rals.
Incubations were carried out nt370C in 0.1 M potassium phosphate buffer
(pH 7.4) and contained per mL: microsomal protein (2 mg). 125 nmol
OTA and a NADPH·regenernting system (see Melhods section 2.15.1).
At timed intervals, two 0.5 mL samples were withdl"'J' vn, one for IIPLC
analysis ofOTA metabolites, and the other for measUlemcnl of MDA
levels. Details aredeseribed in the Methods seclions 2.15.3 and 2.14.2.
Results are means of duplicate detenninalions from each of two scp.mtc
experiments. The difference between the two means at all time poillls was
no more than 23% for metabolism and 16% for lipid pCTOxidalioll. 111C
relatively high degree of variation is likely due to the cytochrome P-450
content of liver microsomes from every individual animal, also due to the
fact that lipid peroxidation is a chain reaction and the f"Jtcs of proragmion
are known 10 vary greatly from an experiment 10 another.
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Figure 20 A. Till1C course of OTA metabolism by liver microsomes
from PeN·treated fats.
n. Time course of lipid peroxid3tion in liver micrusol1les
from PeN·treated fats.
Incubations were carried out at 370(; in 0.1 M potassium phosphate buffer
(pH 7.4) and contained per mL: microsomal protein (2 mg), 125 nmol
OTA and a NADPH-regenerating system (see Methods seeLion 2.15.1).
At timed intervals, tWO 0.5 mL samples were withdrawn, one for HPLC
analysis crOTA metabolites, and the other for measurement of MDA
levels. Details are described in the Methods sections 2.15.3 and 2.14.2.
Results are means of duplicate determinations from each of two Separ:llc
experiments. The difference between the two mCllnS lit all time poillls WllS
no more than 18% formelabolism :lnd 21% for lipid pcroxidation. l1lc
relatively high degree of variation is likely due to the cytochrome p·450
content of liver microsomes from every individual animal. 1ll!'.O due 10 tile
fact that lipid pcroxidation is a chain reaction and the rates of prop:lg,uion
are known to vary greatly from an experiment 10 another.

Figure 21
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Erred of pH on OTA mC!labolisrn (A) and lipid pcroxidntion
(8) by 1i"C!r microsomes from INH4rcatC!d rats.
Incubations were carried out at 370<: in 0.1 M potassium phosphate (pH
5.5 - 8.5) and contained in a total volume of 1 mL: microsomal protein (2
mg), 125 nino} OTA and a NADPH.regeneroting system (see Methods
section 2.15.1). At the endcf3Q min, 0.5 mL from eneh incubaticn was
withdrawn for HPLC analysis of OTA metabolites, and the remaining 0.5
mL was used for measurement of MDA levels. Details are described in the
Methods sections 2.15.3 and 2.14.2. Results are means of duplicate
determinations from each of two separate experiments. TIle difference
between the two means at all time points was no more than 20% for
metabolism and 10% for lipid peroxidation. The relatively high degree of
variation ie likely due to die cr:ochromc P-450 content of liver
microsomes from every individual animaL
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Erred of pH on OTA melnbolism (A) lind lipid peroxidntion
(8) by liver microsomes (rom PCN·lrcnled rats.
Incubations were carried 0\11 al 370C in 0.1 M poc:lSSium phosphate (pH
5.S • 8.5) and contained in a total volume of I mL: microsomal protein (2
mg), 125 nmol OTA and a NADPH-regenerating sySiern (see Melhods
sectioa 2.15.1). AI the end of 30 min, 0.5 mL from each incubation WIS
withdrawn forHPLC analysis ofOTA metabolites and the rem:lining 0.5
mL was used for measlnment of MDA levels. Delails are described in the
Methods sections 2.15.3 and 2.14.2. Results llre means of duplic:ue
detenninations from each of two separate experiments. The difference
between the two means at all time points was no I't'Klre than 40% ror
meta.bolism and 16% ror lipid peroxidalion. The high degree: or variation
is likely due to the cytochrome P-450 content or liver microsomes rrolll
every individual animal, also due to the fact thou lipid peroxidation is:1
chain reaction and the nlles or propagation nrc known to vary srcat1y from
an experiment to another.
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Table 15. Effect of active oxygen scavengers and antioxidant on
NADPU-dependent OTA metabolism and lipid
peroxidation.
Addition 4(R).4.0H·OTA 4(S).4·0H·OTA MDA
--------nmoJ7mgproie7ii----------
Eltp.l/ Exp.2 Exp.11 Exp.2 Exp.ll Exp.2
INH mlcrosomcs
None 0.012/0.016 0.094 / O. 106 26.4/26.9
SOD (35 units) 0.012/0.018 0.008/0.092 26.2/27.5
Catalase (800 units) 0.012/0.018 0.079 / 0.093 24.3/26.5
Mannitol (11 mM) 0.012/0.016 0.060/0.082 22.7/22.9
peN microsomes
None 0.63/0.71 0.19/0.21 23.1/24.7
SOD (35 units) 0.66/0.80 0.24/0.30 19.0/23.4
Catalase (800 units) 0.78/0.94 0.28/0.34 20.5/20.8
Mannitol (Ii mM) 0.69/0.84 0.20 /0.28 19.1/19.8
Incubations were carried oul for 30 min as described in the Methods section
2.15.1. Results are means of duplicate determinations from each of two separate
experiments.
Table 16. Errect of antioxidants and iron chelators on OTA metabolism, lipid per-oxidation and
cytochrome P·450 content.
Addition 4(R).4·0H·OTA
Exp.I/Exp.2
4(Sj.4·0H·OTA MDA
nmollmg protein
Exp.1 / Exp.2 Exp.l/ Exp.2
CytDchromeP·450·
INH microsomes
None 0.012/0.016 0.094/ 0.106 24.5/25.1 0.49 (40 % Loss)
Dcsfernl (SO J1M) 0.025/0.031 0.005 / 0.008 U5/I.31 0.83 ( 0 % Loss)
BPS (IooJ1M) 0.019/0.025 0.007 / 0.009 0.81/0.89
BHA(IO~M) 0.01l/Om5 <0.001 1.93/2.05
DPPD (10 J1M) 0.005/0.011 0.010 / 0.012 0.68/0.72
peN microsomes
None 0.63/0.71 0.19/0.21 21.9/233 0.33 (/5 % Loss)
Desfernl (SO ~) 1.32/1.54 0.24/0.28 1.20/1.64 0.82 (37 % Loss)
BPS(IOO~) 1.74/1.86 0.12/0.14 1.00/1.10
BHA (10 J1M) 0.65/0.69 0.09/0.11 1.90/2.4
DPPD (I0J1M) 0.74/0.78 0.09/0.11 0.81/0.89
Incubations were carried out for 30 min as described in the Methods section 2.15.1. Results are means of duplicate
detenninations from two separate experiments.• The original cytochrome P-450 contents were 0.83 and 1.32
nmoVmg protein for microsomcs isolated from rats treated with JNH and peN respectively.
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Figure 23 Erred of varying DHA concentrations on (A) OTA
metabolism and (8) lipid peroxidntion by live!" microsomes
from INH-trealed rats.
Incubations were carried out at 370(: in 0.1 M potllssium phosphate (pH
7.4) for 10 and 30 min in the presence of 0 - 10 JlM 8HA, and contained
ina total volume of I mL: microsomal protein (2mg), 125 nmol OTA llnd
a NADPH-regenerating system (see Methods section 2.15.1). Altho end
of 30 min, O.S mL from each incubation was withdrawn for HPLC
analysis of orA metabolites and the remaining 0,5 mL was used for
measurement of MDA levels. Detail:; are described in the Melhods
sections 2.15.3 and 2.14.2. Results are means of duplicate dClcnnimuions
from each of two separate experiments. The difference between the two
means at all time points was no more than 33% for metabolism and 30%
for lipid peroxidation, The relatively high degree of variation is likely due
to the eytochrome P-450 content..,f liver microsomes from every
individual animal, also due to the (net that lipid peroxidalion is 3 chain
reaction and the rates of propagation are known to vary greatly from nn
experiment to another.
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Table 17. Effect of nHA and mannitiol on ascorbate.dependent OTh
metabolism and lipid peroxidation.
Addition 4(RH·OH·OTA 4(S)·4·0H·OTA MDA
nmoJlmg protein
Ex.p.1 I Exp.2 Exp.1 I Exp.2 Exp.! I Exp.2
INH microsornes
None 0.018/0.028 0.125/0.155 33.3/ 35.7
Mannitol (II mM) 0.014/0.020 0.150/0.184 29.5 /34.1
BHA(lO~M) 0.014/0.021 0.012/0.028 250/2.96
peN microsomes
None
Mannitol (11 ruM)
BHA(lO~M)
0.010 / 0.050
0.021 /0.037
0.020 / 0.026
0.129/0.137 28.2/33.<
0.122/0.138 26.1/29.0
0.008/0.016 0.77/0.81
Incubations were carried out for 30 min as described in the Methods seclion 2.15.\
with the exception thai ascorbate/Fe2+ (l mM/S JiM, final concentrations) were
used instead of NADPH·regenerating system. Results arc mean of duplicate
detenninations from two separate experiments.
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Tablel8. Ability of various hemoproteins/hydroperoxides to
melabolize OTA.
System 4(R)-4-0H-OTA 4(S)·4-0H·OTA
PeN microsomes/CHP
PCN microsomes/HzOz a
PCN microsomeslLAHP
H!>'CHP
Hb/LAHP
Hematin/CHP
Hcmatin/HzOz
HematinJLAHP
nmollnmof heme
0.530/0.536 0.017/0.039
0.014/0.016 0.012/0.015
< O.OOlb < 0.001
<0.001 < 0.001
<0.001 < 0.001
<0.001 < 0.001
0.005 / 0.008 0.007/0.015
0.006/ 0.009 0.002/0.004
<0.001 < 0.001
Incubations were carried out for 30 min as described in the Methods section
2.15.1. For the different reagents, the following concentrations were used (in 0.5
mL reaction volume): PCN microsomes (1 mg protein), Hb (10 nmol), Hematin
(2.5 nmol), CHP (0.5 mM), H202 (5 mM). LAHP (65 ~M). Results are means of
duplicate incubations from each of two separate experiments.
a 150 11M hydroxylamine included to inhibit contaminating calalase.
b detcction limit.
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Figure 24 Effect of pH on OTA metabolism (A). and lipid p~roxidntion
(B) by liver mlcrosoml!S from PO treated rots.
Incubations were carried out in duplicate 01 370C for 30 min in O. t M
potassium phosphate buffer (pH 5.5 - 8.5).nnd contained in a tOlal
volume of IlnL: microsomal prolein(2 mg), 125 nmolOTA lUld a
NADPH-regenerating system (see Methods section 2.15.1). At lhe end of
30 min. 0.5 mL from each incubation was withdrawn for HPLC analysis
of OTA metabolites, and the remaining 0.5 mL was used for measurement
of MDA levels. Details for analysis of melllbolites are described in the
Methods section 2.15.3. Results are means of duplicate delenninations
from each of two separate experiments. The difference between lhe two
means at all time poims was no more than 17% for metabolism and 16%
for lipid peroxidalion. The relatively high degree of vari:uion is likely due
to the cytochrome P-450 CQment of liver microsomes from every
individual animal. also due to the fact thallipid peroxidation is a chain
reaction and the rates of propagation an: known 10 vary greatly from nn
experiment to :lI1othcr.
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Effecl of pH on OTA metabolism by Ih'er microsomes from
3MC lreated rats.
lneubations (0.5 mL volume) were carried oot in duplic.llc:1I 310C for 30
~n~~~~i~t~rn<r~~).bi~e~~1MA ~;]~and contained
NADPH·regeneratingsystcm(see Methods section 2.15.1). Dctailsfor
analysis of metabolites are dcsaibcd in the Methods section 2.15.3.
Results arc means ofduplicate dctenninations from each of two scpar,lle
experiments. The difference between the two means :It :Ill time points W:lS
no more than 31%. The: high degree of v:triation is likely due 10 the
cytochrome P-450 content of liver microsomes from every individunl
animal.
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Table 19. Comparison of the ability of microsomcs isolated from
rats treated with 3MC. ISF and PO to mclnbolizc OTA al
pH 6.0 and 7.4.
Group pH 4(S)·4·0H·OTA 4(R)·4·0H·OTA
(nmol/mg protein)
3MC 6.0 0.057 ± 0.030 7.98 ± 3.10
3MC 7.4 0.109 ± 0.060 1.03 ±O,45
ISF 6.0 0.033 ± 0.010 5.58 ± 4.02
ISF 7.4 0.111 ± 0.045 1.12±0.66
PB 6.0 0.042 ± 0.033 0.63 ± 0.21
PB 7.4 0.112 ± 0.053 0.34 ± 0.23
Details for conditions are described in the Methods section 2.15.1. Incubations
were carried out in duplicate. Results are means ± S.D. from three different
animals.
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Table 20. The effect of pH 6.0 and 7.4 on the ability of microsomes
isolated from rats treated with 3MC, ISF and PB to
undergo lipid peroxidation and cytochrome P·450
destruction.
Treatment pH MDA Cyt. P·450 Loss (%)
(nmol/mg protein)
3MC 6.0 18.9±8.3 31.6 ± 7.0
3MC 7.4 26.8 ±7.2 57.3 ± 3.5
ISF 6.0 8.0 ±6.9 14.7 ± 20.5
ISF 7.4 17.1 ±5.6 42.6 ± 20.8
PB 6.0 11.8 ±8.8 51.1 ± 23.9
PB 7.4 20.2 ± lO.2 59.2 ± 25.4
Incubations were carried out 31 370C for 30 min in 0.1 M potassium phosphate
buffer (pH as indicated in the Table), and contained per mL: 2 mg microsomal
protein, 125 nmol OTA and a NADPH-regenerating SyS!t:.ffi (see Methods section
2.15.1). The reaction volume was 3 mL. At the end of30 min, 0.5 mL was
withdrawn for measurement of lipid perox.idation and the remaining volume was
diluted 1: I using the same incubation buffer (pH 7.4) (0 give 1 mg microsomal
prorein/mL for measurement of cylochrome P-450 (see Methods section 2.9).
Results are mean ± S.D. from three different animals.
Figure 26
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Erred of pH on the Km and Vrnax of OTA hydroxylation by
liver micro$omes from 3MC treated rats.
Incubations were carried out in dupHc:ne at370C for 30 min in n.t M
potassium phosphate buffer (pH 6.0 or pH 7.4), and contained per Ill!.:
microsomal prolein (2 mg), QTA (10,25,50,75. l2511nd 250 nmol) and
a NADPH !:egenerating system (see Methods section 2.15.1). TIle
amounts of hydroxylated OTA in nmoUrng protein (the initial velocities)
wercmeasured at 30 min (the reaction was linear up to 60 min). Only the
majormetabolitc4(R)-4-OH-DTA was considered in this casc. Dctail5 for
analysis of metabolitcsare described in the Methods section 2.15.3.
Results are means of duplicate determinations from each of two sepamte
experiments. The difference between the two means at all time points W<LS
no more than 30%.
I.' 122
, 1.0
.,
~ 0.'
r 0.'I
5 OA
0.' .. (pH 6.0)
-0.05 0.00 0.05 0.10
l/S u,..Mf'
10
,
c
i
E a~
I
~
(pH 7.4)
-0.05 0.00 0.05 0.10
I(S (.u"I-'
Figure 27
123
Effed of pH on Ihe Km and Vmax of OTA h1droxylalion by
Ii\ler microsomes from ISF treated rals.
~=:'~~~h~~f~t(~J':r.~w;t;~t;,~i:a:~':'J~~lr~L:
microsomal protein (2 mg).OTA (10, 25, 50, 75,125 and 250nmol) and
J. NADPH·n::genCfllting system (see Methods section 2.15.1). The
amounts of hydroxylated OTA in nmoVmg proIein (the initial \lClocitics)
were measured at 30 min (lhereaction was linear ul? to 60 min), Only the
major metabolite 4(R)-4-OH-OTA was considered In this case. Demils for
analysis of metabolites are described in the Methods section 215.3.
Results are means of duplicate determinations from each of two separtllc
experiments. The difference between the two means at all time points WllS
no more than 30%.
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Alkaline phosphatllse activit)' in urine! or control and PD·
Irellted rllts following OTA administrlltion.
~c£ug~~~s":fa~tv~l~r~~~~'~~~r:~~nd
enzyme measurements m given in the Methods sections 2.5.1, 2.6.1 and
2.18.1. Results are means± S.D. (n '" 8 animals per treatment group).
• , means significanlly different from cby 0 (p <0.05, Mann·Whitney
test).
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"ll'-Glutamyl transferase activity in urincs of control and 1)11_
treated rats following OTA administration.
Both groups of rats were given orally OTA (0.5 mg/kg in 50 lIlM
NaHC0) daily for 5 days). Delails of pretrenlments, treatmcnl~ and
enzyme measurements arc given in the Methods sections 2.5.1, 2.6.1 and
2.18.1. Resultsnre means ±S.D. (n:: 811nimnls pcrtrentnlCntllroup).
• , means significantly different ronn day 0 (p < 0.05, Mann-Whitney
test).
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Figure 30
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(t4CjPAH Iransport in renat cortex slices from conlrot (C),
OTA treated (OTA) and PH-pretreated Ireoled with OTA (rn +
OTA) rats.
Rats were given orallyOTA (0.5 mg/kg in 50 mM NaHCOJ daily for 5
days. Details of pretreatments, ttealmenlS and PAH transJXlrt are given in
the Methods sections 2.5.1, 2.6.lllnd 2,17. Results are expressed RS
S/M (slice/medium) mtio at 10 llnd 30 min anJ represent means ± S.D. (n
"" 4 animals per tretment group).•, means significantly different from
control (p <0.05, Ml1Iln·Whitney test).
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Figure 31 PHJOTA levels in serum and urine of control Dnd Illl·treBled
rats 6 hours ancr one oral treatment with (JIIIOTA (28K
~g/kg in 50 mM NcIlCOJ)'
Details for treaunents, sample processing and mdio:tclivity counting are
given in the Methods sections 2.6.2 and 2.18.2. Results nrc means ±
~~~~no~:O~~~O.~~ ~aa~~~~I~ei~~s·t).mcans significanlly different
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Figure 32 [3HlOTA levels in liver and kidney of control Dnd IlB·trealed
rals 6 hours arter one orallrealmenl wilh (JHj()TA (28K
~g1kg in SO mM NalleOJ).
Delails for treatments, sample processing and r:ldioaclivily counting are
given in the Methods sections 2.6.2 and 2.18.2. Results arc me:1l15 ±
S.D. (n '" 4 animals per treatment group).
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Figure 33 (3H]OTA levels in the gut of control :md I)ll·trcalcd rllts 6
hours after one oral treatment with [3H)OTA (288 IlWkG: in 50
mM NaHCOJ).
Details for treatments, sample precessing and radioactivity l'Ounling are
given in the Methods sections 2,6.2 and 2.18.2. Results are me'lns ±
S.D. (n = 4 animals per tre3tment group).
*, means C and PB are significantly different from c:lch other (p <: 0.05.
Mann.Whitney test).
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Figure 34 PHjOTA levels in the gut contents of control lllld I'll·treated
rats 6 hours after one oral treatment with PlilOTA (288
~g/kg in SO mM NaHCO,).
Details for treatments, sample precessing and rndiooctivily counting are
given in the Methods sections 2.6.2 and 2.18.2. Results are means ±.
~:~~n; ~ :~mp~~rs~Ific~IIF;dI;rldrent from each other (p < 0.05,
Mann-Whimeytesl).
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CHAPTER 4
DISCUSSiON
4.1 Involvement of cytochrome P·4S0 in the stimulation of ochratoxin A·
induced lipid peroxldation.
Recently, using a reconstituted microsomal lipid peroxidation system consisting of
microsomal phospholipid. the navoprotein NADPH cytochrome P-450 reductase (Fp),
EDTA and Felt-. we demonstrated that OTA induced lipid peroxidation by chelating Fc3+
and thaI the resulting OTA-Fe3+ chelate was readily reducible by the flavoprotein NADPH
cytochrome P-450 reductase to the OTA-Fe2+complcK. The lauer, in the prescnce of
oxygen, provided the active species that initinted lipid peroxidalion (Ornare! a!., 1990). In
our reconstituted system, the addition of25 ~M EDTA gave a maximum stimulation (4.0-
fold 3120 min) in lipid peroxidntion. Pederson and Ausl (1972) first developed a
reconstituted lipid peroxidation system consisting of phospholipid vesicles, Fp, NADPII.
and iron chelates. In their system, an EDTA·Fe3+ chelate was required in addition to the
standard ADP-Fe3+ chelate. Microsomal lipid peroxidation W:lS first described by
Hochstein and Ernster (1963), who demonstrated the enzymatic nature of the process and a
requirement for NADPH and an ADP·Fe3tchelate (Hochstein ct al., 19(4). TIle
observation that only ADP-Fe3+ is necessary 10 promote lipid peroxidation in microsomcs,
while both EDTA-Fe)t and ADP·FeJ+ are needed to promote it in II reconslituted system,
suggests that there may be microsomlll component(s) that directly reduce AD?-Fc3+ for
which EDTA-Fc3+ can substitute in the reconstituted system (Morehouse and Ausl, 1988).
Cytochrome P-450, being the last electron acceptor among the eat.alytic components of the
NADPH-dependent electron transport chain, is a likely candidate. Ekstrom and Inglcman-
Sundberg (1984) were the fll'St to show thaI incorporation or one of scveral punlied rabbit
liver cytochrome p·450 isozymes inlo phospholipid vesicles containing Fp increa~ed lipid
\40
peTOlddation. Later, Morehouse and Aus! (1988) demonstrated that purified rat liver
cytochrome P·450b could effectively replace EDTA·Fe.3+ in a reconstiluted lipid
peroxidation s}'stemconsistingofphospholipid vesicles, EDTA·Fe3+, ADP-Fe3+. Fp. and
NADPH. Our results show that cytochrome P-450 liB I is also able 10 enhance lipid
peroxidation in a reconstilUied system where OTA·Fe1+ is the chelated form of Fe3+. That
cytochrome P·450 plays a functional role. and is nol merely a convenient source of heme-
iron. is evideol from lite observation that lteat..(Jcnalured cytochrome P-450, hematin, or a
vancty of hcmoprQlcins were either ineffective or only marginally effective in stimulating
lipid peroxidalion (Table 9). Even cytochrome c, a hemoprotein readily reducible by
NADPH·cytochrome P-450 reduclllse, only weakly slimulated lipid peroxidation. Carbon
monoxide (CO) did not inhibit lipid peroxidation. We are unaware of any work in the
lilerJture showing the effects of CO on lipitl peroxidation in a reconstituted mixed-function
oxid:1se system. However, Ernster and Nordenbrllnd (1982) showed that CO did not
inhibit the NADPH-dependent ADPlFeJ+-stimulated lipid peroxidalion of liver
microsomes. The reason for this lack of inhibilion by CO is not clear.
The role of cytochrome P-450 in OTA·stimulated NADPH-dependent microsomal
lipid peroxidation is also implicated from die data showing dlat microsomes isolated from
Co·heme treated rats underwent less lipid peroxidation than mose from control rats (Figure
10). Co-heme treatment has been shown to reduce both cytochrome P-450 and Fp levels,
and thus the reduced ability of Co-heme microsomes to peroxidize might be due to
decreased cytochrome P·450 and/or Fp levels. It is well known that the activity of Fp
gre.1tly exceeds the overnll mixed·function oxidase activity of the various microsomal
cytochrome P-4S0-dependem mixed-function oxidases (Spaethe and Jollow. 1989). Thus,
it seems unlikely that the decrease in Fp activity observed (fable 10) would playa
significant role in the depression of lipid peroxidation. In support of this assertion, we
141
have observed thatfonification· or Co-heme microsome... with Fp (10 levels 18% Oflh:1I in
control microsomes; Table to) only partially increased the extent of lipid pcroxidation to
45% of that of control microsomes (Figure 10). This suggests lhat lower cytochrome fl-
450 levels rather than lower Fp levels were the main cause ofdecreased lipid peroxidation
in Co-heme microsomes. However, it is possible that externally added Fp is nol well
integrated into the microsomes and thU$ may oot be able to function as effectively as the Fp
in control microsomes.
• Co-heme microsomes (2 mg protein) were preincubnted with X4 Fp (640 nmol) which
was subsequently removed by centrifugation. leaving only Fp aClUally incorponucd into the
membrane or adhering to it.
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4.2 Role or cytochrome P·450 In OTA metabolism.
Stormer and Pederson (1980) were the flfSt to show that OTA was metabolized to a
hydroxylated pnxluct (4-0H.QTA) by rat liver microsomes. Later, they (Stenner et al.,
1981) showed the foonation of both 4(R). and 4(S)~4-0H-OTA by human liver
microsomes as well as liver microsomes from control rats and pigs. A subsequent study
by Stormer et a1 (1983) examined the metabolism of OTA by liver microsomes from
control and PB treated rabbits, and Vena (l98Sb) also used 3MC and PB as specific
inducers of cytochrome P-450 enzymes in a study of OTA metabolism. Recently, OSier et
a!. (1991) showed that isolated cytochrome P·450 fractions (not identified) were able to
mctabolizeOTA. Hietanen et al. (1991) showed that a cytochrome P-450 isozyme similar
to that induced by 3MC is responsible for OTA metabolism. None of the above studies
were of sufficient det.nilto examine under the same experimental conditions the effect of
several major cytochrome P-450 inducers on OTA metabolism. We, therefore, carried OUI
a detailed study ofOTA meltlbolism by liver microsomes from ralS treated with inducers of
the major cytochrome P-450 isofonns.
We examined the OTA metabolizing ability of liver microsomes from rats pretreated
with the cytochrome P-450 inducers phenobarbital (PB), 3-methylcholanthrene (3MC),
clofibrate (CLF), isosafrole (ISF), pregnenolone-16oI-carbonittile (PCN) and isoniazid
(INH), Proper controls for the vehicles in which inducers were given were done in
addition 10 n no treatment control group. The microsomal cytochrome P·450 contents of
livers from the differenllreatment groups were in good agreemenl wilh reported values
(Guengerich et al., 1982b; Hielanen et ai., 1986; Graves et aL, 1987). Forlhe fonnalion
of Ihe major metabolite 4(R)-4-0H-OTA, liver microsomes from rats treated with PB,
PCN, 3MC, ISF andCLF gave 67, 55, 39, 34 and 10 fold increaserespcctively as
compared 10 control microsomes from untreated rats, For 4(S)4·0H-OTA (minor
melabolite) formation, liver microsomes from ralS treated with PCN, PD, 3MC, CLF and
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ISF gave a 14, 18, 10, 10 and 8 fold incruse comp:tred 10 control microsomes from
un~ted rats (Figure 12). Microsomcs from INH·tre:ued r:tlS did not give ,my increasc in
the formation of the 4(R) isomer. but formation of lhc 4(5) isomer was increased 3bouI7
fold as compamllo microsomes from control rats (no treatment) (Figure 12). The large
in~ in (!fA metabolism by microsomes from 3MC· and PCN'lrc:lled animals were
n~ due to the vehicles (com oil and Tween BO, respectively) in which they were
administered. Both com oil and Tween 80 did, however, increase the 4(R) and the 4(5)
isomers (onnation over untreated controls by 2.9/2.4-£0Id :ll\d 4.3/1.6-foltl rc~pcclivcly.
Sucrose syrup, the vehicle in which clofibrate was administered, did not increase OTA
metabolism (Figure 14).
OTA hydroxylation activity as well as its inducibility appears to vary with the ~rnin
of I'lIt used. Hictanen et 01. (1986) observed OTA 4-hydtoxyl:lIion "lies of about 2.5 lind
about 0.7 pmoVmin/mg protein with liver microsomes from female Lewis and DA rom
respectively. This activity was inducible. about 2.3-fold and :about l.3-fold in Lewis r:lts,
and about 12·fold and about 2·fold in DA nUs after3MC:and PB pretn:3tmcnl!,
respectively. On the other hand. Stonnerand Pedersen (1980) found II very hig.h rnteof
OTA 4-hydroxylation (about 90 pmoVminlmg protein) in liver microsomes from male
Wl$W'f'ats. and this activily was inducible 3.4-fold on PO pretreatment. In:al1 the :above
studies. it was not indicated whether just 4(R)-4-01-l-0TA (the m:ajor metabolite) or both
epimers were measured. llY comp:uison. we obSClYOO OTA 4-hydroxylation rote of about
1 pmoVrnin/mg protein [Table 14; combined 4(R) and 4(5) mCl:lbolitesj which is more in
line with the values observed by I-lietanen et al. (1986). 1'111$ activity was inducible :lbout
3.8 fold on INH pretreatment but 33 fold on PCN pretreatment (Table 14. values given in
text are for combined metabolites). However, the inability of INH pretreatment 10 induce
4(R)·4-0H.QTA fonnation suggests that cytochrome P-450 IIEI,the miLijor isofonn
induced by INH (Ryan et at, 1985) is unable Ie catalyze its formation. The effect of INll
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and PCN prelfCalmenlS on OTA metabolism has not previously been clUlmincd.
Cytochrome P-450 enzymes range from being very specific to non-specirlC towards
substrates. A few substrultS arc known to react specifically with certain isofonns of
cytochrome P450 e.g. 7-pcnto:\yrtsorufin and 7-etho:-;yresorufin are known to be specific
SUbslJaleS for cylochromes P-450 lIB I (PB inducible) and tAl (3MC inducible)
respectively (Lubel et al., 1985; Burke and Mayer, 1983), We used these twO substrates to
confirm the induction of the desired cytochrome P·4S0 isoforms by the inducers. Thus.
microsomes from PH treated rats showed a3D-fold increase in 7-pemoxyresorufin
metabolism overcontrol microsomes while microsomes from 3MC treated rats showed
only a4.S-fold increase. In contrast, microsomes from 3MC trealed animals were 82/88-
fold more effective Ihan control microsomes in metabolizing 7-ethoxyresorufin while
microsomes from PB treated animals were only 10.5 f 20-fold more efficient (fable 12).
These results confinn thJI PB and 3MC tretllments p~ferentiJlly induced cytochromes P-
450 IIBl and IAl/IA2 respectively.
Cytochrome P-4S0 inhibitors are also uscfullOOls in ch:lr.l.cterizing the involvement
of specific cytochrome P-450 isofonns in metabolic processes. Some inhibitors react
specifically with certainisozymes. Forexample,tt-naphthoflavone (Wiebel et al., 1971)
and metyrapone (Jonen et at, 1974) are two inhibitors of cytochromes P-450 IAltIA2 and
liB I respectively. Inhibition by specit1c cytochrome P·450 inhibitors of a cenain reaction
that proceeds via a specifIC cytochrome P-450 isozyme would mean the direct involvcl"l'M:nt
of that particular isozyme in the reaction.-<.·Naphthoflavone and metyrapone were used in
our studies.o(-Naphthoflavone selectively inhibited (89/95%) formation of 4(R)-4-0H-
OTA by microsomes from 3MC and ISF treated rats, but it inhibited its formation by
microsomes from PB treated rats by only 18/41% (Figure 15). On Ihe other hand,
metyrapone inhibited (94/96%) fonnation of the 4(R) isomer by microsomes from PB
treated mts. but only inhibited its fonnatioo in microsomes from rats treated with 3MC and
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lSF (40/11% and 40/16%) (Figure 15). The effect oflhe two inhibitoD on 4(S)·40H-
OTA formation was less selective (Figure 16). Liver microsomes from rats prctrcmed with
Caball protoporphyrin IX (total cytochrome P·450 depleted by >80%) failed to mclllbolizc
OTA indicating the necessity for cytochrome P-4SO (data not shown).
Use of monoclonal antibodies (MAbs) against specific isofonns of cytochrome P-
450 also provides additional evidence for the involvement of these isoforms in a reaction.
Clones 1-7-1 (againslcytclchrome P-450 IA l/lA2) and 2-66-3 (lIgnins! cytochrome P-450
IIBI) (Nakajima el ai, 1990; Ge1boin, personal communication) were used in these studies.
The highest inhibition crOTA hydroxylation WllS given by only a two fold r.ltio ofMAb
pl'()(cinl microsomal protein using MAb from clone 1-7-1 with microsomes from 3MC
treated ntIS (Figure 17a) and using MAb from clone 2·66-3 with microsomes from PD
treated nttS (Figure I8a). In both cases, a dose dependent inhibition was observed. Small
ncr.-spedfic reaction (inhibition of up to 22%) was observed with the two microsomes
when rabbit IgG was used instead of the MAbs (Figures 17b and ISb). The specificity of
MAbs differ with substTates. A given MAb may inhibit very specifically a reaction of a
certain substrate, but show less or even no specificity towards another sub.wate; this cun be
seen from the results obtained by Gelboin et a!. (1988). From my results, MAb from clone
2-66-3 inhibited more strongly (58% inhibition)OTA metabolism to 4(R)-40H-OTA by
microsomes from PO treated nus although it cross reacted substantially (39% inhibition)
with microsomes from 3MC treated mts. On the other h;lnd, MAb from elone 1-7-1 was
more specific (64% inhibition) for microsomes from 3MC treated nilS although it cross
reacted weakly (23% inhibition) with microsomes from PO treated ntts (Table 13).
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4.3 Possible mechanism of the formation of 4(S)·4.0H.OTA.
Microsomes from INH treated ralS [which mainly fonn the 4(5) isomer] were
chosen to investigate the mechanism of the fonnalion of the 4(5) isomer. Microsomes
from PeN treated rats [that give a high yield of lhe 4(R) isomer] were chosen to study its
formation, PCN pretreatment increased the fannalian of 4(R)-4-0H-OTA more than
5O-fold that in controls. In conll'l1S!, INH pretreatment did not substantially increase
Connation of the 4{R) isomer, but increased levels of the 4(5) isomer7·fold overcontrol
(Table 14).
The formation of 4(R).4-0H-OTA and 4(S)-4-0H-OTA showed clear differences
with respect to pH optima, effect of iron chelator and antioxidants. The pH optima for the
fonnation of the 4(R) isomer by microsomes from rats treated with INH and peN were pH
6.0 and 6.5 respectively (Figures 21 and 22). At pH 7.5 there was a 60% decrease in the
fonnation of the 4(R) isomer by microsomes from rats tre:ued with PCN (Figure 22). A
pH optimum of 6.5 for the fom.'ltion of the 4(R) isomer was also observeci for microsomes
from rats treated with PO (Figure 24a). and of 6.0 for microsomes frnm rats treated with
3MC (Figure 25). Microsomes from ISF treated rats also showed a pH optimum of 6.0
with respect to the 4(R) isomer fonnation (data not shown). The pH optimum for
cytochrome P-45Q-dependent oxidation of most substrates is around 7.5 so it is curious
that the formation of me 4(R) isomer exhibits a low pH optimum. The phenolic hydroxyl
ofQTA has apKaof7.1 (Chu, 1971) soil iSlempting 10 speculate thatOTA with an
unionized hydroxyl group binds preferentially to cytochrome P-450 thus possibly yielding
more 4(R)-4-0H-OTA below this pH. The pH optimum of6.5 for the formation of the
4(R) isomer differs from the value of 7.5 observed by-Stonner and Pedersen (1980) with
liver microsomes from phenobarbital treated Wislar rats, but agrees with the optimum pH
obtained by Ueno (l985b) with liver microsomes from rats (strain not mentioned).
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In contrast to 4(R)·4·0H·OTA, the pH optimum of7.0 observed for the (oml.1\ioll
of 4(S)-4-QH-OTA with microsomes from mls treated with INH and PB also coincided
with the pH optimum for MDA fannation by these microsomes (Figures 21 and 24)
suggesting thaI the two processes may be link.ed. Furthennore. an intact mixed-function
oxidase system is required for the fennarion of 4(R)4-0H-OTA, but not 4(S)-4·0H-OTA
or lipid peroxidalion. Replacement of NADPH by ascorbate resuhs in the direct chemic:!1
reduction of the OTA-Fe3+ complex. giving rise to non-enzymatic lipid perOltidation. The
ability of ascorbate to stimulate microsomal lipid peroxidation is well known (Ernster and
Nordbrand, 1982). In the presence of ascorbate. only the 4(5) isomer was fonned.
suggesting the requirement for an intact mixed function oxidllse systcm for the fOnlmtiofl of
the 4(R) isomer. The need for cytochrome P·450 in the formation of the 4(R) isomcr is
also substantiated by the observation that no OTA mctabolites were detected when liver
microsomes from Co-heme pretreated rats were used. A comlmion between lipid
peroxidation and 4{S)·4-0H-OTA [but not4(R)-4-0H-OTAl fornmtion is further
strengthened by theobsetvation that both processes are remarkably sensitive to inhibition
by the iron cbelators Desferal and BPS and the antioxidants BHA and DPPD (Table 16).
In fact, in the presence of varying concentrations of BHA (Figure 23), both lipid
peroxidalion and 4(S)·4·0H·OTA formation are inhibited in parallel suggesting that either
lipid peroxides are responsible for 4(S)·4-0H-OTA formation or lhat a common species
mediates the formation of both.
The inability ofmicmsomes to produce 4(S)·4·0H·OTA in the presence of linoleic
acid hydroperoxide (LAHP) suggests that lipid peroxides mllY nOI be involved in ils
formation (Table 18). In contrast, microsome~ in the presence ofCHIl gave rise to
substantial amounts of both 4(R)·4-0H·OTA and 4(S}-4·0H-OTA. Cytochrome P-451l is
known to funclion as a peroxidase and the ability of CHP to catalyze the cytochrome
P-4SO·dependent metabolism of xenobiolics has been well documented (Rahimlula and
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O'Brien, 1974; Rahimtula and O'Brien. 1975). A variety of hemopro!eins including HRP
(Corbett and Corbeu, 1987; O'Brien, 1988) and Hb (Catalano and Ortiz de Montellano,
1987) are also known to oxidize xcnobiotics, However, these hemopmleins as well as
hematin were unable to catalyze OTA oxidation in the presenceofa variety of
hydropcroxides suggesting that cytochrome P-450 may be essential (table 18).
The lack of subsumtial inhibition by SOD or catalase suggests that the superoxide
anion or HA lU'e nol directly involved in the fonnation of 4(S)-4-0H.OTA or MDA by
microsomes from rats treated with INH. Both SOD and catalase increased OTA
metabolism by microsomes from rats treated with PeN, possibly by protecting cytochrome
P·450 from radical-induced damage. Previously, we have shown (Hasincff et aI., 1990)
that lhe presence of OTA stimulated supeTOXide and hydroxyl radical fonnation by liver
microsomes. Mannitol. a known scavenger of hydroxyl radicals, did inhibit
4(S)-4·0H·OTA by about 45% with microsomes from rats treated with INH indicating that
hydroxyl radicals may playa role. However, mannitol did not inhibit either the
NADPH-depcndent (by microsomes from PeN treated rats) or the ascorbate-dependent (hy
microsomes from INH and PeN treated rats) metabolism ofOTA. or lipid peroxidarion,
indicating that hydroxyl radicals are probahly not involved in either of these processes.
Guueridge (1982) showed that hydroxyl radicals do not playa significant role in
NADPH-dependem microsomal lipid peroxidation.
The induction of lipid peroxidation (Omar et aI., 1990) and active oxygen species
(Hasinoff et aI., 1990) byOTA can lead to the destruction of cytochrome P-450which is
responsible for 4(R)·4·0H·OTA foonation. Desfernl, by chelating iron, would prevent the
fonnation of the active oxygen species responsible for lipid peroxidation and thus protect
the cytochrome P-450 from destruction. This was indeed observed (Table 16). The fact
thm Dcsferal inhibited the fonnation of 4(S)-4-0H-OTA [but nolthal of4(R)-4-OH-OTA]
and MDA suggests that free iron is essential in their formation. This, together with
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observations that cytochrome P-450 is essential and th:lt free (unbound) reactive oxygen
species are not involved. suggests thaI an active Fe2+-oxygen complex may be respon.dble
for both 4(S)·4·0H·OTA (annadan and lipid peroxidntion (see Figure 35 lit the end of this
chapter). The precise mechanism by which such a hydroxyl.uion occurs is presently not
known. We have already demonstrated (Omar et at.. 1990) that OTA induces lipid
peroxidalion by chelating Fe3+ and th:lt the resulting OTA-FeJ+ chelate is more readily
reducible by the flavoprotein NADPH-cylochrome P-450 reductase to the OTA·Fc2+
complex which, in lhe presence of oxygen, provides the nctive species Ihat initiates lipid
peroxidation. Cytochrome P-450 Is required presumably \0 facilimtc the reduction of lhe
Fe3+ complex 10 the Fe2+ complex. The exact nalure of the initialing Spec1cS is presently
not known and different investigators have implicated the pcrfcrryl ion (Tien el al., [9R I;
Ursini et 0.1., 1989), the ferryl ion (Koppenol, 1985) and the Fc2t-02-Fc3+ complex
(Bucher el 0.1., 1983).
Formation of the 4(R) and 4(S) isomers showed clear difference with respcctto pH
optima. The pH optimum for the fonnalion oflhe 4(R) isomer was (j.O by microsomes
from rals trealed with 3MC (Figure 25) and ISF (data not shown), nnd 6.5 by micro!iOmeS
from rats treated with PB (Figure 24), whereas that for the fonn:llion of the 4(S) isomer
was 7.0 • 7.5; the lalter coincided with the pH optimum for lipid pcroxidation (Figures 21 b
and 24 b). Because of this marked difference in the pH optima for the formation oflhe
4(R) and 4(S) isomers. OTA metabolism was measured at the two different pHs (pI16.0.
optimum for the fonnation of the 4(R) isomer by microsomes from mts tre:ued with 3MC
and 15F, and pH 7.5, optimum for the formation of the 4(S) isomer lmd lipid peroxidation,
were chosen). At pH 6.0 (compared to pH 7.5), the formation of the 4(R) isomer
increased by 7.7 and 5.0 fold using microsomes from rals treated with 3MC and (SF
respectively. On the other hand, at pH 7.5, the formation of the 4(S) isomer increased by
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3.4 and 2.7 fold llsing microsomcs from falS treated with ISF and PH respectively as
compared \0 pH 6.0 (fable 19). This increase in 4(R)-4·()H·OTA formation at pH 6.0
(versus pH 7.5) could be due to less ionizationofOTA at pH 6.0 which would make it
more lipophilic and possibly allow it to access cytochrome P-4SO more readily, and/or it
could be 1I1aliess lipid peroxidalion is occurring at pH 6.0 and rhus cytochrome P-450 is
more protected allowing for increased metabolism. Increased lipid peroxidation at pH 7.5
(versus pH 6.0) could also account for increased 4(S)-4-0H·OTA formation especially if
the two processes are linked. Measurement ofcytochrome P-450 at the end of an
incubation at the two different pHs revealed thaI at pH 6.0, the percentages of cytochl'Omes
P-450 10Sl were 32,15 and51% usingmicTOsomes from rats treated with 3MC, ISFand
PO, respectively (Table 20). The corresponding MDA amounts fanned by microsomes
from the same sources wcre 18.9, 8.0 and 11.8 nmoVmg protein. The percentages of
cytochromes P-450 lost at pH 7.4 were 57. 43 and 59% using microsomes from rats
treated with 3MC.ISF and PB, respectively (Table 20). The corresponding MDA amounts
formed by microsomes from the same sources were 26.8. 17.1 and 20.2 nmoUrng protein.
The greatest loss ofcytochrome P-4SO correlated with the highest MDA formed (fable 20).
Thus, it seems thallipid peroxidation is an important faclor thai detennines the percentage
loss of cytochrome P-450 that in tum affects the membolism of OTA.
The large increase in the rate of OTA hydroxylation at pH 6.0 as compared to pH
7.4 using microsomes from rals treated with 3MC or (SF can be only panially due to the
protective effect on cytochrome P-450 at the lower pH. Similarly, an alteration in the Km
of the substrate also appears not to be the critically important factor because the Km ofOTA
hydroxylation dccTllased at pH 6.0 using microsomes from rats treated with 3MC, but it
increased using microsomes from T;lts treated Wilh ISF. The mosllikely reason for the
increase in OTA at pH 6.0 using microsomes from 3MC or ISF treated rats could be that at
this pH the particular isozymes metabolizing OTA (cytochrome P·450 IAI/1A2) undergo a
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conformational change in a manner that enhances orA hydroxylation. The hydroxylating
Fe3+.oxygen complex is probably brought mtO close proximity of the SlIbstrnte lIthe sile
where hydroxylation occurs. Such. conformational chnngc due to lowering of the pH m.1y
not favor the hydroxylation of ocher substrates which bind to the enzyme differentially,
Also. OIher isozymes (for example. liB1) having a different apoenzyme structure would
undergo conformational changes lIlat may not be conducive loOTA hydroxylation.
IS2
4.4 Role of cylochrome P·4S0 in OTA·induced toxicily.
The hep;tic microsomal cylOChromc P-450 system (mainly cytochrome P-450
families I, n, III and IV) metabolizes a largenumbcrofxenobiotics (chemicals, drugs. and
environmental contaminants). Most metabolism leads 10 delOJ:ification of the xenobiotics
and their rapid excretion, but some compounds are known to be activated to intermediates
lIIat an: toxic and/or can::inogenic, For example. aflatoxin Bl is activated by 3MC inducible
cytochrome P-450-AFB (Fukuharaet aI., 1989 and 1900). Activation of
dimethylnitrosamine and tobaccOosmoke·relaled nitrosnmines to morc genoloxic and
carcinogenic products by different cytochI"omes P-450 (particularly lIE! and I1A6) has also
been shown (Yam.uaki etal., 1992). Enalapril maleale, n dmg used to treat hypertension.
exerts greater hepatotoxicity upon induction of cytochrome P-450 lilA by PeN (Jurima-
Romet and HU3J1g, 1992). Therefore,the cylochromeP-450syslem is imponant in drug
detoxification as well as in drug activation 10 mutagens. carcinogens and toxins. and
genetically determined differences in the activily of these enzymes can innuence individual
susceptibility 10 adverse drug reactions. drug induced diseases and cerain typeS of
chemically indue:cd ca.ncm. Debrisoquineis used aslleSt drug 10 classify individuals into
phenotypes based on Iheir metabolic handlingof iL There are tWO main phenotypes: the
rapid aa:tylalor/atensivc rnetaboliw and slow acetylator/poor melabolizer (Eichelbaum et
al .• 1992).
OIher imponnnt factors thalll.lter the cytochrome P-450 isozyme profile include
alcohol consumplion. smoking and a variety of drugs and xenobiotics. Altering the
cytochrome P-450 profile in the liver may result in serious consequences. Ethanol is
known to inducecYlochrome P-450 liEl (Ekstrom and (ngelman-Sundberg. 1989),
therefore the f:lle of a certain drulV~enobiotic would dirfer in a person woo consumes
alcohol irom that in a person who does not coosume alcohol. One might be more prone 10
drug tOJ{icity th:llllhc other. It was suggested !hac the bioactiv"':'\ of) ''lfN-nitroso-
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dimethylamine (NOMA) by cytochrome P450 lIE1 induced by chronic alcohol
consumption plays a critial role in the hepatotoxicity of NOMA (MOl el al.. 1991). Also.
serious hepatotoxicity may develop in chronic aJcoholics while lhey:are taking therapeutic
doses of acetaminophen. The mechanism of increased slIsceptibility involves induction of
cytochrome P-450 by alcohol, and the depletion of hepatic glUlnlhionc restJVes. both of
which can result from chronic alcohol ingestion and both of which 3ffect 3Celnminophcll
metabolism (Rex and Kumar, 1992). Anttila et &1. (1991) suggested Ihat smoking and
peripheral type of cancer lite relnted \0 high levels of pulmonary cytochrome P·450 1/\ In
(which is involved in metabolic activation of polycyclic (\f()mUlic hydrocarbons and
aromatic amines) in lung callcer patients.
Ochmtoxin A is primarily a nephrotoxin. We therefore reasoned Ihat if induction of
hepatic cytochrome P-4SO leads to more rapid detoxification orOTA nnd ils subsequent
clearance, thcn the kKJneys would be exposed to less toxin and for il shoner time:. lllis
should result in less damage to the kidneys as compared 10 the non-induced group. On the
other h-~nd, if hepatic cytochrome P450 induction results in the acliv:uion ofOTA 10 a
more toxic metabolite then the kidneys would be exposed to 3 more toxic fmm of the toxin
and would show more damage compared 10 the kidneys from a non-induced group. We
lhereforecompared the effect ofOTA adminisffitlion toPS-treated rats (Iivereytochromc p-
450 induced) and 10 control rats. Excretion of renal enzymes in the urine is consicJcrtd to
be a sensitive, non-invasive indicator of renaltoxicily and damage (Price, 1982; Ngaha and
Plummer, 1977). Figures 28 and 29 show UrillC alkaline phosphatase anc!r-glut3myl
transferase levels both in PB trealed and control rots on day 0 (before OTA treatment) and
days I - 5 afterOTA treatment. Levels of both enzymes were elevated on the founh day
after OTA treatment in control ralS, but not in PB treated rats indicating that pretreatment
with PB protected the kidneys. In the caseoft-glutamyllrnnsferase, enlyme levels were
also elevated on days 1,2 and 3 rorcontrol group and on days 2 and 3 for PO group.
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OTA being an anion is known to be transported into the kidneys through the anion
lrnnspon channel (Sokol et at, 1988). II is also known that OTA inhibits the transport of
the anion PAH in kidney cortex slices (Sokol et al., 1988). From our results, the anion
transport system was not affected by the PO treatment (Figure 30) since PAH transport was
inhibited by 55-60% in OTA treated rats compared to control rats, and there was no
significant difference in the inhibition of PAH transpson in OTA treated rats and in PB
pretreated rats treated with OTA (Figure 30). Thus, the effect Cltcrted by PB on OTA is
more likely to be enhanced metabolism and faster elimination through induction of hepatic
cytochrome P-450. TIllS is more evident from the results obtained from the in vivo
experiment using [JH]OTA. Quantitation of OTA in different tissues and body fluids is
helpful because it can provide useful information about the amount absorbed, bound to
serum ttlbumin and excreted in the urine, Figure 31 shows OTA levels in serum and urine
of PB tremed rats and control rats 6 hr afterOTA administration. Even though it was not
significantlydifferem, there was a tendency of increased OTA concentration in the serum of
control rats compared to PB treated rats (OTA is known to bind tightly to serum albumin;
Chu, 1971), Moreover. there was an increase in OTA concentralion in the urine of the PB
treated rats compared to control rats indicating that OTA was absorbed. metabolized and
excreted faster in PO rats as compared to control rats, OTA levels in the tissues (liver.
kidney, stomach, the four portions of small intestine and cecum). and in the gut contents
arc shown in Figures 32, 33 and 34. Higher OTA levels were found in the gut contents
(contents of stomach, small intestine and cecum) of control rats compared to PB treated rats
again indicnting that OTA was absorbed, metabolized and excreted faster in the PB rats,
More OTA was found in the four portions of the smaIl imestinaltissues in the control rats;
this may have been be<:ause there was more unabsorbed orA in the intestinal contents of
the control rats, The high OTA levels in cecum contents might represent, in pan. excretion
of OTA and metah:J!itcs ir, bile since OTA is known to undergo emerohepatic circulntion
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(Fuchs elal., 1988).
The above results suggest thullhe induction of cytochrome P-450 offen; protection
against OTA toxicity. [n support of this view, Hutchison CI at (1971) showed that 4·011-
OTA was,non-toxic to mls at doses up 1040 mglkg, Further suppan came from Mr~ .... i Cl
al. (1985) who showed that the acute toxicity of OTA was reduced in mice by pretreatment
wilh PH for I week. and the LDso increased to 1.5-2.0 times control. They 11150 obscrvlld
increased OTA concentrntion (2-fold) in the bile extrnct of PB-pretre:ucd mice (in which
also they observed unknown metabolite) compared to control, In commst, aTA
concentration if, the urineextrncl was decreased toone-third of control. Moroi CI al. (19115)
suggested that a change in the metabolism of OTA could cause the decrease inlhc toxicity
cCOTA in PH-pretreated mice. In other words, OTA hydroxylation is more likely to be n
detoxjficalion pathway. Thus, il appears that OTA itself is toxic rather than a hydroxylalcll
metabolite. The kidney compared ....ith Ihe liver contnins much lower aClivitic.~of
cytochromes P·450 enzyme system, thus preventing it from effectively dctox.ifying GTA.
In tlIeabsence of rapid aTA metabolism in the liver, the kidney woull1lx: exposed to
higher levels of OTA and tlIus suffer greater toxicity. In addition, OTA is tr:msponed ilUO
the kidney via the anion transpon channel (Sokol et al., 1988) thus increasing its
concentration in that organ. These reasons may account for OTA being more nephrotoxic
Ihanhepatotoxic.
Relevance to human toxicity.
OTA has been shown to be nephrotoxic and hepatotoxic to a variety ofnnimals and
is strongly SIlSpected of being the main etiologic agent responsible for Balkan enUc!1lic
nephropathy and associated urinary tract tumors in humans. The different cytochrome 1'.
450 isozymes are mainly responsible for oxidizing the vmious structurnlly diverse
chemicals to which an organism isex.posed 10 readily excrctable hydrophillic mctaholites.
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Many of these isozymes are highly inducible by a variety of xenobiotics and lheir induction
leads to enhanced metabolism oftlleir substrates. Toxicity to a particular tissue/organ is
most often the end I'"Csult of that tissue/organ being exposed for an appropriate length of
lime to a surfJciel1l concenlmtion of a toxic chemical or its reactive metabolite.
My mullS suggest that OTA is itself toxic since its enhanced metabolism in PB
treated (cytochrome P-450 induced) rats protected against nephrotoxicity. If increased
cytochrome P·450 levels protect against orA nephrotoxicity in humans, then diets rich in
crucirerous vegetables (cabbage. brussels, sprouts), broiled foods or w·3 fatty acids which
induce cytochrome P-450 should protect against OTA nephrotoxicity. Discounting their
side effeclS. cigarette smoke and a variety of cylOchrome P-450 inducing drugs should also
exert a protective effect. It is clear from my studies that severnl cytochrome P-450
lsol.ymes me able to metabolize OTA.
High dietary fat is known to reduce absorption of chemicals and other nutrients
from the gu!. Stlldics carried out in our laboratory with OTA dissolved in corn oil versus
bicarbonate have confinned this, Ahigh fat diet would thus be expected to increase the
half-life of OTA in the botly thus increasing the risk of tissue damage, In humans,
therefore. a low fat diet might protect against OTA nephrotoxicity (reduce OTA toxicity. but
nOI fully protect against it) by enhancing its absorption through the gut and subsequent
elimination.
In conclusion. avoiding or atlenst minimizing exposure to OTA would offer tht:
best protection againstllcphrotoxicity. However, a diet low in fat and rich in cytochrome
P-450 inducers should protect against OTA nephrotoxicity.
This study should be imponanl 10 humans and of relevance because humans have
similarities in a number of their cytochromes P·450 to those of mts, Mostly, they have
more than 70% homology between them on the level of amino acid sequence and DNA (see
Table 21 atllle end of this chapter),
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CONCLUSIONS
Mydata provide evidence fof the stimulatory effect of cytochrome P-450 on OTA·
induced lipid peroxidation in;(~tuted sysltm. and &ttongly implicateeytochrome I)·
450 role in OfA-induccd lipid pc:roxidation inmicrosomes.
The n:sults also show that OTA is melabolized by the main cytochrome P·45()
isofonns lAl/lA2, IIB1 and lilA 1/l11A2. ThisconcillSion is based on sludie.~ using I)
specific cytochrome P450 inducers, 2) specific substnllcs, 3) spedne inhibitors ,1Iut 4)
monoclonal antibodies against spedfic cytochrome P-450 isoronns.
The results from in vim experiments suggest a protective effect ofPlI :lgains! arA
toxicity, probably through enhanced metabolism and detoxificilliolluuc locylochromc p.
450 induction.
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Key wtJrds for indexing:
Ochratoxin, lipid pcroxidalion, cytochrome P·450. inducers, inhibitors,
monoclonal antibodies. rat. platelets, aggregation, secretion.
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Figure 3S Scheme representing Ihe possible mechanism of 4(R)· ,md
4(S)-4·0H-OTA rornmtion and of OTA·stilllulatcd lipid
peroxldation.
P-4S0(Fe3+) OTA > P-4S0(Fe3+)-OTA NAOPH
Fp
·'''''F''
~
P-4 SO(Fe3+) + H20 + 4(R)-4-0H-OTA ( NAOPNlFp P-4 SO(Fe2+ )-OTA
2N+ 02
P-4S0(Fe2+)-OTAXFe3+-0TA
Perferryl
P-4S0(Fe3+)-OTA Fe2+-OTA -r-+ ~e2+_0TA~t Ferryl j
0, 02 Fe3+-02-Fe2+
1!
71LOOO~ LO 4(S)-4-0H-OTA
\6\
Table 21. Sequential homology between rat and human P-4S0 forms
(Adapted from Soucek and Gut. , 1992).
Cyt P-450 form
Rat Human orthologue
Sequential homology (%)
DNA amino acid
CYPIAI CYPIAI
CYP!A2 CYP!A2
CYPIIBI CYPllB6
CYPIIEI CYPIIEI
CYPIllAI CYPlllA3
CYPI1IA2 CYPlllAS
CYPIVAI CYPIVA9
Data not available
80
7S
78
7S
78
70
74
78
78
71
REFERENCES
Abrahamson D, Mills IT, and Boycott BR. Mycotoxins and myconora in animal
feedstuffs in Western Canada. Can J. Compo Med. 47: 23-26,1983.
Albano E, Poli G. Tomasi A, Bini A, Vannini V and Dianzani MU. Toxicity of 1,2-
dibromomethane in isolated hepatocytes: Role of lipid peroxidation. Chern. Riol./meraer.
50: 255-265,1984.
Aleo MD, Wyan RD and Schnellmann RO. Mitochondrial dysfunction is an early event in
ochratoxin A but not oosporein toxicity to rat renal proximal tubules. Toxicof. Appl.
Pharmacol. 107; 73, 1991.
Anttila S. Hietanen E. Vainio H, Camus A-M, Gelboin HV, Park 5S, Heikkila L,
Karjalainen A and Bartsch H. Smoking and peripheral type of cancer are related to high
levels of pulmonary cytochrome P·450 IA in lung cancer patients. Int. J. Cancer47: 681-
685,1991.
Alk,inson RM, Currie JP, Davis B, Prall DAH; Sharpe HM and Tomich EG. Acute toxicity
of cephaloridine, an antibiotic derived from cephalosporin C. Toxicol. AppJ. Pharmacol.
8: 398-406, 1966.
Aust SD. Sources of iron for lipid peroxidation in biological SYStems. In: Oxygen Radical
and Tissue Injury; Proceedingso/an UpjoJm Symposium (Halliwell B, Ed.), pp. 27-33.
Allen Press, Kansas. \988.
Aust SD and Svingen BA. The role ofimn in enzymatic lipid peroxidation. In: Free
Radicals in Biology (Pryor W A. Ed.), Vol. 5, pp. 1-28, Academic Press, New York,
1982.
Balzer T. Bogdanic C and Muzic S. Natural contamination of com (Zea mays) with
mycotoxins in Yugoslavia. Ann. Nutr. Aliment. 31: 425430,1977.
BarDer DJW and Thomas lK. Reactions of radicals with lecithin bilayc:rs. Radiation Res.
74: 5\-65, 1978.
163
Bartlett GR. Phosphorous assay in column chromalOgrnphy. J. Hiol. C/letl1. 234:466·
468, 1959.
Bansch H, Malaveille C, Camus AM, Moel-Planche G, BTUn G. Haulclfcville A. Sab:ldic
N, Barbin A, Kuoki T, Drevon C, Piccoli A and Montesano R. V:llidation and
comparative studies on l80 chemicals wilh S. typhimurium struins and V79 Chinese
hamster cells in the presence of various metabolizing systems. MWalioll Res. 76: I-50,
1980.
Bauer J and Gareis M. Ochratoxin A in dCf NahrungsmillclkcllC. Z. Vetcrillomwd. B. 34:
613-627, 1987.
Beloqui 0 and Cederbaum AI. Prevention of microsomal products of hydroxyl mdicals,
but not lipid peroxid31ion. by the glutathione-glutathione peroxidase system. Dinc!wIII.
PharflUlcol. 35: 2663-2669, 1986.
Bendele AM, Carlton WW, Krogh P and Lillehoj ED, Ochratoxin A carcinogenesis in lhe
(C57BU6JXC3H)FI mousc. I. NaIl. Callcer hisl. 75: 733-739, 19R5.
Benedetti A, Comporti M and Eslcrbnuer H. Idel1lification of 4-hydroxynonenal as II
cytotoxic product originating from the peroxidation of liver microsomal lipids. mochim.
Biophys. Acta 620: 281-296,1980.
Berndt WO and Hayes AW. In vivo and in vitro changes in renal function CllUScd by
ochratoxin A in them!. Toxieol. 12: 5-7, 1979.
Berndt WO, Hayes AW and Phillips RD. Effects of mycotuxins on fCnlll function:
Mycotoxic nephropathy. Kidney Inti. J8: 656·664, 1980.
Bond EJ and De Matteis FA. Biochemicul changes in rat liver after administration of
carbon disulphide. wilh particular reference:o microsomal changes. fljnc1wm. PhnrnUlco/.
18: 2531·2549,1969.
Boonnan G, NTP Technical Repon on the Toxicology and Carcinogenesis Studies of
164
Ochratoxin A. NTPTR 358, NIH Publication No. 88·2813, Research Triangle Park,
Nonh Carolina, 1988.
Braughltt JM, Duncan LA and 0u1se RL The involvement of iron in IipKl peroxidation.
Importance of ferric 10 ferrous rnuos in initiation. 1. Bioi. Chem. 261: 10282-10289,
1986.
Brown MH, Szczech GM and Punnalis OP. Teratogenic and toxic effccts of ochratoxin A
in rats. Toxicol. Appl. Plwrmacol. 37: 331-338, 1976.
Brownlee NR, Hunter JJ. Pangannmala RV and Cornwell DC. Role of Vitamin E in
glutathione induced oxidatativc stress: Methemoglobin, lipid peroxidalion, and hemolysis.
J. Lipid Res. 18: 635·644, 1977.
Bruch RC and Thayer WS. Differential effect of lipid pcroll.idation on membrane fluidity
as dctcnnined by electron spin resonance probes. Biochim. Blophys. Acta 733: 216-222.
1983.
Bucher JR, rICo Mand Aus! SO. The requirement for ferric in the initiation of lipid
peroxidation by Chel:lled ferrous iron. Biochem. Biophys. Res. Commun. 111: 777-784.
1983.
Burke MD and Mayer RT. Differential effects of phenobarbilone and 3·methyleholanthrenc
induction on the hepatic microsomal metabolism and cytochrome P4s()"binding of
phenoxazone and a homologous series of its n-alkyl ethers (alk.oxyresorufins). Chem.
Bioi. Interact. 45: 243-2~8, 1983.
Burk.e MD. Thompson S. Elcombe CR. Halpert J, Haaparanta T and Mayer RT. Ethoxy-,
pentoxy· and benz.yloxyphenoxazones and homologues: A series of substrates to
distinguish between different induced cytochrome P-450. Biochern. Phannacol. 34(18):
3337-3345. 1985.
Casini AF, Pompella A and Comporti M. Liver glutathione depletion induced by
bromobenzcne. iCMiohcnzcne and diethyl maleate poisoning and its relation to lipid
165
peroxidation and necrosis. Am.i. Pat/wi. 118: 225-237,198.5.
Catalano CE and Oniz de MonteUlUIo PRo Oxene tnmsfer, electron absuuctioll and
cooxidation in the epoxid3tion of stilbene and 7.8 dihydroxy- 7,8-dihydrobenzola)pyrenc
by hemoglobin. Biochemistry 26: 8373-8380. 1981.
Cathean R, Schwiers E and Ames BN. Detection of picomole levels of hydropcroxidcs
using a fluorescent dichloronuorescein assay. Anal. Diacllern. 134: 111-116, 19R3.
Chance B, Sics Hand Boveris A. Hydroperoxide metabolism in mamm;lIian organs.
PhysioJ. Rev. 59: pp. 527, 1979.
Chelkowski J, Golinski P .md Szebiolko K. Mycoloxins in cereal grain. II. 'nlC f,lle of
ochratoxin A after processing of wheat and barley grain. NalrrullR 25: 42]·426, 1981.
Chu FS. Interaction of ochratoxin A with bovine serum albumin. Arell. BiocJrim.
Blophys.147: 359·366, 1971.
Cojocel C. Hannemann J and Baumann K. CephaloJridine-induced lipid pcroxidalion
initiated by reactive oxygen species as a possible mechanism of cephaloridine
nephrotoxicity. Bioc1zim. Uiophys. Acta 834: 402·410, 1985a.
Cojocel C, Lacschkc KH, Insclmann G and Baumann K. Inhibition of cephaloridine-
induced lipid peroxidation. Toxicology 35: 295·305, 1985b.
Comporti M. Biology of disease, lipid peroxid3lion and cellulnr dlllnage in toxic liver
injury. Lab. Invest. 53: 599·623, 1985.
Comporti M. Snceocci C and Dinnznni MU. Effect ofCCI4 in vitro and in vivo on lipid
peroxidalion of rat liver homogenatcs and subcellular fractions. E,lzymo!ogia 2\1: 1MS-
204, 1965.
Connole MD, Blaney BJ and Mcewan T. Mycotoxins in animal feeds and toxic fungi in
Queensland 1971-1980. Au.u. VCI.I.S7: 314·318,1981.
166
Corbett MD and Corbelt BR. HRP·catalyzed bioaclivation of carcinogenic hydroxamic
acids. The greater reactivity of glycol)'l- versus acetyl-derived hydroxamic acids. Chern.
Bioi. Interact. 63: 249·264,1987.
Corongiu FP and Milia A. An improved and simple method for determining diene
conjugation in autoxidized polyunsaturated fatty acids. Chern. Biof. Interact. 44: 289·297,
1983.
Creppy EE, Chakor K, Fisher MJ, and DirheimerG. The mycotoxin ocluatoxin A is a
subslrale for phenylalanine hydroxylase in isolated ral hepatocytes and in vivo. Arch.
Toxicol. 64: 279-284, 1990.
Crcppy EE, Kane At Dirheimer G. Lafarge-Fmyssinet C, Mousse! Sand Frayssinel C.
Gcnoloxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen. liver
and kidney. Toxleol. Lett. 28: 29·35, 1985.
Creppy EE, Kane A, Giessen-Crouse E, Roth A, Roschenthaler Rand Dirheimcr G.
Effect of ochratoxin A on enzyme activities and macf\)molecules synthesis in MOCK cells.
Arch. Taxieo/. Suppl. 9: 310-314, 1986.
Crcppy EE, Kern 0, Steyn PS, Vleggaar R, Roschcnthaler Rand Oirheimer G.
Comparative study of the effect of ochratoxin A analogues on yeast aminoacyl-t-RNA
synthetases and on the growth and protein synthesis of hepatoma cells. Toxieo!. Lett. 19:
217-224,1983a.
Crcppy EE, Lorkowski G, Roschcnthaler Rand Dirhcimer G. Kinetics of the
immunosuppressive action of ochratoxin A on mice. In Proceedings, V Internarional
/UPAC SymposilUn Mycotoxins and Phyeotoxins, Sept. 1·3, 1982, Vienna, pp. 289-292.
Austrian Chem Soc, Vienna, 1982.
Creppy EE, Roschenthaler Rand Dirheimer G. Inhibition of protein synthesis in mice by
ochratoxin A and its prevcnsion by phenylalanine. Food Chern. Toxicol. 22: 883-886,
1984.
167
Creppy EE, Stonner Fe, Kern 0, Roschenthaler Rand Dirheimer G. Effects of
ochratoxin A metabolites on yeast phenylaI:myl-tRNA synthetase and on the growlh and in
vivo protein synthesis of hepatome cells. Chem. BioI. lnteracl, 41: 239-247, 19N3b
Csallany AS, Dcrgvan M, Manwaring JD and Addis PD. Free m:llondialdchydc
determination in tissues by high performance liquid chromatography. A/laf. Bioc/wlIl.
142: 277-283, 1984.
Curtis MT, Gilfor 0 and Farber JL. Lipid peroxidation increases the molecular order
microsomal membranes. Arch. Biochern. Diophys. 235: 644-649, 19R4.
Dahle LK, Hill EO and Holman RT. The thiobarbituric acid reaction and the aUlmddmion
of polyunsaluraled fatty acid methyl esters. Arch. Biochcm. Biophys. 98: 253-261,1962.
de Groot H. Noll T and Tolle T. Loss of latent activity of livcr microsomalmcmbranc
enzymes evoked by lipid peroxidation. Studies of nuc1eo~idcdiphosphatasc,glucose-6-
phosphatase, and UDP glucuronyltransferase. Biocllim. Binphys. ACla 815: 91-96, 19R5.
De Scott B. Toxigenic fungi isolated from cereal and legume products. Mycnpath Myco/.
Appl. 25: 213·222, 1965.
Dianzani MU and Torrielli MV. Lipid perOltidution in ethanol-induced liver damage. 1111:
problem of its possible relevance in both acute and chronic alcoholism. Med.1Jinl.
Environ. 9: 177-190, 1981.
Dinnzani MU and Ugnrio G. Lipid peroxidation. In: Biochemical Mec"an(.f1n~fJfUver
Injury (Slater T F. Ed.), pp. 669-707, Academic Pre~s, London, 197R.
Dianzani MD. Lipid peroxidation in ethanol poisoning: A criticlll reconsideration. Afco/wl
and alcoholism 20: 161-173, 1985.
Dietrich DR lind Swenberg JA. Renal carcinogenesis. In: Toxicolol:yo/the Kidney (I-look
J8 and Goldslein RS. Eds.) pp. 495-537, Raven Prc~s, New York, 1993.
168
Dillard CJ. Dumelin EE and Tappel AL. Effect of dietarY vitamin E on expiration of
pentane and ethane by the rat Lipids 12: 109-114, 1977.
Dominguez OV and Samuels LT. Mechanism of inhibition of adrenal steroid Il-beta-
hydroxylase by melhopyrapone (metopirone). Endocritwlogy 73:304-309.1963.
Drummond GS and Kappas A. The cytochrome P·450· depleated animal: An experimental
model for in vivo studies in chemical biology. Proe. Natl. Acad. Sci., USA 79:
2384-2388,1982.
Dwivedi P and Bums RB. Effect of ochratoxin A on immunoglobulins in broiler chicks.
Res. Vet. Sci. 36: 117-121, 1984.
Eichelbaum M. Kroemcr HK and Mikus G. Genetically dctennined differences in drug
metabolism as a risk: factor in drug toxicity. Taxicol. Leu. 64/65: 115·122, 1992.
Eichenberg K, Bohni P, Winterhalter KH, Kaw:lto S and Richter C. Microsomal lipid
peroxidation causes an increase in the order of the membrane lipid domain. FEBS Lett.
142: 59-62. 1982.
Ekstrom T and Hogberg J. Chloroform induced glutathione depletion and toxicity in
freshly isolated hepatocytcs. Biochem. Pharmacol. 29: 3059·3065. 1980.
Ekstrom G and Ingelman-Sundberg M. Cytochrome P·450 dependcnllipid peroxidation in
reconstituted membrane vesicles. Biochem. Pharmacol. 33: 2521-2525. 1984.
Ekstrom G and fngelman-Sundberg M. Rat liver microsomal NADPH·supponed oxidase
activity and lipid pcroxid:nion dcpendent on ethanol-inducible cytochrome P·450 (P.450
IIEI). Biochem.Pharmacol. 38: 1313·1319. 1989.
El-Banna AA and Scott PM. Fate of mycotoxins during processing of foodstuffs. III.
Ochratoxin A during cooking of faba beans (Vida faba) and polished wheat. J. Food. Prot.
47: 189-192. 1984.
169
Ernster Land Nordenbrand K. Microsomal lipid peroxidation. Mechanisms m\d some
biological implications. In: Lipidperoxidcs in biology and medicine {Yllgi K, Ed.).jlp.
55-79. Academic Press, New York, 1982.
Fee lA. Is superoxide toxic and are superoxide dismutases essenlial for aerobic life. In:
Oxygen and Oxy-Radicals in Chemistry alld Biofogy (Rodgers M A J and Powers E L.
Eds.), 205-221, Academic Press, New York, 1981.
Ferrali M, Fulceri R, Benedelli A and Comporti M. Effects of carbonyl compounds (4-
hydroxyalkenals) originating from the peroxidalion of liver micm.'iOlllallipids on
microsomal enzyme system of the liver. Res. Comnum. Chem. Pm/wi. Pharwllco/. 30:
pp. 99, 1980.
Fisher OJ, Fukushima and Gaylor JL. Isolation. pUrifiC1Uioll imd prol>crtics of n unique
Conn ofcylochrome P-450 in microsomes of isosafrolc-trcatcd r"ts. J. 8iol. Clre",. 256:
4388-4394, 1981.
Fold: 1, Lees M and Stanley GM. A simple method for isolation and puril'icatioll of IOlal
lipids from animal tissues. J. BioI. Che",. 226: 497-509, 1956.
Fong K-L, McCay PO, Poyer JL, Keele nn and Misra H. Evidence lhm peroxidution of
lysosomal membranes is initiated by hydroxyl rodicals produced during navin enzyme
activity. J. Bioi. CIJem. 248: 7792-7797, 1973.
Fournel S, Magdalou J, Pinon P and Siest G. Differential induction ofdrng-mcl3bolizing
enzymes after treatment with hypolipidaemic agents. Xennbiotica t 7: 445-457, 19M7.
Frankel EN and Neff WE. FOnTIalion ofmalonaldehyde from lipid ollid,ltion products.
Biochim. Biophys. Acta. 754: 264-270, 1983.
Franklin MR. Inhibition of mixcd-function ollidalions by substrales fonning reduced
cytochrome P-450 metnbolie-intenncdialccomplcxes. Pharmaco/. and Tiler. 2: 227-245,
1977.
170
Fridovich I. Supcroxide dismulase. In: Molecular Mechanisms ofOxygen Activation
(Hayaishi 0, Ed.), pp. 453, Academic Press, New York, 1974.
Fuchs R, Radic B. Peraica M. Hult K and Plestina R. Enterohepalic circulation of
ochraloxin A in rals. Periodicum Bio[ogorwn 90: 39·42, 1988.
Fukuhara M, Mizokami K. Sakaguchi M, Nimura Y, KalO K, Inouye Sand Takanaka A.
Anatoxin BI-specific cytochrome P-450 isozyme (P-450-AFB) inducible by 3-
methylcholanthrene in golden hamsters. Bioc1lem. Pharmacal. 39:463·469, 1990.
I'ukuhara M, Nohmi T. Mizokami K, Sunouchi M, Ishidate M, IT. and Takanaka A.
Ch:uacterization of three forms of cytochrome P-450 inducible by 3-methylcholanthrene in
golden hamster livers with special reference to aflatoxin Bt activation. J. Biochem.
106:253-258,1989.
Galtier P. Devenirde I'ochrntoxine Adans I'organisme animal. I. Transport sanguin de la
toxine chez Ie ral. Ann. Reck lief. S: 311-318, 1974.
Galtier P and Alvinerie M. In vitro transformation of ochratoxin A by animal microbial
noras. Ann. Rech. lIet. 7: 91-98, 1976.
Gallier P, Charpenteau J-L, Alvinerie Mand l.abouche C. The phannacokinetic profile of
ochrntoxin A in the rat after oral and intrnvenous administration. Drug Metabolism and
Dispositioll 7(6):429-43,1, 1979.
Galtier P, Jemmali M and Larrieu G. Enquete sur la presence eventuelle d'allatoxine et
d'ochratoxine et dans des mais recolle en France en 1973 et 1974. Ann. Nutr. AUment.
31: 381-389, 1977b.
Gayarthri AK and Padmanban G. Biochemical effects of 3,S-diethoxycarbonyl-l,4-
dihydroc.>lIidine in mouse liver. Biocllem. Pharmacal. 23: 2713·2725, 1974.
Gelboin HV, Park 55 and Battula N. DNA recombinent aoo monoclonal antibody directed
methods for detemlining cytochrome P-450 specificity. Biochem. PJumnacal. 37: 98-102,
171
1988.
Goldstein RS, Pasino DA, Hewiu WR and Hook JB. Biochcmical1llcchanisllt~ of
cephaloridine nephrotoxicity: Time and concentmtion dependence of pcroxid:l1lvc injury.
Taxieol. Appl. Pharmacol. 83: 261.270, 1986.
Golenski P and Grabarkiewicz-Szczesna J. The first Polish of the detection of ochratoxin
A residues in human blood. Rocz. Pa,lStw. LJkI. Hig. (English Abslnlct) 36: J7R·3KI.
1985.
Gonzalez Fl. Human cytochrome P-450: problems nnd prospects. TiPS Revicw.r 13:346·
352,1992.
Graves PE, Kaminsky LS and Halpert J. Evidence for functional and structuml
muhiplicity of pregnenolone-l6-carbonitrile·induciblc cytochrome P-450 isolymc.~ in rnt
liver microsomes. Bjoclzem. 26: 3887-3894,1987.
Guengerich FP. Oxidation of toxic and carcinogenic chemicals by human cylochrome p.
450 enzymes. Chern. Res. Toxicol. 4: 391·407, 1991.
Guengerich FP. Enzymatic oxidation of xenobiotic chemic3ls. C,it. Rev./Jjochcl1l. Mol.
Biol. 25: 97-153, 1990.
Guengerich FP, Wang P and Davidson N. Estimation of isozymcs of microromal
cytochrome P-450 in rats. rabbits and humans using immunochemicul staining coupled
with SOS·polyacrylamide gel electrophoresis. machem. 21: 1698·1706, 1982a.
Guengerich FP, Dannan GA, Wright ST, Martin MV and Kaminsky LS. Purificalion anti
characteriz.ntion of liver microsomal cylochromes P-450: Electrophr .relic, spcctruJ. eut:lJylic
and immunochemical properties and inducibility of eight isozymes isolated from rats 1TC1lIOO
with phenobarbital or 13·naphthonavone. Diachem. 21: 6019-6030, 1982b.
GUlteridge JMC. Lipid peroxidation: Some problems and conceptS. In: Oxyxcn RlJdicaI
and Tissue Injury; Proceedings of an Upjohn Symposium (Ed. Halliwelll13), pp. 9-19,
172
Allen Press, Kansas, 1988.
Gulteridge JMC. The protective action of superoxide dismulasc on melal ion catalyzed
peroxidation of phospholipids. Biochem. Biophys, Res. COf/1rmlll. 77: 379-3R6, 1977.
GUllcridge JMC. The role of superoxide and hydroKyl radicals in phospholipid
pcroxidation catalyzed by iron sails. FEDS Leu. 150: 454-458, 19HZ.
Guueridge JMC. Ferrous-EDTA-stimulated phospholipid pcroxidut;oll. A re,lClion
changing from alkoxyl-radical to hydroxyl-radical dependent initiation. IUodwtIl. J. 224:
697-701,1984.
Guzelian PS ll11d Swisher RW. Degradation ofcylochromc P-450 heme hy carhon
tC\nIchloride and 2-allyl-2-isopropylacctamide in mllivcr ill vivo and ill vitro: [nvolvCl11CIll
of non-carbon monoxide-fanning mechanisms. Biochcm. J. 184: 4111.4R9, 1979.
Hafeman DO and Hoekstra WO. Protection against carbon tClr.lchloridc-induccd lipid
peroxidation in the rat by dietary vitamin E, Selenium and melhionine liS mellsured by cth:1I1
evolution. J. Nutr. 107: 656·665, 1977.
Halliwell B. Free radicals, oxygen toxiCity and aging. In: !IRe Pigments (Soh:1I R S, Ed.),
pp. 1-62, ElsevierlNorth Holland Biomedical Press, Amsteniam, 1981.
Halliwell Band Guucridgc JMC. Oxygen free radical and iron in relation to biology and
medicine: Some problems and concepts. Arch. Biochem. Diophys. 246: 501-514, 19116.
Halliwell B and Guueridge JMC. The importance of free rJdicals und clltalytic meWI ions
in human disease. Mol. Aspects Med. 8: 89·193, 1985.
Halpert JR, Balfour C, MillerNE and Kaminsky LS. Dichloromethyl compounJs as
mechanism-based inactivalors of rat liver cytochrome P-450 in vilro. Mol.l'harmacol. 311:
19-24,1986.
Hanson LK, Enton WA, Sligar SO, Gunsalus IC. Goutennan M and Connell CR. Origin
173
of the anomalous sorel spectra of car\>oxycytochrome P·450. J. Am. Chern. Soc. 98:
2672-2674, 1976.
Harwig J, Ochratoxin A and related metabolites. In: MyCOloxins (Purchase IFH. Ed.),
pp. 345-368. Elsevier, Amsterdam, 1974.
Hasinoff RB, Rahimtula AD and Omar RF. NADPH· cytochrome P-450 reductase
promoted hydroxyl radical production by iron(IlI)-ochraloxin A complex. Biochjm.
Biophys. Acta 1036: 78-81, 1990.
Haubcck H-D, Lorkowski G, Kelsch E nnd Roschenthaler R.Immunosuppression by
ochratoxin A and its prevention by phenylalanine. Appl. Environ. Microbial. 41:
1040-1042,1981.
l-lnyesAW, Hood RD and Lee HL. Ter.llogenic effects of ochratoxin A in mice.
Terarology9(l): 93-97, 1974.
Hennig A, Fink-Gremmels J and Leislner L. Mutagenicity and effects of ochratoxin Aon
the frequency of sister chromatid exchange after metabolic activation. In: Mycotoxins,
endemic nephropathy and urinary tract tumors (Castegnaro M. Plestina R, Dirheimer G,
Chemozemsky IN and Bansch H, Eds.), pp. 255·260, Lyon. International Agency for
Research on Cancer.IARe, 1991.
Hiet.1nen E, Malaveille C, Camus A·M, Bereziat J·C, Brnn G, Castegnaro M, Michelon J,
Idle JR and Bartsch H. Inlerstrain comparison of hepatic and renal microsomal carcinogen
mclabolism and liver S9 mediated mutagenicity in DA and Lewis rats phenotyped as poor
and extensive metaboJizers ofdebrisoquine. Drug Metabolism Disposition 14: 118·126,
1986.
Hieranen E, Bartsch H, Berezia! J-C, Castegnaro M and Michelon J. Characterization of
the cytochrome P-450 isozyme that metabolizes ochratoxin A, using metabolic inducers,
inhibitors and antibodies. In: Mycotoxins. endemic nephropathy and urinary tract tlU1lOr~
(Castegnaro M, Plestina R, Dirheimer G, Chemozemsky IN and Bartsch H, Eds.), pp.
297·304, Lyon. International Agency for Research on Cancer, IARe. 1991.
174
Hochstein P, Nordenbrnnd K and Ernster L Evidence for the invnlvcmC1\1 ofinlll illlhc
ADP-aclivated peroxidation of lipid in microsomcs and membranes. fliodll'm.lIi(lphy.~.
Res. Commull. 14: 223-238, 1964.
Hochstein P and Ernster L. ADP-aetivated lipid pcroxidation coupled 10 the TPNII m.id:lsc
system of microsomes. Biochem. Biophys, Res. Commun. 12: 388-394, 1963.
Hogberg J, Bergslrond A and Jakobasson SV. Lipid peroxidalioll of rallivcr microSOlllCS:
Its effect on the mkrosomal membrnne and SOT,1e membrane bound rnicrosom:ll cn7.ymcs.
Eu" J. Biochem. 37: pp. 51-59. 1973.
Hollenberg PF. Mechanisms ofcylochrome P·450 and peroxidasc-calalyzed XCllohiotic
metabolism. TIle FASEB J. 6: 686-694, 1992.
Hood RD, Naughton MJ and Hayes AW. PrcnOllal cffectsofochr;lloxin A in hamsters.
Teratology 13: 11-14, 1976.
Honan AA and Fairhurst S. Lipid peroxidalion and mechanisms ortoxicily. eRe CriliCtlI
Reviews in Toxkology 18: 27-79,1987.
Hull K, Hokby E, Gatenbeek S and RUlquistl~ Ochratoxin A in blood rrorn slaughter
pigs in Sweden: Use in evaluation or toxic content or consumed reed. IIppl. £rwimn.
Microbiol. 39: 828-830, 1980.
Hult K, Plestina R, Ceovic S. Habazin-Novak V and Radic n. Ochratoxin A in human
blood: Analytical results and confinn3tionaltcsts from a study in connection with Balkan
endemic nephropathy. In: Proceedings. V International IUPIIC Symposiwn. Myc(J((jxin.~
andPllycoloxins. September 1-3, 1982. Vienna, Austria, pp. 338-341. Austrian Chell1.
Soc.• Vienna, 1982a
Hult K, Plestina R, Habazin-Novak V, Radie Band Ceovic S. Ochratoxin A in human
blood and Balkan endemic nephropathy. Arch, Toxieol. 51: 313-321, 19R2b.
Hult K, Teiling A and Gatenbeck S. Degradation or ochrntoxin A by a ruminant. Appl.
175
Environ. Microhial. 32: 443·444, 1976.
Hunter FE, Jr., Gcbicki 1M, Hoffsten PI, Weinstein J and Scott A. Swelling and lysis of
tat liver mitochondria induced by ferrous ions. J. Bioi. Chern. 238: pp. 828-835, 1963.
Hutchison RD, Slcyn PS and Thompson DL. The isolation and structure of 4-hydroxy
ochratoxin A and 7·carboxy-3.4-dihydro-8-hydroxy-3.rnethyl isocoumarin from
Penicif/ium vcridicatwn. Tetrahedron Letlers 43: 4033·4036, 1971.
Jaeschkc 11, Klcinwllcchter C and Wendel A. The role of acrolein in allyl alcohol- induced
lipid pcroxidation and liver cell damage in mice. Biochem. Phannacol. 36: 51-57, 1987.
Jelinek cr. PoMand AE and Wood GE. Worldwide occulTenccof miCOloKins in foods
and feeds, an updBtc. J. Assoc. Off. Anal. Chern. 72: 223-230, 1989.
Jonco HO, HUlhwohl B, Kahl Rand Kahl OF. Influence of pyridine and some pyridine
derivatives on spectral properties ofrcduccd microsomes and on microsomal drug
melaboli7.ing activity. Oiachem. Pharmacal. 23:1319.1329,1974.
Jones DP, Thor H, Smith MT, Jewell SA and Orrenius S. Inhibition of ATP·dcpendcnl
microsomal Ca2+ sequestration during oxidative slress and its prevention by glutathione. J.
Bioi. Chern. 258: 6390·6393, 1983.
Jordan RA and Schenkman JB. Relationship between malondialdehyde production and
arachidonale consumption during NADPH-supponed microsomal lipid peroxidation
Biocllem. Pharmacol. 31: 1393-1400, 1982.
Josefsson E. SlUdy of ochratoxin A in pig kidneys. Var. Fda. 31: 415-420, 1979.
Jurima-Romet M and Huang HS. Enalapril hepatotoxicity in the rat. Effects of modulators
of cytochrome P-450 and gl'Jlathione. Biachem. Pharmacol. 44(9): 1803·1810, 1992.
Kline A, Creppy EE. Roschenthaler Rand DirheimerG, Changes in urinary and renal
tubular enzymes caused by sub-chronic administration of ochratoxin A to rats. TfJxicology
176
42: 233-243. 1986.
Kanisawa M and Suzuki S. Induction of renal and hepatic tumours in mice by ochratoxin
A, a mycotoxin. Gann 69: 599-600, 1978.
Kappus H and Muliawan H. Alkane fonnalion during liver microsolllallipid pcroxidlllion.
Biochem. Pharmacal. 31: 597·600, 1982.
Khan S. Martin M and Rahimlula AD. Perturbation of liver microsomal calcium
homeostasis by ochratoxin A. Biochem. Pharmacal. 38: 67-72,1989.
Kifada M, Chiba K, Kam:uaki T and Kitagawa H. Inhibition by cyanide of drug
oxidations in rat liver microsomes. lpn. J. Phannacol. 27: 601-608, 1977.
Klinken W, Lorkowski G, Creppy EE, DirheimerG and Roschcntha1cr R. Inhibition of
macrophage migration by ochratoxin A and citrinin, and prevention by phcnylaillninc of the
ochratoxin A-induced Inhibition. Toxicol. fur, Res. 3: 186-189, 19K1.
Koppenol WH. The physiological role ofthc charge distribulion 011 superoxidc dismultl.~e.
In: Oxygen and Oxy-Radicals in Chemistry and Biology (Rodgers M A J and Powers E L.
Eds.), pp. 671-673, Academic Press. New York. 1981.
Koppenol WH. The reaction offerrous-EDTA wilh hydrogen peroxide: Evidence against
hydroxyl radical fannalion. Free Rad. Bioi. Med. I: 281-285.1985.
Krogh P. O:hratoxins: occurrence, biological effects and causal role in disc:lsc. In:
Natural toxins (Eaker 0 and Wadstrom T, Eds.), pp. 673-680, Oxford, Pergamon Press,
1980.
Krogh P, Mycotoxic porcine nephropathy - a possible model for Balkan (endemic)
nephropathy. In: Proceedings o/the second lnrernotional Symposium on Emkmic
Nephropathy. Sofia (Pulchev A, Ed.), pp. 266-270, Bulgarian Academy of Sciences,
1974.
177
Krogh P, Ochralo",ins. In: Mycotoxins in Human and Animal Health (Eds. Rodricks JV.
Hesseltine CW and Mehlman MA), PI'. 489·498. PathotQx Publishers. New York, 1978.
Krogh P and Nesheim S, OchralOltin At Introduction. In: Environmental Carcinogens.
Selected Methods ofAnalysis, Vol. 5, Some Mycoroxins (Sloloff L, Castegnaro M, Scott
P, O'NcillIK, and Bansch H. Eds.), PI'. 247-259. {ARC Scientific Publications, No. 44,
Lyon, 1982.
Kuiper-Goodman T and ScOIt PM. Risk assessment of the mycotoxin ochratoxin A.
Biomcd. Envjron. Sci. 2: 119-248, 1989.
Kumagai Sand AibarJ K. Intestinal absorption and se{.Tetion of ochratoxin A in the rat.
Toxicol. IIppl. Pharmacol. 64: 94-102, 1982.
Kuncl1 KJ and Tappe! AL The effect of vitamin C on in vivo lipid peroxidation in Guinea
pigs as measured by pentane and ethane production. Lipids 18: 271·274, 1983.
Kuo C·H, Mnita K, Sleight SO nnd Hook JB. Lipid pcroxidation; A possible mechanism
ofcephnloridinc-induced nephrotoxicity. Toxieo/. Appl. Pharmacol. 67; 78-88, 1983.
Kurata H. Current scope of mycotoxin research from the viewpoint of food mycology. In:
Toxicology, biochemistry and palhology of mycotoxins (Uraguchi K and Yamazaki M,
Eds.), pp. 162, Kodansha Ltd., Tokyo, 1978.
Laethem RM, L1ethcm CL and Koop DR. Purification and properties of a cytochrome p.
450 arachidonic acid cpoxygenasc from rabbit renal cortex. J. Bioi. Chem. 267(8):5552-
5559,1992.
L,kc BO. Preparation and chnrncleri:wtion of microsomal fractions for studies on
xenobiotic metabolism. In: Biochemical Toxieology (Eds. Snell K and Mulloch B), pp.
183-215. IRL Press Ltd., Oxford. England, 1987.
LWflcnce GO and Cohen G. Ethane exhalation as an index of in..YiY2lipid peroxidalion;
Concenlr.tting elhane from a brcalh collection chamber. AMI. Biochem. 122: 283-290,
178
1982.
Lea T, Stcicn K and Stenner Fe. Mechanism of ochratoxin A-induced
immunosupprc-ssion. Mycopat}wlogia 107: 1.53-159, 1989.
Lee SC, Berry IT and Chu FS. Immunohistochemical fate of ochnlloxin I, in mice.
Toxicol. Appl. PJuJrmacol. 72: 218-227, 1984.
Levi CPt Trenk HL and Mohr HK. Study of the occurrence of ochmlOllin A ill green
coffee beans. J. Assoc. Off. Anal. Chern. 57: 866·870, 1974.
Lowry OH, Rosebrough NJ, Farr AL and Randell RJ. Protein measurclllcllIlVith the r"Olin
phenol reagent. J, 8iol. Chern. 193: 265-275, 1951.
Lubet AR. Mayer RT, Cameron JW, Nims RW, Burke MD, WolffT and GUCnllcrich Fr.
Dealkyla.tion of pentoxyresorufin: A rapid and sensitive assay for nlcasuring induction of
cytoehrome(s) P-450 by phenobarbital and olher xenobiotics in lhe ml. Arch. mochem.
Biophys. 238(1): 43-48, 1985.
Luster MI, Gcnnolec DR, Burleson GR, Jameson CWo Ackenmmn MF, L:nmn KR :lIld
Mayer lIT. Selective immunosuppression in mice of natural killerccllllclivity by
ochratoxin A. Cancer Res. 47: 2259-2263.1987.
Ma X-L, Baraona E, Lasker JM and Lieber CS. Effects of ethanol consumplion on
bioaclivation and hepatotoxicity of N·nitrosodimethylamine in rats. Biochcm. PJuJnnacol.
42: 585-591, 1991.
Marquardt R and Frohlich A. A review of recent advances in understanding
oc:hratoxicosis. l. Anim. Sci. 17: 3968-3988. 1992.
Marquardt RR. Frolich AA, Sreemannarnyana 0, AbmffiSOn 0 and Bemalsky A.
Ochratoxin A in blood from slaughter pigs in western Canada. Can.l. Vet. Re.f. 52: 1116-
190.1988.
179
Marquardt RR. Frohlich A and Abramson D. Ochr.Hoxin A::lJl importenl western
Canadian storage mycotoxin. Con.l. Physiol. PhDrmacol. 68: 991·999,1990.
May HE and McCay PD. Reduced diphosphopyridine nucleotide oxidase-calaIyzcd
altcr.uions of membr;J,ne phospholipids. 1. 8iol, Chof!. 243: 2296-2305. 1968.
Mayura K, Reddy RV. Hayes AW and Berndt WOo Embryocidal. fctotoxic and
teratogenic cffeclS of ochratoxin A in rats. Toxicol.25: 175·185. 1982.
Meisner H. Encrgy-dependcnt uptake ofochratoxin A by mitochondria. Arch. Biochem.
Oiophys. 173: 132-)40, 1976.
Meisner H and Chan S. Ochratoxin A, an inhibitor of mitochondtiallrilnSport system.
Biocllem. 13: 2795-2800, 1974.
Meisner H, Cimbala MA o.nd Hanson RW. Decrease of phosphoenolpyruvatccarboxylase
RNA and poly(A)RNA level by ochratoxin A. Arch. Blochem. Biophys. 223: 264-270.
1983.
Meisner H:md Krogh P. Phosphoenolpyruvate carboxykin:.sc as a selcctive indic:ltor of
ochrntoxin A induced nephropathy. D~. Toxieol. Environ. Sci. 14: 199·206, 1986.
Meisner H and Meisner P, Ochratoxin A, an in vivo inhibitor of~naJ phosphoenolpyruvate
carboxykinase. Arch. Biocht!m. Biophys.208: 146-153,1981.
Meisner H and Polsinelli L. Changes or renal mRNA species abundance by ochratoxin A.
Bioclrem. Pharmacol. 3S~ 661·665,1986.
Meisncr Hand Selanik P. Inhibition of renal gluconeogenesis in rats by ochratoxin.
Biochem. J.180: 681·684, 1979.
Ministry of Agriculture, Fisheries and Food. Survey of myCOtoxins in the United
Kingdom. London, MinislIy of Agricuhurc. Fisheries and Food, Food Surveillance Paper
No.4.
180
Miootti G and AUll SO. The role of iron in the inili:uion oflipid peroxidalion. Chcm.
Phys. Lipids 44: 191-208. 1987a.
Minotti G and Aust SO. The requirement of Iron (110 in the initi:lIion of lipid peroltidallon
by Iron (Il) and hydrogen peroxide. J. BwI. Chern. 262: 1098-1104, 1987b.
Mishin V. Pokrovsky A and Lyakhovich VV. Interactions of some occcptors with
superoxide anion radicals formed by the NADPH-specific f1avoprOl:cin in rot liver
microsomal fractions. Biocllem. J. 154: 307-310.1976.
Monastory K. Lakatos Band Vereczkey L. Cytochrome P-450: Structure, function,
induction and practical significance. Acta PIJarm. Hung. 62(6): 318-332,1992.
Moore m and Truelove. Ochratoxin A, inhibition of mitochondrial re.~pirnlion. Scicm:e
(Washington DC) l(i8: 1102. 1970.
Morehouse LA, TIeo M, Bucher JR and AUSI SO. Effcct of hydrogen peroxide on the
initialion of microsomal lipid peroxid:nion. Biod~m. Pharmacol. 32: 123-121, 1983.
Morehouse LA and Aus! SO. ReconstiNt,:d microsomal lipid peroxid:ltion: ADP-r-eJt-
depcndenl peroxid:ltion of phospholipid vesicles conlaining NADPH-cytochromc P·450
rcdoclase and cylochrome P-4SO. Free. Rati. BioI. Med. 4: 269-277, 1988.
Moroi K, Suzuki S, Kuga T, Yamazaki M and Kanisawa M. Rcducl)on ofochrmoxin A
loxicily in mice treated wilh phenylal:lnine and phenob:lrbiml. Toxieol. Lett. 25:1-5,
1985.
Muller A and Sics H. Assay of elhanc and pentane from isolated organs and cells. In:
Methods in Enzymology (Packer L, Ed.), Vol. 105: pp. )11.)19, Academic Press, New
York, 1984,
Murray Ardies, Lasker JM, B10swick BP and UeberCS. Purification ofNADPII-
cytochrome C reductase from hamstcr liver microsomes by detcrgent cx.tract)on and affinity
181
chromatography. Anal. Biochun. 162: 39·46, 1987.
Nakajima T. Elovaan E, Park 55, Gelboin HH, Hietanen E and Vaioia H. Monoclonal
antibody-directcd characterization of benzene, ethoxyresorufin and pentoxyresorufin
melabolismin rntlivc.rmicrosomes. Biochem.Phmmacol. 40: 1255-1261,1990.
Nakajima T, Wang R·S. E10vaara E. Park SS,Gclboin HV. Hietanen E and Vainio H.
Monoclonal antibody-directed characterization ofcytochrome P·4.50 isozymes responsible
fortolucoc: metabolism in ratlivu. Biochem. Pharmacal. 41: 395-404, 1991.
NarJhayashi H, Takcshige K and Minakami S. Alterations of inner-membrane components
and damage to electron'lTllnsfer activities of bovine heart submitochondrial particles by
NADPH-dependenllipid peroxidation. OioclJem. J. 202: 97·105, 1982.
Nebert OW. Adesnik M. Coon MI. Estabrook RW. Gonzalez FI, Guengerich FP,
Gunsa.lus IC. Johnson EF. Kemper B, Levin W, Phillips IR, Sato Rand Watennan MR.
The cylOchrome P·4SO gene superfamily: Recommended nomenclature. DNA and Cell
8iol.6: 1-11, 1987.
Ngaha EO and PtUlM\Cr DT. Toxic renal damage: 0l3nges in enzyme levels. Biochort.
Med. J8: pp. 71. 19n.
Niehaus WG and Samuelssoo B. Formation of malondialdehyde from phospholipid
amchidon:lIe during microsomal lipid peroxidation. Eur.J. Biochem. 6: 126-130, 1968.
O'Brien PJ. Intracellular mechanisms for the decomposition of a lipid peroxide. 1.
Decomposition of a lipid peroxide by roctal ions. heme compounds, and nuclcophiles.
Call. J. Biochem. 47: 485·492, 1969.
O'Brien PJ. Radical fonnalien during the peroxidase catalyzed metabolism of carcinogens
and xenobiotics: the reactivity of these radicals with GSH, DNA, and unsaturated lipid.
Free. Rail. Bioi. Med. 4: 169·183, 1988,
O'Connell MJ and Garner A. Radiation-induced generation and properties oflipid
182
hydroperoxide in liposomes. Int. J. Radiation Bioi. 44: 615·625. 1983.
Omar RF. Mechanism of ochratox.in A stimul;ued lipid peroxid:ltioll. A Mastcr'5 Illt!Sis.
Biochem. Dept., Memori~ University, St. John's, NF, Canada. 1990.
Omar RF, Hasinoff BB. Mejilla F and Rahimrula AD. Mechanism ofochratoxin A
stimulatedlipidperoxidation. BiodlLm.Phal71lQcol. 40: 1183-1191,1990.
Omura T and Salo R. The carbon mc.noxide-binding spectrum oC liver microsomcs. J.
Bioi. Chern. 239: 2379-2384, 1964.
Orrcnius S and Bellomo G. Toxicological implications of perturbation of Ca2+
homeo:tasis in hepatocytes. In: Calcium andccflfimctiorl (Cheung WY, Ed.), pp. 185
Academic Press, Orlando. Fl., 1986.
Ortiz de Montellano PR and Reich NO. Inhibition of cytochrome P-450 enzymes. In:
Cytoc!Jronti! P-450: Structure, mechanism and biochemistry (Ortiz. de Montcllano, Ell.)
Ch.8. pp. 273·314, Plenum Press. New York and London, 1986.
Ortiz de Montcllano PR and Correia MA. Suicidal destruction ofcytochrome P-450 during
oxidative drug metabolism. Ann". R~. Pharmacol. To,xicoJ.13: 481-503, 1983.
Osborne BG. 1l\e occurrence ofochratoxin A in mouldy bread and flour. Fot)(J Cn~mCl.
Toxicol.18: 615-617, 1980.
OsterT, Jayyosi Z, Creppy EE. S. EI Amri H and Batt A-M. Charnclerization of pig liver
purified cytochrome P-450 isozymcs forochraloxin A metabolism studies. Toxicol. Ult.
57: 203-214. 1991.
Palmer ON, Rabin DR and Williams OJ. A subpopulation ofl1ltliver membrane·bound
ribosomes that are detached in vitro by carcinogens and centrifugalion. Oiochcm.J. 176:
9-14,1978.
Parkinson A, Thomas PE, Ryan DE, Gorsky LD, Shively JE, Sayer JM, Jerina OM and
183
Levin W. Mechanism of inactivation of ralliver microsomal cytochrome P·45OC by 2-
Bromo-4'·nitroacetophenone. J. Biul. Chern. 261(25): 11487·11495, 1986.
Peckham Je. Doupnik Jr. B and Jones Jr. OH, Acute toxicily of ochratoxins A and B in
chicks. Apr', Microbial. 21: 492.494,1971.
Pederson Te, Buege JA and Aust SO. Microsomal electron transport. The role of
NADPH,cylochrome C reductase in liver microsomal lipid peroxidation. J, Bioi. Chern.
248:7134-7141.1973.
Pederson TC and Aust SO. NADPH-depcndenllipid peroxidation calalyzed by purified
NADPH·cytochrome c reductase from rat liver microsomes. Siocl/em. Biopllys. Res.
Commun. 48: 789-795, 1972.
Petkova·Bocharova T, Chcmozemsky IN and Castegnaro M. Ochratoxin A in human
blood in rel;uion to Balkan endemic nephropathy and urinary system tumors in Bulgaria.
Food Additive.f and Contamination S: 299-301, 1988.
Poli G, Albano E and Dianzani MV. The role of lipid peroKidation in liver damage. Chern.
Pllys. Lipids 45: 117-142, 1987.
Price RO. Urinary enzymes, nephrotoxicity, and renal disease. Toxicology 23: 99-134,
1982.
Prior MG. MycoloKin in detenninations on animal feedstuffs and tissues in Western
Cnn;tda. Can J. Compo Med. 40: 75-79, 1976.
Pryor WA and Castle L. Chemical methods for the detection of lipid hydroperoxldes. In:
Methods in Enrymology (Packer L, Ed.), Vol lOS: pp. 293·299 , Academic Press, New
York,1984.
Purchase IFH and Theron JJ, The acute loxicity of ochrntoxin A to rats. Food Cosmer.
Toxieol.6: 479-483, 1968.
184
Rahimtula AD, Bereziat J-C, Busscchini·Griol V and Bansch H. Lipid pcroltidalion llS:t
possible cause of ochratoxin A toxicity. Biochern. PIWnnflLYlf. 37: 4469-4477, 198N.
Rahimtula AD. Zachariah PK and O'Brien PJ. Differencial effects of :Ililioxidants. steroids
and other compounds on bcnzo(a)pyrene 3 hydroxylase activities in various tissues (If rat.
Br. J. Cancer 40:105-112, 1979.
Rahimtula AD and O'Brien PJ. Hydroperoxide catalyzed liver microsomal aromatic
hydroxylation reactions involving cytochrome P-4S0. Biochem. Iliophy.f. Re,(. COIII/IIII1l.
60: 440-447, 1974.
Rahimtula AD and O'Brien Pl. Hydroperoxide dependent O·dcalkyl:nion relIction:;
catalyzed by liver microsomal cytochrome P·450. Biochcln. Biophy.t. Re,l', COlI/tIIllII. 62;
268-275, 1975.
Recknagcl RO, Glende EA, Waller RL and Lowrey K. Lipid pcroxid:nion: Biochcmistry,
measurement, and significance in liver cell injury. In: ToxicologyofthcUvcr(pl:m G Imtl
Hewitt W R, Eels.), pp. 213-241, Raven Press, New York, 1982.
Recknagel RO and Glende EA, Jr. Spectrophotometric detection of lipid conjugll1cd
dienes. Methods /n enzymology, Vol. 105: 331·337 (Packer L, Ed.), Academic Prc.~s,
New York, 1984.
Rex·DK and Kumar S. Recognizing acetaminophen hepatotoxicity in chronic Illcoholics.
Postgrad. Med. 91: 241·245,1992.
Roschenthaler R, Crcppy EE and Dirheimer G. Ochratoxin A: On the mode of llCtiol1 of an
ubiquitous mycotoxin. J. Toxieo/. 3: 53-86, 1984.
Ryan DE, Ramanathan L, lida S. Thomas PE, Haniu M, Shively lE, Lieber CS and Levin
W, Characterization of a major fonn of rat hepatic microsomal cytochrome P-450 induced
by isoniazid. J. BioI. Chern. 260: 6385·6393, 1985.
Sandy MS, Moldeus P, Ross D and Smith M. Role of redox cycling and lipid JlCroxidalion
185
in bipyrid)'1 herbicide cytotoxicity. Studies with a compromised isc laled hepatocyte model
system. Biochem. Pharmacol. 35: 3095-3101,1986.
Scou PM. Van Walbeck W, Kennedy B Md Anyeti D. Mycotoxins (ochratoxin A, citrinin
and stJegmatocyslin) and toxigenic fungi in grains and Olheragricullural prcxllJCtS. J.
Agrie. FoodCh~m. 20: 1103-1109. 1972.
Shotwell 01.. Goulden ML. Hesseltine CWo Survey of US wheal for ochr,lloxin and
afl:lIox:n. J. Assuc. Of/. Anal. CMm. 59: 122.124, 1976.
Shreeve OJ, Patterson OSP and Roberts BA. The cany-ovcrof aflatoxin, ochratoxin and
l.caralenone from naturally contaminated feed 10 tissues, urine and milk of dairy cows.
Food Cosmet. Tnxicol. 17: 151-152, 1979.
Sics Ii (Ed.). Oxidative Slress. Academic: Press, London. 1985.
Silverblalt F, Turck M nnd Bulger R. Nephrotoxicity due to cephaloridine: A light· and
electron-microscopic study in I1lbbits. J. In/tel. Dis. 122:33-44, 1970.
SlllterTF (Ed.). Free Radical Mechani.rms in Tissue Injury, Pion Pre$5 Ltd.• London,
1972.
Slllter TF. Aetiv:nion of carbon leb"achloride: Cbemical principles and biological
signincilIlcc. In: Free Radicals, Upid PeroxidaJion and eanar (McBrien D CHand Slater
TF. Ed.s.), pp. 243·274, Academic Press. London, 1982.
Smith JE and Moss MO (Eds.). Structure Ilnd ronnlltion or mycotoxins. In: Mycoroxins:
/ormOlion, analysis and significance, pp. 31-49. 1985.
SL·iol p. Ripich G, Holohan P and Ross C. Mech:tnism or ochratoxin A transpon in
kidney. J. Pharmacol. Exp. Thcr.246: 460·465, 1988.
Soucek P and Gut I. Cytochromes P-450 in rats: stnK:tures, functions, propenies and
relevant hum:1n fonns. Xellobio/ica 22: 83-103. 1992.
186
Spaethe SM and JaUow OJ. Effect of cobalt protoporphyrin on hepmic drug metabolizing
enzymes. Biochem. Pharmacol. 38: 2027·2038. 1989.
Steyn PS and Holzapfel Cwo The isolation of the methyl and ethyl esters of ochratoxin A
and B metabolites of Aspergillus ochraccus Wilh. J. S. Afr. Chen/. IIu'l. 20; 18(l·IKlJ.
1967.
Stormer Fe, Storen 0, Hansen CE, Pedersen J1, and Aasen AJ. FomlUtion of 4(R)- lind
4(S)·4-0H-ochratoxin A and 1O-0H-ochrntoxin A from ochrlltr)xin A by rabbit liver
microsomes. AppJ. Environ. Microbiol. 45: 1183-1187, 1983.
Stormer Fe, Hansen CE, Pedersen JI, Hvistendnhl G and Aasen AJ. FOnll<lliol1 of 4(R)-
and 4(S)4·0H-ochratoxin A from ochratoxin A by liver microsomcs from YllriollS species.
Appl. Env;rOl1. Microbiol. 42: 1051· 1056, \981.
Stormer Fe and Pedersen JI. Formation of 4-0H-ochrntoxin 1\ from ochraloxin 1\ by mt
liver microsomes. Appl. Environ. Microbinl. 39: 971-975, 1980.
Subramanian S, Kanl!::-samy A, Balasubrnmanian N, Sekar N and Govindasamy S.
Ochratoxin A toxicity on carbohydrate metubolism in rals. Bull. Environ. C(JIltam. Toxit'ol.
43: 180.IS4, 1989.
Suzuki S, Satoh T and Yamazaki M. Effect of ochratoxin A on carbohydmtc mctaoolism in
rat liver. Toxicol. Appl. Pharmacol. 32: t 16-122,1975.
Svingen BA, O'Neal FO and Aust SO. The role of superoxide and singlct oxygcn in lipid
peroxidation. Photochem. PholObiol. 28: pp. 803,1978.
Szczech GM, Carlton WW and Caldwcll R. Ochratoxin A toxicosis in swillc. VCI./Jathol.
10; 347-364, 1973.
Testa B and Jenner P. Inhibitors of cytochrome P-450s and their mechanism of action.
Drug Met. Rev. 12: 1-1l7,19B!.
187
Ticn M, Svingen SA and Aust SD. Initiation of lipid peroxidlltion by perferryl complexes.
In: OXYRen and Oxy-radicals in Chemistry and Biology (Rodgers MAl and Powell EL,
Eds.), pp. 147-152. Academic Press, New York, 1981.
Tomasi A, Billing 5, Gamer A, Slater TF and Albano E. The metabolism of halothane by
hepatocytes; A comparison between free radical spin trapping and lipid peroxidation in
relation (0 cell damage. Chem. Bioi. fnteraci. 46: 353-368, 1983.
Tsubouchi H, Yamamoto K, Hisada K, Sakabc Y and Udagawa S. Effect of roasting on
ochnlloxin A level in green coffee beans inoculated with Aspergillus ochraceus.
Mycopathologia97: Ill-liS, 1987.
Tune OM and Fravert D. Mechanisms of cephaloridine nephrotoxicity, A comparison of
cephaloridine and cephaloglycin. Kidl/cy 1m. 18: 591-600. 1980.
Vcno Y. TIle toxicology of mycotoxins. eRC Crit. Rev. Toxicol. 14: 99-132, 1985a.
Ucno Y. Biotrnnsfonnation of mycotoxins in the reconstituted cytochrome P-450 system.
Proc. Ipn. As.fOe. Myeotoxicol. 22: 28-30,1985.
Ursini F, Maiorino M, Hochstein P and EmsterL. Microsomal lipid peroxidation:
Mechanisms of initiation. The role of iron chelators. Free Rod. Bioi. Med. 6: 31·36,
1989.
Vander Merwe KJ, Steyn PS a.nd Foune L The constitution of ochratoxin A, Band C
metabolites of Aspergillus ochmceus Wilh. I. Chem. Soc. 7083·7088, 1965b.
Van der Merwe KJ, St('.yn PS, Fount L, Dc Scali B and Theron 11. Ochratoxin A, a toxic
metabolite produced by Aspergillus ochrnceus Wilh. Nature (Lond) 205: 112-113, 1965a.
Vcsela D, Vesely D, Jelinek R, and Kusak, V. Detection of ochratoxbl. A in feed barley.
Vel. Med. 23: 431-436, 1975.
Vladimiro" VA, Olene" VI, Suslova TB and Cheremisina ZP. Lipid peroxidation in
188
mitochondrial membrane. In: Advances i/lUrid Research (PaolcUi Rand Kritchcvsky D,
Eds.), Vol. 7, pp. 173·249, Academic Press, New York, 1980.
Wehner Fe. Thiel PO, van Rensburg 5J aM Demasius IPC, Mutagenicity to Salmonella
typhimurjum of some Aspergillw and Pcnicj{fium mycoloxins. Mwat. Re.f. 58: 193-203,
1978.
Wei YH, Lu C-Y, Lin T·N and Wei RD. Effect of ochratoxin A on rallivcr mitochondrial
respiration and oxidative phosphorylation. Toxieol. 36: 119·130. 1985.
Wendel A and Feuerstein S. Drug induced lipid pcroxidaliol1 in mice -1: Modulation of
monooxygenase activity, glutathione and selenium status. Biochem. PhamlfJcnl. 30; 2513-
2520, 1981.
Werner M, Maruho D and Aloba M. Use of gel fillrntion in the USllllY of urinary enzymes.
J. Chra-Ilatograplly 40: 254.263, 1969.
Wiebel Fl, LeutzJC, Diamond Land Gelboin HV. Aryl hydrocarbon (llen7.0[u!flyrclH:)
hydroxylase in microsomes from raltissues: Differential inhibition and stimulation by
benzonavone and organic solvenls. Arch. Biochem. Biophys. 144: 78-86,1971.
Wills ED and Wilkinson AE. Release of enzymes fron1lysosomes by irrndiation and thc
relation of lipid peroxide fonnation to enzymic release. Bioe/tem.1. 99: 657·()66, 19M.
Wislocki PO. Miwa GT and Lu AYH. Rcactions catalyzed by the cytochrome 1'·450
system. In: EnzYrnJJtic basis ojdetoxijicalion (Jakoby WB. Ed.) Vol. I, pp. 135-IR2.
Academic Press, New York, 1980.
WoolfL. The heterozygol advantage in phenylketonuria. Am. J. Human Genetics 3H:
773·775, 1986.
World Health Organization. Environmental Health Criteria 105: Selected mycoloxins:
Ochratoxins. lrichothecenes, ergot. WHO, Geneva, t 990.
189
Yamazaki H. Inui Y. Yun CH. Guengerich FP, Shimada T. Cytochrome P-4502El and
2A6 enzymes as major catalysts for metabolic activationof N·nitrosodialkylamines and
tobacco-related nitrosamillCs in human livermicrosomes. CarcilUJgenesis 13(10); 1789-
1794,1992.




